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1. Introduction 
 
Over the past few years phytosterols (plant sterols) have become a focus of interest in 
science as well as in public due to their serum cholesterol lowering effect. According to 
literature a daily phytosterol uptake of 1.5-3 g can lower serum LDL cholesterol levels 
by 10-15 % (Katan et al., 2003), thus a protection against cardiovascular disease is 
assumed (Hendriks et al., 1999). Consequently, an increasing number of products 
fortified with plant sterols has been introduced to the international market during the 
last decade. However, besides their positive aspects concerns in terms of health are 
emerging. 
Due to their unsaturated ring structure, oxidation is the reaction of main concern. 
Similar to the structurally related cholesterol, phytosterols are susceptible to oxidation 
when exposed to heat, air, light or radiation (Dutta and Savage, 2002). Intense research 
has been performed on possible health implications induced by cholesterol oxidation 
products (COPs). Their mutagenic, carcinogenic, angiotoxic, cytotoxic and atherogenic 
properties can be considered as generally acknowledged (Guardiola et al., 1996; Osada, 
2002). 
In contrast, at present only limited information is available on the biological effects of 
phytosterol oxidation products (POPs) (Hovenkamp et al., 2008). However, in first 
studies on cytotoxicity similar patterns for phytosterol and cholesterol oxides were 
observed, although in general higher concentrations of POPs were needed for the same 
effect (Roussi et al., 2005; Roussi et al., 2007; Ryan et al., 2005). 
Due to the fact that standards of phytosterol oxidation products are not commercially 
available so far, in many investigations blends rather than individual oxides were used. 
Although based on former publications (Maguire et al., 2003; O'Sullivan A et al., 2005) 
it might be assumed that mixtures of sterol oxides and single compounds act in a 
different way. 
Since POPs have been detected in human plasma (Grandgirard et al., 2004b), more 
investigations to better understand their biological significance are necessary. 
Therefore the overall aims of the present thesis were: 
1. To scale up a method for the isolation of single phytosterol oxidation products, 
as for the subsequent toxicity assessment gram scale amounts of toxicologically 
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relevant oxides were needed. This part of the work was carried out in co-operation 
with the Department of Applied Chemistry and Microbiology, University of 
Helsinki under the supervision of Prof. Dr. Vieno Piironen.  
2. To investigate the biochemical potential of various isolated phytosterol 
oxidation products derived from β-sitosterol, namely 7-ketositosterol, 7- β -OH-
sitosterol, 7- α -OH-sitosterol, a mixture of 6-β-OH-3-keto-sitosterol/6-α-OH-3-
keto-sitosterol (ratio 4:3)  and a mixture of polar β-sitosterol oxidation products. 
Therefore the following in vitro tests were conducted: 
• Salmonella microsome assay (mutagenic/oxidative properties were analyzed 
using Salmonella thyphimurium strains TA98, TA100 and TA102 in different 
setups) 
• Cell culture assays using HepG2-cells 
o Viability assays (Trypan blue exclusion assay, MTT- assay) 
o Flow cytometric measurements (apoptosis versus necrosis, superoxide anion 
production (O2•-)) 
o Measurement of lipid oxidation (MDA) 
o Comet assay (detection of DNA-strand breaks) 
o Quantification of the phytosterol oxide uptake in HepG2-cells, which was 
done at the Department of Applied Chemistry and Microbiology, University of 
Helsinki as well. 
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2. Review of Literature 
2.1 Phytosterols 
2.1.1 Chemical structure 
Phytosterols (plant sterols) as secondary plant metabolites are structural and biological 
counterparts of cholesterol, the main sterol in mammalian cells. Plant sterols are 
responsible for permeability and fluidity of cell membranes. Further they act as 
precursors of brassinosteroids, thus regulating storage and transport processes, and of 
numerous other metabolites such as glycoalkaloids and saponins (Piironen et al., 2000). 
 
To date over 250 different phytosterols and related compounds have been identified in 
plant and marine materials (Salo et al., 2003). The main important plant sterols are β-
sitosterol (24α-ethylcholest-5en-3β-ol), campesterol (24α-methyl-5-cholesten-3β-ol) 
and stigmasterol (5,22-cholestadien-24 α –ethyl-3β-ol), which represent about 45-95 %, 
30 % and 25 % of total sterols present in plants, respectively (Lutjohann, 2004). 
 
In general sterols are derived from squalen and consist of a tetracyclic 
cyclopenta[α]phenanthrene structure with a hydroxyl group at C-3 and a flexible side 
chain with 8-10 carbons at C-17 (Piironen et al., 2000). Plant sterols and cholesterol are 
structurally nearly similar, differing mainly in their side chain by an additional methyl 
or ethyl group at C-24 (figure 2.1). 
On structural and biosynthetic basis plant sterols can be divided into 4-desmethyl 
sterols, 4α-monomethyl sterols and 4,4-dimethyl sterols according to the number of 
methyl groups at C-4. 4α-monomethyl sterols and 4,4-dimethyl sterols are both 
precursors of the 4-desmethyl sterols and only found in trace amounts in plants. 4-
desmethyl sterols, with no methyl group at C-4, represent the major group of 
phytosterols. Depending on the position and number of double bonds in the B ring they 
can further be classified as Δ5-, Δ7- or Δ5,22-sterols, the former being the most 
common one (Moreau et al., 2002). 
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Phytostanols are saturated analogies of 4-desmethyl sterols with no double bond in their 
structure and occur in certain cereals (corn, wheat, rye, and rice), fruits and vegetables 
(figure 2.1). Concentrations are far lower than that of unsaturated plant sterols. 
 
In plants, sterols occur not only as free alcohols, but also as conjugated forms as steryl 
fatty acid esters, hydroxycinnamate steryl esters, steryl glycosides and esterified steryl 
glycosides (Moreau et al., 2002).  
 
Fig 2.1 Structures of main sterols. Numbering is according to the International Union of 
Pure and Applied Chemistry and International Union of Biochemistry (IUPAC-IUB) 
recommendations (Moss, 1989). 
 
 
2.1.2 Dietary sources of plant sterols 
Phytosterols are not synthesized by animals or humans. In a natural form they only 
occur in plants. Cereals, margarine, vegetables and vegetable oils contribute as main 
sources in the human diet (Piironen et al., 2004). Total levels of phytosterols in 
vegetable oils range between 1-5 g/kg, with corn oil, rice bran oil and sesame oil being 
the richest source. Through the refining process plant sterol amounts get reduced. 
Depending on the applied conditions losses of 10-70 % were observed (Piironen et al., 
2000).  
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For cereals total levels of 350-1200 mg/kg fresh weight were found, with rye (955 
mg/kg) and barley (761 mg/kg) being the richest sources (Piironen et al., 2004). 
Although levels are lower than those of vegetable oils cereals are the main contributors 
of plant sterol intakes as in general higher amounts of cereals than oils are consumed 
(Piironen et al., 2000). 
Also vegetables, fruits and berries are essential sources, accounting for 20-25 % of plant 
sterol consumption (Valsta et al., 2004). Among vegetables broccoli, Brussels sprout, 
cauliflower, green and black olives represent the richest sources with amounts over 300 
mg/kg fresh weight. Plant sterol levels in fruits were found to be between 116–228 
mg/kg. In berries contents ranging from 60–279 mg/kg were detected, whereas 
remarkable higher concentrations were measured in wild than in cultivated berries 
(Piironen et al., 2003). 
 
2.1.3 Estimated daily intakes 
The average daily intake of plant sterols from natural sources is estimated to range 
between 150-450 mg (Ostlund, 2002; Ellegard et al., 2000), depending on the respective 
country and the type of diet. For vegetarians intake levels of 1 g/day and more have 
been found (Piironen et al., 2000). Recent studies have shown intakes of 305 mg/d for 
men and 237 mg/d for women in Finland and 307.3 mg/d for men and 262.9 mg/d for 
women in the Netherlands (Valsta et al., 2004; Normen et al., 2001). Density of plant 
sterols in the diet (mg/1000kJ) was higher for women (34.9) than men (32.3) (Valsta et 
al., 2004). When analysing the amount of plant sterols in different US diets, a rise in 
phytosterol intake levels with increasing consumption of polyunsaturated fat has been 
observed, whereas the intake of saturated fat was inversely related to plant sterol 
contents in the diet (Phillips et al., 1999). In general plant sterol intakes are steadily 
increasing, reflecting the change from animal fat to vegetable oils, but also the 
increasing number of phytosterol enriched products on the market (Morton et al., 1995; 
Valsta et al., 2004).  
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2.1.4 Phytosterol metabolism 
While cholesterol absorption in humans varies from 30-60 % (Bosner et al., 1999), 
absorption of plant sterols is rather low. Observed levels for campesterol (9.4-14.8 %) 
are approximately 3 times higher than for sitosterol (3.1-4.5 %) and stigmasterol (~4 
%). Absorption of campestanol and sitostanol was shown to be even lower (0.1-2 %) 
(Miettinen et al., 2000; Piironen et al., 2000; Sanders et al., 2000). 
Differences in the absorption efficiency of sterols depend strongly on their molecular 
structure. The presence of a double bond between C5 and C6 has been shown to 
increase the absorption rate, whereas it decreased by increasing length of the side chain 
(Ostlund et al., 2002).  
Absorption of plant sterols occurs under the same conditions as that of cholesterol and 
other lipids (figure 2.2). They have to be emulsified and incorporated into mixed 
micelles to be absorbed from the lumen. For a long period a passive transfer into the 
enterocyte has been assumed. Recent studies suggest an involvement of a specific 
protein the Niemann-Pick C1-like protein (NPC1L1) in the brush border membrane in 
the uptake of sterols by the enterocyte (Jessup et al., 2008).  
The rather poor absorption of plant sterols compared to cholesterol could be due to the 
low affinity of acyl- CoA cholesterol acyltransferase (ACAT) for plant sterols (De Jong 
et al., 2004). After being taken up by the enterocytes both cholesterol and phytosterols 
have to be esterfied for transportation in chylomicrones by ACAT. Esterfication rate of 
plant sterols is however 60 times lower than that of cholesterol. Hence, only a small part 
of the absorbed phytosterols is esterfied in enterocytes and incorporated into 
chylomicrons. Therefore the absorption of phytosterols is mostly prevented. Adenosine 
triphosphate (ATP) – binding cassette (ABC) - half transporters ABCG5 and ABCG8 
are suggested to be responsible for the transportation of unesterfied sterols back in the 
intestinal lumen. Mutations in these two transporters lead to sitosterolemia, a plant 
sterol storage disease, which is characterised by increased serum levels of plant sterols 
(7-16% of total cholesterol concentration in plasma) and causes mainly premature 
atherosclerosis, coronary heart disease, tendon and tuberous xanthomas (Salen et al., 
1992). Yet the full mechanism is not completely understood. 
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Fig 2.2 Absorption of cholesterol (C) and phytosterols (PS) in the intestine (adopted 
from Chen et al. (2008)). 
 
Those parts of plant sterols taken up by the liver are incorporated into very low density 
lipoproteins (VLDL) or secreted via the biliary route (Plat and Mensink, 2005). Plant 
sterols have been shown to be stored in the cytoplasma or incorporated into the cell 
membrane. Labelled phytosterols were located in adrenal glands, ovary and testis of 
animals, which suggests similar metabolic pathways to cholesterol (Trautwein et al., 
2003). 
To date it is assumed that plant sterols are not metabolized into normal C24-bile acids 
but excreted as polar compounds, presumably di- and trihydroxylated C21-derivates 
(Boberg et al., 1990). Biliary excretion of phytosterols appears to be faster than that of 
cholesterol. This, together with the lower absorption rate, leads to serum levels (0.3-1.7 
mg/dl) far lower than that of cholesterol (140-320 mg/dl) (Piironen et al., 2000).  
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Cholesterol Plant sterols Plant stanols
Dietary intake 300-500 mg/d 150-450 mg/d 10-60 mg/d
meat, egg yolk, vegetable oils, cereals,
dairy products fruits, vegetables, berries
Endogenous
synthesis
Absorption 30-60 % 5-15 % 0.1-2 %
Plasma
concentration
Excretion 40-60 % 85-95 % >98 %
140-320 mg/dL 0.3-1.7 mg/dL 0.01 mg/dL
Dietary scources wheat, rye, corn
800-1200 mg/d not synthesized not synthesized
 
Tab 2.1 Summary of sterol metabolism (modified according to Salo et al. (2003)). 
 
2.1.5 Cholesterol lowering action of plant sterols 
2.1.5.1 Historical perspective 
As early as in 1951 Peterson (1951) for the first time observed the cholesterol lowering 
property of plant sterols when feeding soysterols to chicken on a high cholesterol diet. 
Shortly after, this effect has also been shown in humans after administration of 5-10 g 
sitosterol a day (Pollak, 1953). These findings were followed by a broad range of 
investigations. Knowledge on the poor absorption of plant sterols in their crystalline 
form led to the use of rather high doses (up to 20-30 g/d). 
In the late 1970s first studies with plant stanols were conducted and their better 
efficiency compared to sterols in reducing cholesterol levels was suggested (Sugano et 
al., 1976; Heinemann et al., 1986). Already small doses (1.5 g/day) resulted in a 
measurable decrease in cholesterol levels (Piironen et al., 2000). However, inconsistent 
data focused the research on the importance of their physical state (Katan et al., 2003). 
Finally esterfication of first plant stanols and later also sterols with fatty acids of 
vegetable oils was developed. Hereby their solubility was improved. Hence their 
application in a wide variety of food was facilitated and through their better dispersion 
in the intestine their efficiency in cholesterol reduction was enhanced as well (Katan et 
al., 2003). Soon, in the year 1995, the first plant stanol ester enriched commercial 
Literature                                                                                                                       9   
 
application, Benecol® (Raisio Plc., Raisio, Finland) margarine was launched in Finland 
(Moreau, 2004). In 1999 Unilever’s Take Control® (also marketed under the brands 
Becel, Rama or Flora Pro activeTM), a phytosterol enriched margarine, was introduced 
to the US-market. Because of their simpler and less expensive production, Unilever had 
a distinctive marketing advantage especially since the effectiveness of both sterol and 
stanol esters was gradually accepted as equipollent (Moreau et al., 2002). 
To date two main sources for phytosterols exist: tall oil, a by-product of the pulp 
industry and deodorizer distillate of vegetable oils. Although phytosterols could in fact 
be isolated of most vegetable oils (for example corn, rape, peanut, corn fibre and rice 
bran oil) soybean oil is the most commonly used source. Composition of the obtained 
phytosterols differs between tall oil and soy oil. Whereas the former contains mainly 
sitosterol (92 %, 8 % campesterol) in the latter the ratio of sitosterol and campesterol is 
68:32 (w/w). However, it seems that statistically there is no difference in cholesterol-
lowering efficiency (Salo et al., 2003). For the production of stanols as an additional 
step catalytic hydrogenation for saturation of the ring structure is necessary. 
 
In recent years further strategies for the incorporation of plant sterols and stanols in food 
matrixes have been developed. In 2001 Christiansen et al. (2001b) investigated the 
effect of microcrystalline free phytosterols and found reduced total- and LDL - 
cholesterol levels after administration of only 1.5 g/day. This process is being 
commercialized under the name Diminicol® by the Finnish company Teriaka (Helsinki, 
Finland).  
Emulsification of phytosterols and stanols with lecithin or diacylglycerol reduces the 
required amount of sterols and enhances their solubility. Both methods seem to be 
promising approaches to a simpler and more effective cholesterol lowering effect (Salo 
et al., 2003; Ostlund et al., 1999). After having been marketed in Japan for several years 
a diacylglycerol rich oil fortified with phytosterols is now also approved in the 
European Union (EU) (see table2.2). 
Further Multibene, a product that combines phytosterols with various minerals as 
calcium, magnesium, and potassium or phytosterols esterfied with conjugated linoleic 
acid (CLA) and docosahexaenoic acid (DHA) has been developed. A further 
improvement of the health effects through these combinations is expected. 
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2.1.5.2 Current spectrum of plant sterol/-stanol enriched food 
After the start in Finland and the USA plant stanols and sterols enriched food is now 
being sold in over 20 countries all over the world (Moreau, 2004). The success of the 
first fortified applications have given rise to a number of other products, meanwhile 
varying form fruit juices to ice cream and snack bars. However, in the EU growth has 
been slow-going as the regulatory system is quite complicated (for detailed information 
see table 2.2).  
While Benecol spread was already approved in Finland as Foodstuff for Particular 
Nutritional Purposes (PARNUT) before the country became a member of the EU, 
Unilever’s Take Control had to pass a long approval process, since in the EU 
phytosterol and -stanol enriched products have to be applied as novel food or novel food 
ingredient according to the EC Regulation No. 258/97. However, the complicated 
regulatory application process can be simplified if a newly launched product is 
substantially equivalent to an existing food application 
(http://ec.europa.eu/food/food/biotechnology/novelfood). 
In the USA products enriched with plant sterol esters, plant stanol esters, plant sterols, 
plant stanols and microcrystalline phytosterols received GRAS (generally recognised as 
safe) status by the Food and Drug Administration (FDA). In the year 2000 FDA has 
authorised a health claim for reducing the risk of coronary heart disease for food 
products containing plant stanol and sterol esters. Stanol ester enriched spreads, salad 
dressings, snack bars and dietary supplement as well as spreads and salad dressings 
fortified with sterol ester were included in this regulation. Total fat has to be restricted 
to 13 g per serving or 50 g in the whole product. Spreads and salad dressings, however, 
were excluded from this regulation (Moreau, 2004). 
While in Japan, Australia and New Zealand plant sterol and stanol enriched food is also 
marketed, Canada withdrew the approval of Becel Pro-Active after only a few months 
in 2001, as health risks for certain groups are possible (Moreau, 2004). 
In Austria, currently only phytosterol enriched milk products are available. Unilever 
markets 3 Becel Pro-Active products: a low fat spread containing 7.5 g plant sterols / 
100 g, a low-fat yoghurt drink containing 2 g plant sterols / 100 g and a low fat milk 
containing 0.3 g plant sterols / 100 mL. Recently also Danone launched a low fat 
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phytosterol enriched yoghurt drink (1.6 g / 100 g) using the brand Danacol, which is 
also marketed in several but not all EU-countries.  
 
In general, spreads were the first phytosterol enriched commercial product available on 
the markets and still they are the most widespread application. Nearly all studies on the 
cholesterol lowering effect have been done with spreads (Berger et al., 2004). Their 
fatty food matrix provides optimal solubility of the added compounds. Furthermore 
spreads can be easily incorporated into the daily diet.  
Currently dairy food represents the steeply rising area of sterol enriched applications. 
Similar to spreads plant sterols can be incorporated into the fat-phase and low fat 
products are in general considered as part of a healthy diet (Salo et al., 2003). Especially 
yoghurt and milk based drinks can be used as convenient single servings. 
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2.1.5.3 Factors affecting the influence of plant sterol and stanol enrichment on 
cholesterol reduction 
 
Effective dose 
Numerous studies investigating the cholesterol lowering effect of plant sterols and 
stanols in a wide variety of subjects including normo- and hypercholesterolemic adults 
and children as well as patients with familiar hypercholesterolemia, type II diabetics on 
statin therapy or type II diabetic hypercholesterolemic subjects have been conducted 
(Berger et al., 2004). Administered amounts ranged from 0.8 to 3.8 g/day (Nguyen, 
1999). 
A meta-analysis of 41 randomized trails comparing the effects of plant sterol and stanol 
ester enriched products found that an average daily intake of 2 g of plant sterols and 
stanols induces a reduction of LDL-cholesterol levels by approximately 10 % (Katan et 
al., 2003). Hallikainen et al. (2000b) compared the effects of increasing concentrations 
of plant stanol esters (0, 0.8, 1.6, 2.3, 3.2 g/d) and found a dose dependent effect. The 
reduction at 2.3 and 3.2 g/d, however, didn’t really differ from that reached by an intake 
of 1.6 g/d. 
In general a reduction of 5-15 % in total cholesterol levels and 10-20 % in LDL-
cholesterol levels is achieved by an intake of 1.5-3 g plant sterols or stanols (Normen et 
al., 2004; Nguyen, 1999). Levels below 1.5 g/day were shown to exhibit no significant 
cholesterol lowering actions (Nguyen, 1999; Hallikainen et al., 2000b). Doses higher 
than 3 g/d should be avoided as - if at all - only a small improvement has been observed 
and negative side effects of large intakes can’t be absolutely excluded (Katan et al., 
2003). The cholesterol-lowering effect was already noted after two weeks of treatment 
(Wester, 2000). A stop in phytosterol or -stanol intake, however, leads to a return to 
cholesterol baseline levels within two weeks (Jones et al., 1997). 
 
Intake frequency 
From the very beginning it has been suggested that for achieving an optimal cholesterol 
lowering effect plant sterols or stanols have to be consumed together with meals. This 
theory was based on the assumption that plant sterols/stanols have to be present in the 
lumen for interference with cholesterol uptake (Katan et al., 2003). Plat et al. (2000) 
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compared the effect of one single daily dose to 3 divided doses of stanol-ester enriched 
margarine and found similar efficiency in LDL-cholesterol reduction. This finding was 
confirmed by a second investigation (Matvienko et al., 2002). Hence, it seems that the 
number of phytosterol/-stanol doses per day is not important (Rozner and Garti, 2006) 
and that plant sterols and stanols exert a longer-lasting effect on cholesterol metabolism. 
Yet it seems that the time of intake affects the cholesterol lowering effect as this is more 
pronounced when the single dose is consumed with lunch or the principal meal than 
with or before breakfast (Doornbos et al., 2006). 
 
Plant sterols versus plant stanols 
Several intervention trials have shown that plant sterols and stanols consumption 
efficiently lower LDL cholesterol levels. Yet it was always assumed that phytostanol 
intake was the more effective option, although reliable comparison was not possible as 
conducted studies varied a lot regarding the administered dose, intervention periods and 
analysing methods (Moreau et al., 2002). With the performance of the first side-by-side 
comparisons (Weststrate and Meijer, 1998; Hallikainen et al., 2000a; Jones et al., 2000; 
Normen et al., 2000; Noakes et al., 2002) no significant difference in the plasma 
cholesterol reducing properties of both sterols and stanols was found.  
However, besides equal effectiveness of sterols and stanols in cholesterol reduction in 
the aforementioned short term studies, their effects in the quite limited number of long 
term studies (>1 year) doesn’t seem to be that certain. While consumption of a stanol 
enriched margarine led to significantly different serum cholesterol levels compared to 
the control group even after one year of treatment (Miettinen et al., 1995), spreads 
fortified with sterols showed only little long term effects (Hendriks et al., 2003). As it 
has been observed that cholesterol reduction has to last for at least one year before 
positive effects on the patient’s clinical manifestations of atheromatous arterial disease 
could be noted (Law et al., 1994), research on long term intervention studies has to be 
encouraged (Katan et al., 2003). 
 
Low-fat versus high-fat formulations 
As incorporation of plant sterols and stanols in high-fat products like margarine is 
contradictory to dietary recommendations for a healthier life style, the development of 
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low-fat and also not-fat alternatives was encouraged. In various studies (Mensink et al., 
2002; Volpe et al., 2001; Nestel et al., 2001; Korpela et al., 2006) reduction of LDL-
cholesterol (7-14 %) by low-fat applications was found to be comparable to that 
observed in investigations using high-fat spreads. Yet it has to be mentioned that the 
enriched low-fat products were consumed with meals. Already Doornbos et al. (2006) 
found cholesterol reduction by two yoghurt drinks (2.2 and 3.3 % fat) to be irrespective 
of the fat content, but a higher cholesterol lowering effect was found when the drink 
was consumed as part of a meal. 
On the other hand Jones et al. (2003) couldn’t find reductions in total and LDL-
cholesterol using low-fat and non-fat beverages enriched with unesterfied phytosterols. 
The authors concluded that solubility of the added compound is important for optimal 
efficacy. 
Similar Clifton et al. (Clifton et al., 2004) testing four types of phytosterol ester-
enriched low-fat food (bread, breakfast cereal, milk and yoghurt) found that they were 
all able to reduce cholesterol levels, low-fat milk, however, was almost three times more 
effective than bread or cereals. These findings may be due to phytosterol incorporation 
into the milk globule membrane, thus being easier available for the transport into 
micelles. 
It seems that for achieving the best possible action in cholesterol metabolism an 
accurate solubilisation in the food vehicle (independent of the fat content) is crucial. 
 
Impact of background diet 
The cholesterol lowering effect of plant sterols and stanols was found to be independent 
of the various background diets. As they reduce both bilary and dietary cholesterol 
absorption, this finding doesn’t really seem surprising (Berger et al., 2004). However, 
also lack of efficiency when combined with a low-cholesterol diet was reported (van 
Heyningen, 1999). Yet observed reduced activity may be due to solubility problems as 
sitosterol was administered in its unesterified, crystalline form. 
Since plant sterol and stanol enrichment lower cholesterol levels also in people not 
eating healthy diet, a certain risk of neglecting other recommendations for the 
prevention of CHD such as enhanced intake of dietary fiber, essential fatty acids, fruits 
and vegetables does exist. 
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2.1.5.4 Mechanism of action 
Dietary intake of plant sterols has shown to lower serum total cholesterol levels and 
LDL-cholesterol, without altering high density lipoprotein (HDL) cholesterol or 
triglycerides (Katan et al., 2003). Absorption of both dietary and endogenously 
synthesised cholesterol is decreased. Reduced absorption of cholesterol leads to 
suppressed feedback-regulation of enterohepatic cholesterol circulation, hence 
increasing the endogenous cholesterol synthesis. The net result is, however, a decreased 
serum cholesterol concentration. The exact mechanism is not yet completely 
understood, but several theories are being discussed. 
 
Co-crystallization of cholesterol and plant sterols 
Through co-crystallization of cholesterol and plant sterols in the gastrointestinal tract 
poorly absorbable mixed crystals are formed, leading to a reduced intestinal uptake of 
cholesterol.  A limited number of studies analysing this co-precipitation have confirmed 
this theory (Christiansen et al., 2001a), information on crystal formation in 
triacylglycerol oil or under in vivo conditions is, however, lacking (Trautwein et al., 
2003).  
Further for plant stanols, which proved to be as efficient as phytosterols in lowering 
cholesterol levels, no crystal formation was observed. Hence, reduced absorption may 
not solely depend on the formation of poorly soluble precipitations.  
 
Competition for incorporation into mixed micelles 
Cholesterol as virtually water insoluble compound has to be incorporated in mixed 
micelles for its transfer through the brush border membranes into the enterocyte. Also 
phytosterols require the micelle mediated transport for their absorption and as more 
hydrophobic compounds they even have a higher affinity to the micells (Ling and Jones, 
1995). Therefore it is believed that increased uptake of plant sterols leads to a reduced 
capacity to incorporate cholesterol.  
The fact that the cholesterol lowering effect showed to be the same regardless whether 
the whole dose of phytosterols was consumed at once or split into 3 doses over the day 
supports the assumption that several mechanism are involved in the 
hypocholesterolemic process. 
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Competition between cholesterol and plant sterols for esterase activity 
Before being absorbed cholesterol esters have to be hydrolysed by the pancreatic 
cholesterol-esterase. Due to their structural similarity also plant sterol esters could serve 
as substrates. This may lead to a reduction of cholesterol in its absorbable form or in 
case that the esterase activity is not sufficient enough remaining cholesterol esters could 
be transferred to more distal parts of the intestine, where absorption is not as efficient 
(Trautwein et al., 2003). 
 
Competition between cholesterol and plant sterols for cholesterol transporters 
It is assumed that uptake of sterols is facilitated by transporters as the Niemann Pick 
like 1 protein in the intestinal brush border membrane. Due to their similar structure 
plant sterols instead of cholesterol could be transported into the enterocyte, reducing the 
uptake of cholesterol. 
Plant sterols have been shown to upregulate ABCA1 gene expression, thus increasing 
the efflux of unesterified cholesterol back into the lumen. ABCA1 expression has been 
shown to be controlled by receptors like the liver X receptor (LXR) or the retinoid X 
receptor (RXR), to which plant sterols may act as ligands (Trautwein et al., 2003). 
However, further research on cholesterol transporters is necessary before the influence 
of plant sterols can be elucidated. 
 
Inhibition of the ACAT activity by plant sterols 
Once absorbed in the mucosal cell cholesterol is re-esterified by the intestinal ACAT. It 
has been shown that mainly esterified cholesterol is incorporated into chylomicrones, 
therefore the esterification step seems to be essential for cholesterol absorption (Salo et 
al., 2003). Esterification of plant sterols has been shown to occur to a lesser extent, 
causing suppressed activity of ACAT. As a possible consequence the uptake of 
cholesterol is reduced due to the higher concentration of intracellular free cholesterol. 
On the other hand in rabbits an enhanced induction of ACAT gene expression 
stimulated through the increasing concentration of free cholesterol has been observed 
(Trautwein et al., 2003). 
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Competition for the incorporation into chylomicrones  
As cholesterol and plant sterols have to be incorporated into chylomicrones to be 
transported from the enterocytes into the lymph a competition between both sterols 
might take place. It seems that the incorporation depends mainly on the esterification of 
the sterols as 70-80% of the transported cholesterol is present in its esterified form 
(Ikeda et al., 1988). As discussed above plant sterols are esterified to a far lesser extent 
than cholesterol. Therefore their ratio in chylomicrones is low. Up to now no studies 
exist suggesting that plant sterols in the cytoplasm could alter the uptake of 
cholesterolesters in chylomicrones. Also in patients with sitosterolemia plant sterol 
concentration in the lymph is lower than that of cholesterol (Salen et al., 1992). It seems 
that a decreased rate of cholesterol in chylomicrones could be only due to a lower 
absorption of cholesterol from the lumen. 
 
2.1.6 Safety  
Plant sterols and stanols have been in use as functional food components for many 
years. To date no distinct adverse health effects have been observed (Katan et al., 2003; 
Ling and Jones, 1995). Long term experience, however, is lacking. 
 
Hepburn and co-workers have performed a comprehensive safety evaluation of plant 
sterol and stanol esters. Although some earlier studies suggested their estrogenic effect, 
plant sterols were not found to bind to estrogen receptors in vitro using a recombinant 
yeast strain. In addition no indication for estrogenicity was observed by oral 
administration of up to 500 mg/kg body weight/day to immature female rats (Baker et 
al., 1999). In a two-generation reproduction study an intake of up to 8.1 % plant sterols 
esters in the diet (w/w) showed no effect on the development of pups, on reproduction 
and on sexual maturation. Also in a further 90 days feeding study on subchronic toxicity 
with rats using same plant sterol ester doses no treatment related changes were noticed. 
Therefore the highest applied dose of 8.1 % plant sterols esters in the diet (w/w) 
corresponding to 6 g/kg body weight/day was determined as no-observed-adverse-effect 
level (NOAEL). In a later study of Kim et al. (2002) an oral dose of 9 g/kg body 
weight/day of plant sterol esters led to decreased body weight gain in both sexes and 
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increased incidence of cardiomyopathy in male rats and was therefore considered as the 
absolute toxic dose. 
 
Plant sterols and their esters showed no genotoxic activity in various in vitro assays  
(bacterial mutation assay, chromosome aberration assay in human peripheral blood 
lymphocytes and mammalian cell gene mutation assay in L5178Y mouse lymphoma 
cells) and in vivo assays (rat bone marrow micronucleus assay and unscheduled DNA 
synthesis in rat liver) (Wolfreys and Hepburn, 2002). 
 
Similar results were obtained for stanol esters. No evidence for genotoxicity, estrogenic 
activity or adverse effects on reproduction were found in several toxicity studies 
(Turnbull et al., 1999b; Turnbull et al., 1999a; Whittaker et al., 1999).  Subchronic 
ingestion of stanol esters at levels up to 5 %, however, resulted in a decrease in liver 
weight, plasma levels of vitamin K1, E and D and hepatic levels of vitamin E and D in 
Wistar rats (Turnbull et al., 1999c). 
 
High amounts of phytosterol ester intake (8.6 g/day) were also investigated in humans. 
No effects on gut microflora and serum sex hormone levels in females were found 
(Ayesh et al., 1999). The significant reduction of progesterone levels in female subjects 
was considered to be of no importance (De Jong et al., 2004).  
So far only a few studies exist investigating the effects of high intake levels of 
phytosterols in humans. Usually no endpoints other than the reduction of cholesterol 
and fat soluble vitamins were included. Therefore to date detailed clinical information 
in humans on a daily consumption exceeding 8.6 g is lacking (Brufau et al., 2008).  
Based on the currently available data the European Food Safety Authority (EFSA) 
concluded that an intake of more than 3 g per day of added phytosterols should be 
avoided (EFSA, 2008).  
 
2.1.6.1 Possible negative side effects 
Several studies with animals, cell models and humans did not show any adverse effects 
of plant sterols and stanols. However, there exist some aspects that may require further 
attention. 
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2.1.6.1.1 Effect on plasma levels of fat soluble vitamins 
Besides their cholesterol lowering effect, the uptake of plant sterols and stanols also 
lead to a reduction in plasma concentrations of lipophilic hydrocarbon carotenoids. In a 
metaanalysis of 18 trails testing the impact of 1.5 g/d or more of plant sterols and 
stanols on the plasma levels of fat soluble vitamins a reduction of α-carotene by 9 %, β-
carotene by 28 % and lycopene by 7 % was found. As LDLs act as carrier molecules for 
carotenes, adjustment for their decrease after plant sterol or stanol consumption has to 
be done. After correction a statistically significant reduction in the plasma concentration 
was found for β-carotene (-12.1 %) only (Katan et al., 2003). 
 
As low levels of β-carotenoids have been associated with health risks such as 
cardiovascular disease and cancer, questions arose concerning a consequently higher 
potential risk of chronic diseases due to the lower amount of circulating lipid soluble 
antioxidants (Katan et al., 2003). 
However, observed β-carotene reduction remained within the seasonal changes noted in 
individuals (Ntanios and Duchateau, 2002).  
In 2000 the Scientific Committee on Food (SCF) concluded that no β-carotenoid 
fortification of phytosterol enriched products is necessary, but recommended the use of 
natural β-carotenoids sources to compensate the undesirable effects. For people with a 
higher requirement for vitamin A, as for example pregnant or lactating women and 
young children, β-carotene reduction should be considered with more caution (SCF, 
2000). 
2.1.6.1.2 Effects on membrane properties 
Plant sterols and stanols are easily incorporated into membranes, thus increasing 
membrane rigidity (De Jong et al., 2003). In stroke-prone spontaneously hypertensive 
rats high levels of plant sterols were shown to shorten life span, presumably due to the 
replacement of cholesterol in membranes (Ratnayake et al., 2000). Similar results were 
found for plant stanols, although different mechanisms seem to be responsible 
(Ratnayake et al., 2003). Whether these findings are relevant in humans as well has to 
be further explored. However, in patients with sitosterolemia episodes of hemolysis 
have been reported (Moghadasian, 2000). Conversely, De Jong et al. (2006) found no 
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modification of the osmotic fragility of erythrocytes after 16 weeks of phytosterol and -
stanol treatment in patients receiving statin therapy. 
 
2.1.6.1.3 Increasing serum levels of plant sterols  
Numerous intervention trails in humans have shown an increase in serum levels of plant 
sterols by 34 to 73 % after an intake of 1.5-3 g plant sterols per day, while plant stanols 
reduced both cholesterol and plant sterol serum levels but increased serum 
concentrations of stanols (Hallikainen et al., 2000a; Weststrate and Meijer, 1998; 
Fransen et al., 2007). The effects of this increase have not been elucidated yet.  
However, the rare disease sitosterolemia (less than 100 have been reported in literature 
worldwide (Lee et al., 2001)), which induces high serum levels of plant sterols mostly 
in absence of hypercholesterolemia and leads to premature atherosclerosis, suggests 
plant sterols to be an additional risk factor for coronary heart disease (Katan et al., 
2003). The fact that also patients with a positive family history for coronary heart 
disease were found to have increased serum levels of plant sterols supports this 
hypothesis (Jessup et al., 2008). Recently Weingärtner et al. (2008) found a significant 
correlation of plasma sitosterol and campesterol levels to their concentrations in tissue 
and aortic valve cusps in humans. Further an increase in plant sterol concentrations was 
also reported for people on statin medication.  
Numerous studies on a potential atherosclerotic effect of plant sterols have also been 
done in animal models. Very recently Weingärtner et al. (2008) found that an increase 
in serum plant sterol concentration worsens arterial function in normal and 
apolipoprotein-E-deficient mice. Yet animal studies demonstrating a reduction of 
atherosclerotic plaque formation have been published as well (Brufau et al., 2008). 
However, due to differences in the sterol metabolism of rodents and humans, these 
animal species may not present optimal models for the evaluation of possible negative 
effects of increased serum phytosterol levels (Jessup et al., 2008). 
Thus, the role of plant sterols in the progress of atherosclerosis is not known. More 
treatment studies including cardiovascular end points are necessary, especially since a 
combined intake of statins and enriched food products is suggested to improve 
cholesterol reduction.  
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2.1.7 Impact of increasing levels of plant sterols and stanols in nutrition, 
long term efficiency  
After the introduction of their first phytosterol ester enriched product, Unilever started a 
post –launch monitoring programme, in order to elucidate among others if the product is 
used as recommended. There the authors concluded that the intake levels were even less 
than expected (Lea and Hepburn, 2006). However, although evidence existed that 
besides the phytosterol ester enriched margarine also stanol spreads and other enriched 
food were consumed only intake data of the Unilever product were included in the 
calculation.  
 
As the spectrum of plant sterol and stanol enriched food is further increasing, concern 
about the extent of their eventual intake is emerging. The recommended daily dose of 
1.5-3 g alone leads to a consumption of 8-12 times the amount obtained of natural 
sources (SCF, 2000). Two investigations of De Jong et al. (2004) and Raulio et al. 
(2001) estimated the extent of plant sterols and stanols intake in case more than one 
enriched product is consumed simultaneously. Both found similar results: replacement 
of 3-4 conventional products by their sterol enriched forms easily led to intake levels of 
more than 4 g/day in men and women. For men intakes of up to 9 g/d were noted as 
well. 
 
Further, although plant sterols and stanols seem equally effective in reducing 
cholesterol levels in short-term studies, only plant stanols have been shown to maintain 
their efficiency over longer periods (O'Neill et al., 2005).  
After a five year consumption of a phytosterol and -stanol enriched margarine total 
cholesterol levels had not significantly changed from baseline values (Wolfs et al., 
2006). Intake of plant stanol fortified margarine for one year yielded to an average 
reduction of 14.4 % in LDL-cholesterol (Miettinen et al., 1995), whereas Hendriks et al. 
(2003) only found a slight reduction of 6 % in LDL levels after one year of sterol ester 
spread consumption. In women, however, long-term treatment with plant sterols was 
reported to be ineffective (Miettinen and Gylling, 2004).  
As shown in a meta-analysis of Law et al. (1994) long term reduction (up to one year or 
longer) of cholesterol levels (10 %) is necessary in order to reduce the risk of ischaemic 
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heart disease. Based on the limited available data plant stanols seem to be the better 
option, as in addition to maintaining their cholesterol lowering ability they also reduce 
plant sterol levels. However, more long term investigations and head to head 
comparisons of plant sterols and stanols are of importance. 
Further one should bear in mind that the link between lower cholesterol levels and a 
reduction in clinical manifestations of heart disease is based on the assumption that 
persons with a lower cholesterol level are in general people with a healthier life style. 
The use of plant sterol or stanol enriched food will neither change fat or energy content 
of the diet nor increase vegetable, fruit, fibre intake and daily exercise levels. Additional 
targeted education at least on the fortified products would be necessary (Thurnham, 
1999). 
 
2.1.8 Formation of phytosterol oxidation products 
The increasing availability of products fortified with phytosterols rose questions 
concerning their stability and reactivity. Hereby their susceptibility towards oxidation is 
of main concern (Piironen et al., 2000). This is attributed to the presence of an 
unsaturated bond between C-5 and C-6 in the ring structure.  
 
The most common oxygen species involved in the oxidation of sterols is triplet oxygen 
(3O2), which is in general rather unreactive due to its small electrostatic energy (Frankel, 
1998). However, during processing and storage conditions sterol oxidation may be 
initiated by activating factors such as heat, light, air, metal ions and photosensitizers. 
 
Extensive research has been done on the oxidation mechanism of cholesterol. Useful 
information therefore was gained from earlier investigations conducted on fatty acid 
oxidation. Although studies on the oxidation mechanism of plant sterols are scarce, due 
to their structural similarity, it is assumed that oxidation of other Δ5-sterols than 
cholesterol follows the same reaction pathways (Piironen et al., 2000; Lercker and 
Rodriguez-Estrada, 2002).  
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Basically, sterols can be oxidized via the enzymatic and the non enzymatic pathway 
(Dutta, 2004), whereas the nonenzymatic pathway can further be divided into the free 
radical mechanism (i.e. autoxidation) and the nonradical mechanism (i.e. photo-
oxidation) (Lercker and Rodriguez-Estrada, 2002). This chapter will mainly focus on 
the autoxidation pathway, as the most common oxidation mechanism for sterols. 
Within the oxidation products two groups can be distinguished based on the polarity of 
the generated products (Dutta and Savage, 2002). The present work was done with 
oxidation products more polar than unoxidized sterols, therefore called polar oxidation 
products. The systematic and trivial names of the main polar secondary oxidation 
products of β-sitosterol are listed in table 2.3. Non-polar oxides, compounds less polar 
than unoxidized sterols, result from dehydration or dehydrogenation reactions occurring 
at high heating conditions. 
Abbreviation Trivial name Systematic name
sitosterol sitosterol (24R)-ethylcholest-5-en-3β-ol 
6α-OH-3-ketositosterol 6α-hydroxy-3-ketositosterol (24R)-ethylcholest-4-en-3-one-6α-ol 
6β-OH-3-ketositosterol 6β-hydroxy-3-ketositosterol (24R)-ethylcholest-4-en-3-one-6β-ol 
5α,6α-epoxysitosterol sitosterol-5α,6α-epoxide (24R)-5α,6α-epoxy-24-ethylcholestan-3β-ol 
5β,6β-epoxysitosterol sitosterol-5β,6β-epoxide (24R)-5β,6β-epoxy-24-ethylcholestan-3β-ol 
7-ketositosterol 7-ketositosterol (24R)-ethylcholest-5-en-3β-ol-7-one 
6β-OH-sitosterol 6β-hydroxysitosterol (24R)-ethylcholest-5-en-3β,6β-diol 
 7α-OH-sitosterol 7α-hydroxysitosterol (24R)-ethylcholest-5-en-3β,7α-diol 
7β-OH-sitosterol 7β-hydroxysitosterol (24R)-ethylcholest-5-en-3β,7β-diol 
sitostanetriol sitostanetriol (24R)-ethylcholestan-3β, 5α,6β-triol
 
Tab 2.3 Trivial and systemaic names and commonly used abbreviations of the main 
secondary polar oxidation products of β-sitosterol. 
 
2.1.8.1 Autoxidation 
Autoxidation, a free radical chain reaction, is the most common oxidation mechanism 
for sterols. It has been reported to follow the same pathway as monounsaturated fatty 
acids. The first free radical is formed by the abstraction of an allylic hydrogen form the 
double bond between C-5 and C-6 in the ring structure. Basically both C-4 and C-7 
seem to be equally susceptible to oxidative attack, allowing the reaction of molecular 
oxygen at the position 4, 5, 6 or 7. Yet abstraction occurs predominantly at C-7, since 
C-4 is stabilized by the hydroxyl group at C-3 and the tertiary C-5 (Smith, 1981).  
The free radical formed then reacts with molecular triplet oxygen, which leads to the 
formation of 7-peroxyl radicals. These radicals are stabilized by hydrogen abstraction, 
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forming the more stable 7-hydroperoxides (7-OOH) as primary oxidation products 
(Dutta, 2004; Tai et al., 1999; Lercker and Rodriguez-Estrada, 2002). 7α-OOH and 7β-
OOH further decompose to the more stable 7-hydroxysterols (7α-OH and 7β-OH). 7-
ketosterol, the most abundant oxidation product, is formed either through dehydration of 
7-OOH or dehydrogenation of 7-OH compounds.  
 
Another major oxidation route is the formation of epoxy-compounds, 5α,6α- and 5β,6β-
sterols, by a bimolecular reaction between hydroperoxides and intact sterol molecules 
(Lercker and Rodriguez-Estrada, 2002). It has been noted that the generation of the 
5β,6β-epimer is more favoured than 5α,6α-sterol. This may be explained by the steric 
hindrance of the hydroxyl-group at C-3 (Lercker and Rodriguez-Estrada, 2002). The 
hydration of both epimers of 5,6-epoxysterol in acidic environment leads to the 
formation of the same compound,  3β, 5α, 6β-triol. 
 
Also side chain oxidation products can be formed by oxygen attack of the tertiary 
carbons in the lateral chains. Degradation of the primary formed hydroperoxides results 
in the formation of the more stable hydroxides. In heating studies with plant sterols 24-
OH- and 25-OH-sterols were detected (Johnsson and Dutta, 2003; Johnsson et al., 
2003). In the case of cholesterol also 20-OH- and 26-OH-compounds were found 
(Lercker and Rodriguez-Estrada, 2002). For cholesterol, oxidation of the side chain was 
reported to occur only in solid state or crystalline form, not in solution or dispersion. 
Further it seems to be far less pronounced than oxidation at C-7. However, research of 
plant sterol side chain oxidation products is rather limited (Dutta, 2004; Tai et al., 
1999).  
The formation pathways of some β-sitosterol oxides are summarised in figure 2.3. 
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Fig 2.3 Autoxidation pathways of some β-sitosterol oxidation products (adapted from 
Tai et al. (1999)).  
 
2.1.8.2 Photo-oxidation 
In the photo-oxidation pathway singlet oxygen (1O2) instead of triplet oxygen (3O2) 
initiates the oxidation process. Photosensitizers (e.g. chlorophyll) absorb energy as 
radiation and transfer it to triplet oxygen to form singlet oxygen (Dutta, 2004; Min and 
Boff, 2002). 
 
Information on photo-oxidation of plant sterol oxides is rather scarce. However, it was 
already shown that the oxidation behaviour of plant sterols is similar to that of 
cholesterol (Bortolomeazzi et al., 1999; Säynäjoki et al., 2003).  
 
Singlet oxygen is highly reactive and can rapidly attack the double bond in ring B of 
sterols. This leads to the generation of mainly 5α-OOH-sterol with lower quantities of 
6α-OOH- and 6β-OOH-sterols. In non polar solvents 5α-OOH-sterol can be rearranged 
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to 7α-OOH-sterol which can further epimerize to 7α-OOH-sterol. The fact that the 
oxidation products formed by photo-oxidation differ qualitatively and quantitatively 
from those generated by autoxidation facilitates the identification of the occurring 
process (Lercker and Rodriguez-Estrada, 2002; Tai et al., 1999).  
 
2.1.8.3 Oxidation behaviour of sterols 
In general, sterols are rather stable molecules when heated in pure state. Osada et al. 
(1993) investigated the stability of cholesterol during heating and nearly no oxidation 
products could be detected after 24 hours at a temperature of 100 °C. This behaviour 
changed at heating conditions of 120 °C and above. When cholesterol was heated at 200 
°C total degradation was observed already after 6 hours of heating. 
Research on the oxidation behaviour of plant sterols has not been as extensive as that of 
cholesterol. However, the results obtained from the limited studies conducted on 
phytosterols support the assumption that observed reaction mechanisms could be valid 
for both cholesterol and plant sterols.  
Recently Zhang et al. (2005b) found similar results as Osada et al. (1993) for β-
sitosterol. After 30 min of heating at 100 °C no oxidation products could be found, 
whereas at temperatures of 150 and 200 °C all common secondary oxides, as 7α-
hydroxy, 7β-hydroxy, 5α,6α-epoxy, 5β,6β-epoxy, and 7-ketositosterol, were formed.  
Johnsson and Dutta (2003; 2005) also detected side chain oxidation products, 24-
hydroxy- and 25-hydroxy- compounds, triols as well as 6α-OH-3-keto- and  6β-OH-3-
ketosterol, oxides with medium polarity, after heat treatment of stigmasterol and a 
mixture of campesterol/sitosterol for 72 hours at 120 °C. Further oxidation products 
found include 6-hydroxy derivates, 6-keto derivates and 4-hydroxy-derivates 
(Grandgirard et al., 2004c). Formation of the various oxidation products were highly 
influenced by the oxidation conditions applied. Although always the same kind of 
oxidation products were formed, irrespective of the different heating temperatures, the 
amount of the single products differed (Kemmo et al., 2005).  
 
In contrast to oxidation studies carried out on pure sterols, in food numerous other 
factors such as the presence of lipids and water could affect the oxidation mechanism 
(Chien et al., 1998).  
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Lampi et al. (2002) investigated the oxidative stability of phytosterols in rapeseed oil or 
tripalmitin at various temperatures. While at heat treatments of 80 °C sterols showed to 
be rather stable, significant losses could be observed at 120 °C and above. When 
phytosterols were heated in different oils a greater variety of oxidation products was 
found at lower temperatures (100 °C and 150 °C) than after heating at 180 °C. At 
temperatures of 150 °C and 180 °C degradation of sterols occurred (Oehrl et al., 2001).  
Conflicting results were reported on the influence of the lipid matrix. On the one hand 
plant sterols seemed to be more stable in rapeseed oil than in tripalmitin when heated at 
180 °C (Lampi et al., 2002). On the other hand a greater amount of sterol losses was 
observed for sterols heated in canola and soybean oil instead of coconut and peanut oil, 
thus a higher ratio of polyunsaturated fatty acids could be linked to higher levels of 
oxidation (Oehrl et al., 2001). Recently Soupas et al. (2004a) found plant sterols to be 
more stable in unsaturated lipid matrices when heated at high temperatures, whereas at 
temperatures of 140 °C and beneath the situation seemed to be reverse.  
 
2.1.9 Content of POPs in food 
At the moment only little information is available on the content of plant sterol oxides 
in various food products. The lack of commercial standards, the great number of 
compounds with very similar structures and the fact that sterol oxides in food usually 
represent only trace components in a huge complex of interfering matrix compounds 
account for the complexity of the analysis of POPs (Guardiola et al., 2004). In contrast 
to food of animal origin containing only cholesterol oxides the number of different 
oxidation products found in plant based food is at least 3 times higher (Dutta, 2002), 
thus analysis is even more challenging. 
To date small amounts of plant sterol oxides have been detected in various food, 
including wheat flour (Nourooz-Zadeh and Appelqvist, 1992), potato chips, potato 
crisps and French fries fried in different oils as well as commercial samples (Dutta and 
Appelqvist, 1997; Dutta, 1997; Tabee et al., 2008a; Tabee et al., 2008b), a range of 
plant oils (Dutta, 1997; Bortolomeazzi et al., 2003; Zhang et al., 2005b; Johnsson and 
Dutta, 2006) plant sterol enriched and non-enriched spreads (Grandgirard et al., 2004c; 
Conchillo et al., 2005; Johnsson and Dutta, 2006), enriched milk and milk powder 
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(Soupas et al., 2006) and liquid infant food (García-Llatas et al., 2008) (for detailed 
information see table 2.4) . 
The main oxides detected were 7-OH and 7-keto derivatives, followed by 5,6-epoxy and 
triol compounds. In general detected plant sterol oxides resemble those commonly 
found in the analysis of COPs. Oxidation products of β-sitosterol dominated, but those 
of campesterol and brassicasterol were found as well. 
Total amounts of the quantified plant oxides seem to be low and not all the tested food 
may represent an important source of oxidation products. The increase in fortified 
products could, however, change this situation. Grandgirard et al. (2004c) found 68 µg 
plant sterol oxides /g enriched spread. In order to achieve the recommended daily dose 
of 1.5-3 g of plant sterols, an intake of 19-37 g of spread would be necessary, containing 
at the same time 1.3-2.6 mg of oxidation products. That is an amount quite close to the 
reported daily consumption of 2-4 mg of cholesterol oxides per day (Grandgirard, 2002; 
Dutta, 1999). 
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2.1.10 Absorption and metabolism of phytosterol oxidation products 
Information on the absorption mechanism and plasma levels of plant sterol oxidation 
products is still quite limited.  
Grandgirard et al. (1999b) investigated the lymphatic absorption of β-sitosterol and 
campesterol oxides (7-keto and 5, 6-epoxid derivates) in male Wistar rats. Absorption 
of 7-ketositosterol (1.5 %) and -campesterol (2.9 %) was quite low, although absorption 
rates of 7-ketositosterol were not significantly different from those of its parent sterol. 
For 5, 6-epoxy compounds a higher absorption rate (4.7 %) was found, whereas 5β,6β-
epoxysterols were more efficiently absorbed than 5α,6α-epoxysterols. In addition also 
stigmasteroltriol was detected in the lymph, although it hadn’t been administered to the 
animals, which indicates a possible in-vivo transformation of epoxides to triols.  
Corresponding results were found when the lymphatic absorption of 7α-OH, 7β-OH, 
5α,6α -epoxy, 5β,6β -epoxy, triols and 7-keto compounds of β-sitosterol or campesterol 
was analysed in Sprague-Dawley rats. Highest recovery was observed for 7-hydroxy 
derivates. Absorption rates of β-sitosterol oxides were lower than those of 
corresponding campesterol oxides. However, recovery of all oxidation products was 
higher than that of their parent sterols (Tomoyori et al., 2004). 
A dose dependency between the amount of oxysterols in the diet and their recovery in 
plasma, aorta, liver, kidneys and heart was found in Golden Syrian hamsters receiving a 
diet containing different levels (0.1, 0.5 or 0.25 % of the diet) of a mixture of β-
sitosterol and campesterol oxides. 7β-OH, 5β,6β -epoxy, triols and 7-keto compounds 
were found in noticeable amounts in all tissues after feeding with 0.25 % of oxidation 
products. 7α-hydroxysitosterol and 5α,6α-epoxysitosterol, however, were only detected 
in the plasma, which could be due to a better metabolism of these two oxides. The 
transformation of 5α,6α-epoxysitosterols to triols is also possible. In animals fed a diet 
containing 0.1 % of an oxidation mixture only sitostanetriol was found. Equally to 
previous studies cited above the amount of campesterol oxides recovered in the plasma 
was higher than provided in the diet, whereas amounts of β-sitosterol oxides were 
approximately the same. As already observed for non-oxidized phytosterols the length 
of the side chain could be responsible for different absorption degrees (Grandgirard et 
al., 2004a). 
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Information on in vivo metabolism of phytosterol oxides is missing. However, some 
investigations on their in vitro formation have been conducted. Conversion of β-
sitosterol to oxidized derivates (mainly 7α-OH, 7β-OH, 5,6-epoxide and triols) has been 
accomplished by the use of rat liver preparations (Aringer and Eneroth, 1973). Also the 
enzymatic oxidation of the side chain, probably induced by hydroxylases, has been 
determined. 26-OH and 29-OH products of β-sitosterol, sitostanol and campesterol were 
detected, whereas the hydroxylation of C-24 and C-25 seemed to be prevented by the 
additional ethyl or methyl group at C-24 (Hovenkamp et al., 2008). 
 
Excretion of plant sterol oxidation products does most likely proceed via the bile, 
whereas different excretion rates according to different oxides structures are assumed. 
For example, sitostanetriols were found to be slowly eliminated from the organism 
(Grandgirard et al., 2004d). Besides comparable absorption rates, 7α-OH-phytosterols 
seemed to be faster metabolized than 7β-OH-sitosterol. Their transformation in bile 
acids, similar to what was observed for 7α-OH-cholesterols, is possible (Tomoyori et 
al., 2004; Hovenkamp et al., 2008).  
 
Some studies on the plasma concentration of phytosterol oxides were conducted with 
humans. Grandgirard et al. (1999a) detected 7-ketositosterol, 5β,6β –epoxysitosterol and 
sitostanetriol in human plasma samples with a total concentration of 0.3 µg/mL.  
High amounts of phytosterol oxides were found in plasma of a patient with 
phytosterolaemia. Approximately 1.4 % of the amount of β-sitosterol in plasma was 
found in its oxidized form (7-keto, 7β-OH, 5α,6α –epoxid and 5β,6β –epoxid). In the 
same study no oxidized plant sterols were detected in a pooled plasma sample of 
healthy volunteers, presumably due to the relatively high detection limit of the method 
applied (Plat et al., 2001). 
On the contrary, oxyphytosterols in the range from 4.8 to 57.2 ng/mL were quantified in 
the plasma of 13 healthy volunteers (Grandgirard et al., 2004b). Oxides of β-sitosterol 
(7-keto, 5α,6α –epoxid, 5β,6β –epoxid and triol) dominated. However, compared to 
plasma levels of the main oxycholesterols (3-154 ng/mL) detected levels were 
comparable or lower (Hovenkamp et al., 2008). 
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2.1.11 Safety 
In recent years extensive research has been done on cholesterol oxidation products. 
Numerous in vitro studies have proven their mutagenic, carcinogenic, angiotoxic, 
cytotoxic and atherogenic potential. Further, COPs may play part in the onset and 
development of atherosclerosis (Guardiola et al., 1996; Osada, 2002). 
By contrast, data on phytosterol oxides are limited. Moreover a large part of the 
conducted studies was done with mixtures instead of single oxides, although different 
effects of mixtures and purified compounds have already been shown for COPs. 
However, due to their structural similarity with COPs, analogous functions and 
biological effects are expected. 
 
Meyer et al. (1998) investigated the influence of different β-sitosterol, stigmasterol and 
cholesterol oxides on the mortality of meal worms (Tenebrio molitor). The effects of 
phytosterol oxides were comparable to those of cholesterol oxides, especially triols 
showed toxic effects. However, tested phytosterol oxidation products were by a factor 
of five less active than oxycholesterols. 
 
As part of a comprehensive safety evaluation of plant sterols Lea et al. (2004) 
investigated a mixture of phytosterol oxides in a series of in vitro genotoxicity assays 
(bacterial mutation, chromosome aberration and micronucleus). No mutagenic effect on 
Salmonella typhimurium strains (TA98, TA100, TA102, TA1535 and TA1537) and no 
significant increase in chromosome aberrations or frequency of micronuclei were found. 
In addition, in a 90 days subchronic feeding study in Wistar rats (0.44-0.45% POPs in 
the diet) no evidence of a genotoxic potential was found.  
 
Likewise no genotoxic effects were found when a mixture of β-sitosterol oxidation 
products were investigated in the single-cell gel electrophoresis - and the sister 
chromatid exchange assay using U937 cells (Maguire et al., 2003). 
 
Very recently, an in vivo evaluation of the genotoxic potential of triol and epoxid 
compounds derived from β-sitosterol or campesterol using the micronucleus assay has 
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been conducted. In line with the previous mentioned investigations no significant 
effects were observed (Abramsson-Zetterberg et al., 2007). 
 
For the evaluation of cytotoxicity different cell lines were used. The activity of oxide 
mixtures of β-sitosterol (Maguire et al., 2003) and β-sitosterol/campesterol (Adcox et 
al., 2001) was evaluated using a human monocytic blood cell line (U937) and a 
cultured-derived macrophage cell line (C57BL/6), respectively. In the former study 
reduced cell viability, incidence of apoptotic cell death and decreased glutathione levels 
were observed, in the latter study cell viability, mitochondria dehydrogenase activity, 
lactate dehydrogenase (LDH) leakage and protein content were determined. In both 
investigations similar cell damage to that caused by COPs was found, although in 
general higher concentrations of POPs were needed. Non oxidized sterols showed no 
cytotoxic effects. Further Magurie et al. (2003) assumed that isolated phytosterol 
oxidation products might behave differently to individual compounds. 
 
Isolated oxidation products of β-sitosterol (7β-OH, 7-keto, sitostanetriol and a mixture 
of 5α, 6α-epoxide/5β, 6β-epoxide (6:1)) and their corresponding COPs were tested in a 
human monocytic cell line (U937), a colonic adenocarcinoma cell line (CaCo-2) and a 
hepatoma liver cell line (HepG2). While oxides caused apoptotic cell death in U937 
cells, necrosis was detected in CaCo-2 and HepG2-cells. 7-keto- and 7β-OH-sitosterol 
were found to be the most cytotoxic compounds, when cell viability, apoptitic cell death 
and DNA fragmentation was assayed, while 5α,6α-epoxysitosterol showed no toxicity at 
all. 7β-OH-sitosterol was the only β-sitosterol oxide that caused glutathion depletion 
(Ryan et al., 2005). As already observed for oxide mixtures, toxicity caused by POPs is 
similar but less severe compared to the corresponding COPs. 
 
Roussi et al. (2005) compared the antiproliferative effects of 7β-OH-sitosterol and 7β-
OH-cholesterol. In contrast to Ryan et al. (2005) for both compounds apoptotic cell 
death was observed in CaCo-2 cells. However, different apoptotic mechanisms may be 
involved as 7β-OH-sitosterol enhanced caspase-3 and -9 activities and DNA 
fragmentation, whereas for 7β-OH-cholesterol no activation of caspase-3 and a delay in 
the activation of caspase-9 and DNA fragmentation was observed. In a further study 
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different modulators of apoptosis were assessed. Both 7β-OH-sitosterol and 7β-OH-
cholesterol caused apoptosis by mitochondrial membrane permeabilization, 
independently of Bcl-2 or Bax alterations. Endonuclease G expression was enhanced 
after exposure to both sterol oxides, although for 7β-OH-cholesterol a certain delay was 
observed. Enhanced endonuclease G expression and enhanced production of reactive 
oxygen species were detected in 7β-OH-cholesterol treated cells only. 7β-OH-sitosterol 
was more potent in increasing lysosomal membrane integrity (Roussi et al., 2007). 
 
2.1.12 Analysis of phytosterol oxidation products 
In the past research on the oxidation of sterols concentrated on cholesterol while 
phytosterol oxides remained rather disregarded. Consequently, to date analysis of POPs 
is mostly based on methods developed for oxycholesterols, which mainly consist of 
extraction of total lipids of the sample material, saponification of lipids (preferably at 
room temperature), purification and enrichment of oxidation products and 
chromatographic analysis. In general, high temperatures, exposure to oxygen and light 
should be avoided as this would lead to artefact formation and further reactions of the 
sterol oxides (Piironen et al., 2000). 
However, compared to the research of COPs, methods for the analysis of phytosterol 
oxides require higher selectivity and higher sensitivity, as the number of plant sterol 
oxides found in plants are 3 to 4 times higher than those of cholesterol oxidation 
products in animal based sources and therefore single oxides may be present in 
relatively low amounts (Dutta, 2002). 
Another challenge in the POP-analysis is the lack of pure phytosterol standards. To date 
only Δ5-stigmasterol (purity: 95%) and β-sitosterol (purity: ≥ 97% or ≥ 95%) are 
commercially available, the latter one in very small amounts and at an excessively high 
price (Zhang et al., 2005a). Hence, POPs standards are also not available and have to be 
laboratory-prepared.  
 
2.1.12.1  Formation of oxidation products 
Applied methods are manifold and depend on the respective oxides to be obtained. 
Basically at the moment no validated, internationally accepted methods for the 
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preparation of oxidation products exist. Distinction may be drawn between formation of 
oxides by irradiation (Bortolomeazzi et al., 1999; Säynäjoki et al., 2003), by chemical 
synthesis (Zhang et al., 2005a; Geoffroy et al., 2008; Julien-David et al., 2008) and by 
thermo-oxidation, whereas in this case preparation can further be divided in thermo-
oxidation in solid state (Daly et al., 1983; Lampi et al., 2002) or in aqueous dispersion 
(Dutta and Appelqvist, 1997; Conchillo et al., 2005). 
 
2.1.12.2 Purification and Enrichment of oxidation products 
Because of the small amount of oxides compared to the excess of native sterols and the 
complexity of the gained blend, cleanup and enrichment is essential before separation 
techniques to isolate single oxidation products are applied (Dutta, 2002). Thus co-
elutions of oxidized and non oxidized material may be prevented. 
In the sample clean up solid phase extraction (SPE) cartridges and preparative TLC are 
commonly employed (Guardiola et al., 2004; Piironen et al., 2000). For the purification 
of bigger sample amounts, column chromatography (CC) on alumina or silica is 
generally used (Dinan et al., 2001). Compared to SPE-columns self prepared glass 
columns offer a higher loading capacity. In both cases separation is achieved by a 
stepwise elution with increasing solvent polarity (Piironen et al., 2000). A mixture of n-
hexane/diethylether has proven to be the most effective combination, whereas for the 
elution of the oxidation products containing fraction acetone is commonly employed 
(Ulberth and Buchgraber, 2002).  
In TLC analysis polar eluent mixtures, n-heptane/ethyl ether and diethyl/cyclohexane, 
are generally used. Compared to SPE and CC, TLC offers the possibility to isolate less 
polar oxidation products as their own fraction (Piironen et al., 2000). 
 
2.1.12.3 Separation, Identification and Quantification of oxidation products 
2.1.12.3.1 Thin layer chromatography (TLC) 
Besides HPLC and GC, TLC is frequently used in the analysis of sterol oxides, 
especially when a rapid procedure is favoured. For compounds with a higher polarity 
than non-oxidized sterols good resolution was observed. However, its application is 
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usually limited to the qualitative determination as quantitative results are not as reliable 
as other techniques (Lebovics, 2002). Identification is achieved by comparing the 
position of the sample spots with those of COP standard reference substances. 
Visualisation of the generated spots can easily be done by spraying with sulphuric acid 
and following heat treatment. Noteworthy to say that 7-ketosterols do not give a colour 
reaction, but can be detected using UV light (Lebovics, 2002). 
Nevertheless, in the preparative analysis TLC is rather appropriate for the processing of 
small sample amounts. In addition to its low loading capacity it also allows long 
exposure of the sample to air, which facilitates the possibility of artefact formation. 
Further it involves laborious scraping steps (Dutta and Appelqvist, 1997; Csallany et al., 
1989). 
 
2.1.12.3.2 High pressure liquid chromatography 
In the analysis of sterol oxides HPLC has become an alternative to GC methods. Due to 
its non destructive characteristic and its possibility to operate at room temperature 
HPLC is particularly suitable for the investigation of thermolabile compounds. Both 
normal- and reverse phase chromatography has already been successfully used for the 
analyses of cholesterol (Caboni et al., 1997; Chien et al., 1998; Mazalli et al., 2006) and 
plant sterol (Kemmo et al., 2007; Kemmo et al., 2005) oxidation products. In general 
normal phase chromatography is considered to be the more effective option. However, 
no full resolution over the entire polarity range of the oxidation products is possible 
under isocratic conditions (Maerker et al., 1988). In normal phase applications silica or 
cyano (CN) columns are most frequently used. As mobile phases binary systems 
consisting of usually heptane or hexane with varying percentages of polar modifiers, in 
most cases 2-propanol, are employed (Abidi, 2001). 
Further HPLC can be performed either as preparative or analytical technique and can be 
coupled to a wide range of detectors. Among all detection systems available UV 
detection is still the most frequently applied for sterol analyses. In general single sterol 
oxidation products have their maximum UV absorption at different wavelengths 
(Caboni et al., 1997; Osada et al., 1999). However, wavelengths between 205-210 nm 
are those commonly employed for oxysterol analysis (Rodriguez-Estrada and Caboni, 
2002). Compared to measuring the absorbance at one single wavelength photodiode 
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array detection (PDA) has the advantage to acquire a series of spectra over different UV 
wavelengths (Rodriguez-Estrada and Caboni, 2002). However, both UV and PDA 
detection possess limitations since products without double bonds as epoxy- epimers 
and triols do not respond to UV detection and are therefore not seen with this kind of 
detectors (Caboni et al., 1997; Moreau, 2005). 
By the use of refractive index (RI) detectors (Chen and Chen, 1994), light scattering 
detectors (LSD)(Caboni et al., 1997) or evaporative light scattering detectors (ELSD) 
(Lakritz and Jones, 1997) also those compounds which are transparent to UV detection 
can be included in the measurement. RI detection is approximately 1000 times less 
sensitive than UV detection (Chen and Chen, 1994). Further it is not suitable for 
gradient elution systems (Rodriguez-Estrada and Caboni, 2002). Regarding the 
sensitivity LSD is similar to UV detection, except in the case of 7-ketocholesterol, 
where far higher detection limits were observed (Caboni et al., 1997). In recent years 
ELSD has become more popular in the lipid analysis. For detection the analyte has to be 
more volatile than the mobile phase, the detector response is based on mass. ELSD 
works with isocratic and gradient elution systems. It has been shown to be more 
sensitive than RI, but less sensitive than UV (Rodriguez-Estrada and Caboni, 2002; 
Abidi, 2001). In addition it shows a limited range of linear response (Lakritz and Jones, 
1997).  
Recently also HPLC-MS has become more common in the analysis of sterol oxides 
(Kemmo et al., 2007; Mazalli et al., 2006; Razzazi-Fazeli et al., 2000). 
In HPLC analysis quantification with both internal and external standards is possible. 
Again COP reference solutions are commonly used in the POP analysis. In the more 
common external standard method the preparation of calibration curves for each oxide 
is necessary (Rodriguez-Estrada and Caboni, 2002). Similar to GC analysis 19-
hydroxycholesterol can be used as internal standard (Caboni et al., 1997).  
 
2.1.12.3.3 Gas chromatography 
To date GC is still the most common method used for the determination of sterol oxides 
(Guardiola et al., 2002). It is normally coupled to a flame ionization detector (FID) but 
also to mass spectrometry (MS) (Abidi, 2001).   
Literature                                                                                                                       41   
 
Due to the high boiling points of sterols and their oxides, it is necessary to apply 
elevated temperatures in GC methods. In order to avoid degradation and artefact 
formation oxysterols are usually converted to trimethylsilyl ethers (TMSE). For 
derivatisation combinations of hexamethyldisilazane (HMDS) and trimethylchlorosilane 
(TMCS) (Johnsson and Dutta, 2006; Conchillo et al., 2005) or N,O-bis-
(trimethylsilyl)trifluoroacetamide (BSTFA) and TMCS (Lampi et al., 2002; Soupas et 
al., 2004b) are quite commonly used. Usually silulation is performed in pyridine at 
room temperature or accelerated at elevated temperatures. As water would compete with 
hydroxyl groups of sterol oxides an anhydrous condition is essential (Guardiola et al., 
2004). 
Compared to FID the use of MS for the detection of sterol oxides also allows the 
quantification and identification of overlapping peaks. Further its sensitivity was shown 
to be similar to or better than that of FID (Guardiola et al., 2004). Quantification of 
sterol oxidation products is generally done by the internal standard (ISTD) method. The 
use of 19-hydroxycholesterol has been proven to be the most effective option. As 
commercial standards of plant sterol oxidation products are not available, also in the 
analysis of phytosterol oxides oxycholesterols are used as standard compounds (Plat et 
al., 2001). 
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3. Material and Methods 
3.1 Production and isolation of phytosterol oxidation products 
3.1.1 Chemicals and Reagences 
Substance Supplier Product number
24β-Ethylcholest-5-en-3β-ol Fluka 85451
5-Cholesten-3β-ol Sigma S957623
Cholest-5-en-3β-ol-7-one Sigma C2394
Cholestan-5α,6α-epoxy-3β-ol Sigma C2773 
Cholest-5-en-3β,7β-diol Steraloids C6430-000
5-Cholesten-3β,19-ol Steraloids C6470-000
Acetone Rathburn Chemicals 
Bis(trimethylsilyl) trifluoroacetamide Merck 110255
Diethyl ether Merck 100921
Ethyl acetate Merck 100868
n -Heptane Rathburn Chemicals 
Methanol Rathburn Chemicals 
2-Propanol Rathburn Chemicals 
Pyridine Fluka 82703
Sulphuric acid Merck 112080
Trimethylchlorsilan Fluka 92360 
 
Tab 3.1 Chemicals and Reagences used for plant sterol oxide analysis 
 
3.1.2 Equipment  
Equipment Supplier Product number
Acrodisc Syringe Filters with 
GHP Membrane, 13 mm, 0.45 µm PALL 4563
Silica gel 60 ( 0.2-0.5mm) Merck 107733
TLC silica gel 60 aluminium sheets 
(0.5mm layer thickness) Merck 105553
 
Tab 3.2 Equipment used for plant sterol oxide analysis 
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Fig 3.1 Schematic overview of β–sitosterol oxides production  
 
3.1.3 Preparation of oxides by thermo-oxidation 
Commercial available β–sitosterol was used for the generation of phytosterol oxidation 
products. First its composition was determined by GC-FID and GC-MS. 
 
Tab 3.3 Composition of employed β–sitosterol 
 
POPs were formed by thermo-oxidation. Commercial available β–sitosterol was heated 
in open glass vials (300 mg, 25 mm, I.D.) in a ventilated oven. After the heating period 
the samples were cooled down in a dessicator, dissolved in 15 mL of n-heptane/diethyl-
ether (90/10, v/v), solubilised using a sonicator and finally stored in a freezer (- 20 °C). 
 
purity %
β-sitosterol 76
sitostanol 13
campesterol 9.5
campestanol 1.5
rest 1
isolated
fractions
mixture of oxidized and
unoxidized sterol
compounds
TMS
thermo-
oxidation
β- sitosterol
130°C ,24h
purification
CC: silica gel
HPLC
TLC
GC-MS
GC-FID
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To determine the optimal conditions different temperatures and heating periods (130 
°C/24 h, 120 °C/48 h and 130 °C/48 h) were tested. Resulting oxidation mixtures were 
analysed using GC-FID and GC-MS.  
 
3.1.4 Purification and enrichment of phytosterol oxidation products by 
column chromatography (CC) 
The purification method used was based on former investigations by Lampi et al. (2002) 
and Apprich and Ulberth (2004).  
72 g silica gel was dry packed into a glass column and pre-wetted with 150 mL n-
heptane.  All oxides obtained of 300 mg heated β–sitosterol and diluted in 15 mL n-
heptane/diethyl-ether (90:10, v/v) were applied to the column. First nonoxidized sterols 
and apolar components were eluted with 150 mL n-heptane/diethyl-ether (90/10, v/v) 
followed by 450 mL n-heptane/diethyl-ether (50/50, v/v). Thereafter POPs were 
extracted with 150 mL acetone. The acetone fraction was evaporated to dryness. To get 
rid of the water ethanol was added during the evaporation step. Finally the residue was 
dissolved in 550 µL n-heptane/2-propanol (93/7, v/v).  
The yield of oxidation products was increased when the silica gel was loaded with 10 % 
distilled water. 
 
3.1.5 Confirmation of the purification by thin layer chromatography (TLC) 
100 µL of the purified sample were applied to silica gel G 60 TLC plates. As eluent n-
heptane/ethyl-acetat (50/50, v/v) was used. Components were visualized by spraying 
with 10 % sulphuric acid in methanol and a following heat treatment of a few minutes at 
100 °C. The identification of the single oxidation products was conducted using a 
cholesterol oxides standard solution (5α,6α-epoxy-, 7-hydroxy- and 7-ketocholesterol).  
 
3.1.6 Separation of single oxidation products by a NP-HPLC-UV system 
For the collection of single oxidation products a preparative normal–phase HPLC-
method was used. The method was based on papers published by Kemmo et al. (2005; 
Säynäjoki et al., 2003) with some modifications. 
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In pre-testes several mobile phase systems (90/10, 92/8, 93/7, 94/6, 95/5 and 97/3 n-
heptane/2-propanol, v/v) and flow rates (5, 7, 9.9, 15 and 17 mL/min) were examined. 
For the first tests a semi-preparative silica column (25 cm x 10 mm, 5µm, Supelcosil) 
was used. Good seperation was achieved with a mobile phase of n-heptane/2-propanol 
(92/8, v/v) and a flow rate of 9.9 mL/min, but obtained yields of oxidation products 
were rather low. Therefore a preparative silica column (25 cm x 21.1 mm, 12µm, 
Supelcosil) was used for the following HPLC runs. 
 
Tab 3.4 HPLC conditions used for the separation of POPs 
 
The performance of the separation was checked daily using a cholesterol oxide standard 
solution (7-ketocholesterol, 7β-hydroxycholesterol and 7α-hydroxycholesterol) by 
monitoring the retention times.  
 
3.1.7 Identification and quantification  
For identification and quantification of the collected fractions GC-mass spectrometry 
(GC-MS) and GC-flame ionization detection (GC-FID) were used, respectively. Both 
methods have been developed earlier by co-workers (Lampi et al., 2002; Soupas et al., 
2004b), are routinely used for analysing POPs and were implemented under supervision 
of the respective person responsible. 
Prior to the GC analysis the samples were converted to TMS-ether derivatives. 
Therefore 100 µL aliquots of each fraction and 1 mL of internal standard solution (19-
HPLC conditions
mobile phase n -heptane/2-propanol (93/7, v/v)
flow rate 17 mL/min 
injection volume 1.8 mL
detection UV-detection, 206 nm
Waters Delta Prep 3000, preparative HPLC - instrument (Walters, Milford, USA) 
HPLC system
Waters 484 UV detector (Walters, Milford, USA) 
Supelcosil silica column (25 cm x 21.1mm, 12µm) (Supelco, Bellefonte, PA, USA)
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OH-cholesterol, 18.55 µg/mL) were evaporated to dryness under nitrogen, dissolved in 
100 µL of pyridine and subjected to silylation by 100 µL BSTFA/TMCS (100 µL, 99/1, 
v/v) over night at room temperature. The reagent mixture was then evaporated and the 
residue was dissolved in 200 µL n-heptane before GC analysis. 
 
3.1.7.1 GC–MS analysis 
For identification of the collected oxidation products and verification of the purity of the 
fractions GC–MS analysis was done as described in Soupas et al. (2004b).  
Tab 3.5 GC-MS conditions used for the identification of POPs 
 
3.1.7.2 GC–FID analysis 
Quantification of the collected oxides was done by GC-FID as described by Lampi et al. 
(2002). 
 
carrier gas helium (>99.996%)
flow 1.2 mL/min (constant flow)
temperature programm 70°C (1 min)
40°C/min to 280°C (kept for 35 min)
interface temperature 280°C
ion source 230°C
ionization electron impact 70 eV
scan modus full scan mode, m/z 100-600
Rtx-5MS w/ Integra fused-silica capillary column 
(60m x 0.25mm i.d., crossbond 5% diphenyl – 95% dimethyl polysiloxane, 0.1µm film with 
10m Integra-Guard column; Restek, Bellefonte, PA, USA) 
Agilent 5973 mass spectrometer (Palo Alto, CA, USA)
GC-MS conditions
GC-MS system
Hewlett Packard 6890 Series gas chromatograph (Wilmington, PA, USA)
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Tab 3.6 GC-FID conditions used for the quantification of POPs 
 
3.2 Salmonella microsome assay 
The Salmonella microsome assay (Salmonella test; Ames test) is a short-term bacterial 
reverse mutation assay and a well established marker for the detection of a wide range 
of chemical substances that can produce genetic damage thus leading to gene mutations. 
The principle behind this assay is that the used Salmonella typhimurium strains need the 
amino acid histidine as a growth factor, which is a consequence of a pre-existing 
mutation. By adding a mutagenic substance this pre-existing mutation can be reverted 
(Göggelmann, 1993). The intensity of the increase in bacterial growth is an indicator for 
the mutagenic potential of a tested substance (Mortelmans and Zeiger, 2000).  
 
In this study the Salmonella strains TA98, TA100 and TA102 were used. TA98 gives an 
indication of frameshift mutations and TA100 gives information on base-pair 
substitutions. The strain TA102 was developed as a strain that, in contrast to the others, 
contain its mutant site at AT instead of GC base pairs. It is able to detect cross- linking 
agents and can be reverted by mutagens that cause oxidative damage (table 3.7). In 
carrier gas helium (>99.996%)
flow 1.4 mL/min (constant flow)
temperature programm 70°C (kept for 1 min)
60°C/min to 245°C (kept for 1 min)
3°C/min to 275°C (kept for 41 min)
detector temperature 300°C
flame ionization detector (Hewlett-Packard, Karlsruhe, Germany)
GC-FID system
GC-FID conditions
HP-7673 autosampler (Hewlett-Packard, Karlsruhe, Germany)
Hewlett Packard 6890 Series II gas chromatograph (Hewlett-Packard, Karlsruhe, Germany)
RTX-5w/ Integra fused-silica capillary column 
(crossbond 5% diphenyl - 95% dimethyl polysiloxane; with film thickness 0.10 μm, 60 m × 
0.32 mm i.d.) (Restek, Bellefonte, PA, USA) 
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order to detect mutagens acting via different kind of mechanisms experiments including 
different tester strains are necessary (Mortelsmann & Zeiger, 2000). 
Tab 3.7 Genotypes of Salmonella tester strains used in the Ames test 
 
3.2.1 Chemicals and Reagences  
Tab 3.8 Chemicals and Reagences used in the Salmonella microsome assay 
 
Allele Strains DNA target Reversion event
HisG46 TA 100 -G-G-G- Base-pair substitution
HisD3052 TA 98 -C-G-C-G-C-G-C-G- Frameshifts
HisG428 TA 102 -T-A-A- Transitions/transversions
Substance Supplier Product number
Agar nr. 1 Oxoid/ Bertoni LP011P
2-Aminofluorene Sigma A9031
Ampicillin trihydrat Sigma A6140
Citric acid monohydrate Sigma C1909
Crystal violet Sigma C3886-25G
D-Biotin Sigma B4639
Dimethylsulfoxid Sigma D5879
Dulbecco´s phosphate buffered saline PAA Laboratories H15002
D-(+)-Glucose Sigma G8270
D-Glucose 6-phosphate Sigma G7250
Hydrochloric acid Riedel-de Haën 30723
Hydrogen peroxide, 30% Riedel-de Haën 31642
L-Histidine.HCl Sigma H8125
Magnesium chloride Sigma M9272
Magnesium sulfate Sigma 434183
Nicotinamide adenine dinucleotide Sigma N0505
Nutrient broth nr. 2 Oxoid/ Bertoni CM 067B
Potassium chloride Sigma P5405
Potassium phosphate dibasic Sigma P3786
Rat liver homogenate Biomedica/ ICN 50412
Salmonella thyphimurium strains
TA98, TA100 and TA102 
Trinova Biochem GmbH
(Giessen, Germany)
Sodium ammonium phosphate Sigma S9506
Sodiumazide Sigma S8032
Sodium chloride Sigma S5886
Sodium hydroxide Sigma O6203
Tert-butylhydroperoxide Sigma B2633
Tetracycline hydrochloride Sigma T3383
2,4,7-trinitro-9-fluoren unknown unknown
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3.2.2 Equipment  
Tab 3.9 Equipment used in the Salmonella microsome assay 
 
3.2.3 Investigated samples 
Three individual oxidation products, 7-ketositosterol, 7β-OH-sitosterol, 7α-OH-
sitosterol, a mixture of 6β-OH-3-keto-sitosterol/6α-OH-3-keto-sitosterol (ratio 4:3) and 
a mixture of the polar oxidation products of β-sitosterol were investigated.  
 
3.2.4 Solubility experiments 
Solubility of the plant sterol oxidation products was determined in different solvents 
(H2O, DMSO, acetone (95 %, 100 %), hexane, EtOH (95 %) and 2-propanol). 
Unfortunately phytosterol oxides are not water-soluble therefore unpolar solvents had to 
be tested as well. These unpolar solvents are at the same time considered to be 
potentially toxic, thus maximal added concentrations had to be identified in pre-tests. 
However, either the oxides were not dissolved in the solvents, or the solvents were too 
toxic for the used bacteria. Therefore for dissolving the samples the emulsifier Tween80 
had to be used. 
 
 
Equipment Supplier Product number
Petri dishes Bertoni 101VR20
Diluting loops Semadeni 3224
Autoclavable bags Semadeni 2054
Autoclave band Semadeni 4343
Cryogenic tubes, 2 mL Semadeni 4190
Helipur disinfectant VWR-Merck 148F4124
Incubation tubes (100 x 16-mm) Dr. F. Bertoni 2775/14
Analytical balance ( LC 4801P Sartorius)
Incubator   ( Memmert Modell 500)
Water bath   ( GFL Müller und Scherr)
Vortexer   ( Heidolph Reax 2000)
Laminar flow   ( Holten LaminAir HB 2472)
Autoclaves   ( Melag Autoklav 23, Varioklav 500)
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3.2.5 Preparation of reaction mixtures 
In order to obtain appropriate dilutions, respective amounts of oxidation products 
(dissolved in 2-propanol) were evaporated with nitrogen and pre-dissolved in a mixture 
of acetone/Tween80 (3/1, v/v). Afterwards two parts of sterile, distilled water was 
added to keep the concentration of acetone as low as possible and to avoid potential 
toxic effects on the bacterial strains. This procedure was tested to be safe for the strains 
in pre-experiments. 
 
The concentrations range used was broad, from very low to non physiologically high 
concentrations, but all below the solubility range, which is recommended for this test 
procedure (Ames et al., 1973; Mortelmans and Zeiger, 2000). Considering the results of 
pre-tests, four concentrations (0.04, 0.2, 1.0 and 5.0 mg per plate (≈ %)) of each 
compound were prepared. 
 
Due to precipitation problems in the highest concentration of 7α-OH-sitosterol, only 3 
doses of this compound could be used (0.04 – 1 %). There were similar but minor 
solubility problems with the mixture of 6β-OH-3-keto-sitosterol/6-α-OH-3-keto-
sitosterol, therefore as highest concentration 2.5 mg/plate was tested. On the other hand 
the mixture of all oxidation products showed very good solubility, so a 10 mg/plate 
dilution could also be included in the experiments (table 3.10). 
 
Tab 3.10 Overview of the used concentrations of the reaction mixtures  
 
 
 
10% 5% 2.5% 1% 0.2% 0.04%
7-ketositosterol x x x x
7β-OH-sitosterol x x x x
7α-OH-sitosterol x x x
6α-OH-3-keto-/
6β-OH-3-keto-sitosterol x x x x
mixture x x x x x
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3.2.6 Metabolic activation 
Some carcinogenic chemicals such as aromatic amines or polycyclic aromatic 
hydrocarbons are biologically inactive unless they are metabolized to active forms. On 
the other hand some mutagens are active but are inactivated during metabolization. 
Bacteria do not have a cytochrome-based P450 metabolic oxidation system. In order to 
simulate in vivo conditions the oxidation products were treated with a rat liver enzyme 
mixture (S9, which mainly consists of phase I enzymes) for metabolic activation 
(Mortelmans and Zeiger, 2000). The S9 mix was prepared according to the recipes of 
Maron and Ames (1984). It was stored on ice throughout the whole experiment and 
discarded after 50 min. 
 
3.2.7 Experimental design 
The Salmonella microsome assay was performed according to Maron and Ames (1984). 
In order to allow a closer contact of the test compounds and the indicator strain as well 
as to detect short term reacting mutagens the preincubation assay with an incubation 
period of 25 min (37 °C) was chosen, as successfully applied prviousely (Wagner et al., 
2007). 
Because of the highly sensitive nature of plant sterol oxides, samples had to be prepared 
freshly for every test run. 
 
 
Fig 3.2 Scheme of the Salmonella microsome assay 
 
Briefly, 500 µL of PBS or S9 mix, 200 µL of reaction mixture and 100 µL of overnight 
bacterial culture were added to test tubes. The tubes were shortly vortexed and then 
 
37°C, 48h 
Counting 
 of the 
 revertant 
colonies 
Salmonella  
Typhimurium 
 strain 
(100µl) 
Test-substance 
 (100µl) 
S9 – Mix 
(optional) 
2 ml Top agar 
Materials and Methods                                                                                                   53   
placed in an incubator on a rotary shaker and incubated for 25 min at 37 °C. Thereafter 
2 mL of molten top agar were added to each tube. The mixture was vortexed and poured 
on minimum glucose plates. As soon as the agar had solidified the plates were inverted 
and stored in an incubator for 48 h at 37 °C. Thereafter his+- revertants were counted 
manually (figure 3.2). 
 
To further investigate the anti-/pro-oxidative effects the pro-oxidant tertiary-butyl 
hydroperoxide (tBOOH, 0.7 mM) was used for challenge tests. The concentration of the 
oxidant was chosen in order to obtain suitable numbers of revertants on the plates. 
Therefore 720 µL of the test sample and 720 µL of tBOOH were first mixed and then 
400 µL of this mixture was added to 500 µL of PBS or S9 mix and 100 µL of overnight 
culture. Besides, these challenge tests were performed in the same way as without pro-
oxidative stressing. 
All test procedures were conducted with and without metabolic activation. 
 
For each compound and each concentration three plates were prepared and every test 
was repeated under the same conditions on another day. So, altogether 6 replicates of 
each test sample were produced. 
In addition, each test includes a positive control to confirm the reversion properties and 
specificity of each tester strain as well as a negative control, the sample solvent, for the 
assessment of the spontaneous revertants (Mortelmans and Zeiger, 2000). 
For the strains TA98 and TA102 2,4,7-Trinitro-9-fluorenone and for TA100 
Sodiumazide was used as positive controls for tests without metabolic activation, while 
for tests with metabolic activation 2-Aminofluorene was used for all strains.  
Detailed description of the test performance and solvent recipes can be found in other 
Master and PhD Theses that have been done at the Department of Nutritional Sciences, 
University of Vienna: e.g. ‘Wirkungen von Phytosterin-Oxidationsprodukten im Ames 
Test’, Cornelia Fritz-Ton, 2007.  
3.2.8 Statistical analysis and evaluation of the mutagenic experiments 
All data are expressed as mean ± SD (standard derivation). Obtained data (n = 6 for 
each concentration used) were analysed by one-way analysis of variance (ANOVA) and 
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the Student’s t-test since they were all normally distributed, using SPSS 15.0 for 
Windows. Statistical differences were considered significant at a value of p < 0.05. 
In addition to the statistical, a nonstatistical evaluation was carried out. According to 
Mortelmans and Zeiger (2000) a compound is considered as ‘mutagenic’ if the total 
number of his+- revertants per plate was at least twice as high as the negative control 
(200 %). Moreover a dose related increase of the number of his+- revertants has to be 
shown. 
3.3 Cell culture assays 
3.3.1 Solutions and Reagents 
Tab 3.11 Chemicals and Reagences used in the cell tests 
Substance Supplier Product number
Amino acids non essential PAA Laboratories M11-003
AnnexinV-PE detection kit I BD Biosciences 559763
Camptothecin Sigma C9911
Dimethylsulfoxid Sigma D5879
3-(4,5-Dimethyl-2-thiazolyl)-
2,5-diphenyl-2H-tetrazolium bromide Sigma M5655
Dulbecco´s phosphate buffered saline PAA Laboratories H15002
Ethanol Riedel-de Haën 32221
Ethylenediaminetetraacetic acid Sigma E6758-500G
Ethylenediaminetetraacetic acid 
disodium salt dihydrate VWR 443882G
Ethidium bromide aqueous solution Sigma E1510
Foetal Bovine Serum "GOLD" PAA Laboratories A15-151
Dihydroethidine Sigma 37291
Hydrogen peroxide, 30% Riedel-de Haën 31642
Hydrochloric acid Riedel-de Haën 30723
Low melting Agarose Invitrogen 15517014
Methanol Merck 106007
Minimal essential medium (MEM) 
with Earle's Salta with L-Glutamine PAA Laboratories E15-825
Sodiumhydroxide Riedel-de Haën 6203
Normal melting Agarose Invitrogen 15510019
Phosphoric acid, 85% Riedel-de Haën 30417
Potassium chloride Sigma P5405
Potassium dihydrogen phosphate Riedel-de Haën 30407
Sodium chloride Sigma S5886
Sodium hydroxide Sigma S5881
Sodium pyruvate Sigma P2256
1,1,3,3-Tetraethoxypropane Sigma T9889
2-Thiobarbituric acid Sigma T5500
Tris Sigma T1503
Triton X-100 Serva T8787
Trypsin/EDTA PAA Laboratories L11-659
Trypan blue solution Sigma T8154
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3.3.2 Equipment 
Tab 3.12 Equipment used in the cell tests 
 
 
3.3.3 Preparation of general solutions and reagents for cell tests 
 
Culture media (500 mL): 
445 mL Minimal Essential Medium Eagle (MEM) 
50 mL fetal bovine serum (FBS) 
5 mL non essential amino acids 
1 mL Sodium pyruvate (500 mM) 
Equipment Supplier Product number
Centrifuge tube, 15 mL Dr. F. Bertoni 15PPR
Centrifuge tube, 50 mL Dr. F. Bertoni 36050NPG
Coverslips  (24x50 mm) Dr. F. Bertoni 990
Disposable syringe, 10 mL Dr. F. Bertoni 309110
Disposable syringe, 20 mL Dr. F. Bertoni 309296
Electrophoresis chamber, horizontal VWR 730-1796
Frosted slices VWR 6311304
Gloves ( nitril) VWR 112-2220
Syringe filters (22μm) Dr. F. Bertoni 2052-025
Injection cannula
Terumo Neolus Nr 18,
26G x23, 0,45x 23mm
pharmacy Lot 0606023
Round-Bottom Tubes, 5mL VWR 734-0443
Tissue culture flasks, 25cm2 Dr. F. Bertoni 3103-025
Tissue culture flasks, 75cm2 Dr. F. Bertoni 3123-075
6 well plates Dr. F. Bertoni 3810-006
24 well plates Dr. F. Bertoni 3820-024
96 well plates Dr. F. Bertoni 3860-096
Incubator   ( Heraeus Instruments Function Line Typ BB16)
Water bath   ( GFL Müller und Scherr)
Analytical balance ( LC 4801P Sartorius)
FACSCalibur flow cytometer ( multicolor system, BD Biosciences)
BD CellQuest Pro Software ( BD Biosciences)
Fluorescence microscope (Axioskop 20, Zeiss)
Microscope ( Axioskop, Zeiss; Wilovert, Hund Wetzlar)
Rotary Shaker ( ELMI Ltd. laboratory equipment)
POWER Supply   (Peqlab)
Komet 5.5, image analysis system   (Kineting Imaging)
Fluostar Optima microplate reader   (BMG labtechnologies)
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NaCl –solution (0.9 %): 
0.9 g NaCl  
100 mL Aqua bidest.  
 
Sodium pyruvate (500 mM): 
1.1 g Sodium pyruvate 
20 mL NaCl- solution (0.9 %) 
 
Positive control: 
0.00375 % H2O2 in MEM (incubation time: 10 min) 
 
3.3.4 HepG2-cells 
For the following cell culture experiments human hepatoma cells (HepG2) were used. 
The cells were isolated from the liver tissue of a 15 year-old Caucasian male from 
Argentina in 1975. HepG2-cells are perpetual adherent, epithelial in morphology and 
routinely used for toxicology studies (Aden et al., 1979). 
 
3.3.5 Cell maintenance 
HepG2 were cultured as monolayers in MEM supplemented with 10 % (v/v) FBS, 2 
mM L-glutamine, 1 mM sodium pyruvate and 1 % (v/v) non-essential amino acids in a 
humidified atmosphere at 37 °C in 5 % CO2 in the absence of antibiotics. Cells were 
passaged weekly and the culture medium was changed every 3-4 days. Cultures were 
allowed to reach 80 % confluence before experiments were performed. 
 
3.3.6 Passage 
Subconfluent cells were washed with Dulbecco´s Phosphate-buffered saline (PBS), 
harvested with trypsin-EDTA solution (1.5 mL for T25-flasks, incubation time: 3 min) 
and gently centrifuged (5 min, 800 RPM). Thereafter the cell pellet was resuspended in 
10 mL pre-warmed culture medium and a single-cell suspension was prepared by 
Materials and Methods                                                                                                   57   
pressing the cell suspension through an injection cannula. 1/15 of the cells were seeded 
in a new flask.  
 
3.3.7 Investigated samples 
Three individual oxidation products, 7-ketositosterol, 7β-OH-sitosterol, 7α-OH-
sitosterol, a mixture of 6β-OH-3-keto-sitosterol/6α-OH-3-keto-sitosterol (ratio 4:3) and 
a mixture of the polar oxidation products of β-sitosterol were investigated.  
 
3.3.8 Sample preparation 
For delivery to the cells all compounds were dissolved in ethanol and added to reduced 
serum media (2.5 % (v/v) FBS). Within all experiments 3 different concentrations (30 
µM, 60 µM, 120 µM) and an incubation period of 24 hours were considered in order to 
guarantee uniformity and comparability. The final concentration of ethanol in cultures 
did not exceed 0.4 % (v/v) and did not affect cell proliferation. Equivalent quantities of 
ethanol were added to control cells. 
 
3.3.9 Cell treatment 
For treatment cells were cultured in different multiwell dishes depending on the 
respective experiment at a density of either 2x104 cells/well in 250 µL (96-well plates), 
2x105 cells/ well in 2 mL (24-well plates) or 1x 106 cells/ well in 3 mL (6-well plates) of 
complete medium. After 24 hours medium was removed and cells were incubated with 
the different β-sitosterol oxide samples. At the end of the incubation period, both 
floating and attached cells were collected for analysis. 
 
3.3.10 Trypan blue exclusion assay 
Trypan blue is an acid di-azo group dye. Its anions can bind to cell proteins, but as long 
as the cell membranes are intact it is not able to interact with the cells. Therefore, viable 
cells exclude the dye, whereas dead cells will be stained blue, thus can be easily counted 
using a light microscope.    
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3.3.10.1 Assay procedure 
At the end of the incubation period culture media was collected in order to include 
floating cells in the analysis. Cells were washed once with 1 mL pre-warmed PBS, 
harvested with trypsin/EDTA solution (100 µL, 4 min incubation), resuspended in 1 mL 
of complete media and mixed with the collected media containing the floating cells. 
With the help of an injection cannula a single cell suspension was prepared. 100 µL of 
this cell suspension were mixed with 100 µL of trypan blue solution and incubated for 3 
minutes. Thereafter 20 µL of this mixture were filled into the haemocytometer and the 
number of viable (bright cells) and non-viable cells (stained blue) were counted using a 
light-optical microscope. 
Results were presented as number of viable cells expressed as percentage (%) of 
negative control values. Additionally percentage of cell death was calculated according 
to the percentage of dead cells of the total cell population.  
Experiments were performed in triplicates. 
 
3.3.11 MTT (3,(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-tetrazolium-bromid) 
assay 
In metabolically active cells the yellow, water soluble tetrazolium salt MTT (3,(4,5-
dimethylthiazol-2-yl)-2,5-diphenyl-tetrazoliumbromid) is converted to purple, water 
insoluble formazan by dehydrogenase enzymes of the mitochondria (figure 3.3). The 
resulting intracellular formazan is directly proportional to the number of metabolically 
active cells. This colorimetric reaction can be measured spectrophotometrically 
(Mosmann, 1983). 
 
 
Fig 3.3 Reduction of yellow MTT to purple formazan. 
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3.3.11.1 Preparation of solutions and reagents 
MTT-solution (5 g/L): 
50 mg MTT 
10ml PBS 
MTT-solution was protected from light and stored at 4°C. For delivery to cells 20 µL 
MTT-solution was added to 180 µL media (final concentration 0.5 mg/mL). 
 
3.3.11.2 Assay procedure 
At the end of the incubation period culture medium was discarded and cells were 
washed with 200 µL of pre-warmed PBS. 200 μL of MTT in culture medium was added 
and incubated for 1 hour at 37°C. Thereafter the MTT containing media was carefully 
removed and cells were washed with 200 µL of pre-warmed PBS. 100 µL of DMSO 
was added and formazan crystals were dissolved under gentle shaking (30 min). 
Absorbance was read at 540 nm with a Fluostar Optima microplate reader 
Results were expressed as the number of viable cells as percentage (%) of control cells. 
Measurements were made in triplicates. 
 
3.3.12 Flow cytometric measurments 
With the help of flow cytometry it is possible to simultaneously examine multiple 
characteristics of single cells. Based on light scatter properties (forward scatter channel 
(FSC), side scatter channel (SSC)) it is possible to determine cell size and granularity. 
At the same time specific cell parameters can be analysed by labelling definite targets 
with special fluorescence markers. In most cases these markers are antibodies which are 
also bound to fluorescence groups. 
 
3.3.12.1 Detection of apoptosis 
During the early phase of apoptosis phosphatidylserine, which is normally located on 
the inner surface of the cell membrane, is translocated from the inner to the outer 
surface (Koopman et al., 1994). The expression of phosphatidylserine on the external 
surface is a universal event during apoptosis occurring before the loss of membrane 
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integrity arise, independent of the respective cell type. This loss of plasma membrane 
asymmetry is precedent for the recognition and removal of damaged cells by 
macrophages (van Engeland et al., 1998). 
AnnexinV, a phosphlipid binding protein, specifically binds to phosphatidylserine in a 
Ca2+ dependent reaction. Thus staining with fluorescent labelled AnnexinV-PE allows 
identifying cells in the early stage of apoptosis (figure  3.4).  
 
 
Fig 3.4 Schematic representation of the Annexin V assay (www.bdbiosciences.com). 
 
Annexin V is not an absolute marker of apoptosis, as phosphatidylserine translocations 
can also occur during the process of necrosis. Therefore in addition to Annexin V the 
dye 7-amino-actinomycin D (7-AAD) was used to mark necrotic cells. 7-AAD binds to 
nucleic acids inside the cell but is not able to diffuse intact cell membranes. Hence only 
those cells with damaged membranes, a condition commonly occurring in the later 
stages of apoptosis or in necrosis, are marked with 7-AAD (Vermes et al., 1995). 
AnnexinV positive/7-AAD negative cells were defined as early apoptotic, while 
AnnexinV positive/7-AAD positive cells were classified as late apoptotic or necrotic.  
 
3.3.12.1.1 Preparation of solutions and reagents 
 
AnnexinV-PE detection kit I: 
AnnexinV-PE 
7-AAD 
Binding buffer (0.1 M HEPES/NaOH (pH 7.4) 1.4 M NaCl, 25 mM CaCl2) 
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Positive control: 
Camptothecin  
Stock solution (1 mM) 
6.967 mg Camptothecin 
20 mL DMSO 
For delivery to cells 5 µL Camptothecin-solution was added to 12 mL media (24 h 
incubation). 
 
3.3.12.2 Assay procedure 
For detection of apoptosis an AnnexinV-PE detection kit (BD Pharmingen) was used 
and analysis was done following the manufacturer’s instructions.  
Briefly, at the end of the incubation period culture media was collected in order to 
include floating cells in the following analysis. Cells were washed with 1 mL pre-
warmed PBS and harvested with trypsin/EDTA solution (300 µL, 4 min incubation). 
After the incubation period 700 µL of complete media was added, mixed with the 
collected media of step 1 and centrifuged (5 min, 800 RPM). 
Resulting cell pellets were washed twice with cold PBS. Then cells were resuspended in 
binding buffer at a concentration of approximately 1 x 106 cells/mL. 100 µL of this 
suspension was transferred into 5 mL culture tubes and 5 µL of Annexin V-PE and 7-
ADD were added. Cells were incubated for 15 min at RT in the dark. Then 400 µL of 
binding buffer was added to each tube and samples were analysed by flow cytometry 
within one hour. 
For each sample 10.000 cells were acquired and data management was done with 
CellQuest Pro Software (FACScan, BD Biosciences, USA). Experiments were 
performed in triplicates.  
 
3.3.12.3  Intracellular Superoxide anion (O2•-) generation 
Hydroethidine (HE) was used for the detection of O2•- in living cells. It is a non-
fluorescent compound, which diffuses easily through the cell membrane. Under the 
action of O2•- HE is dehydrogenated to ethidium bromide and intercalates DNA. The 
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red fluorescence of ethidium can be measured by flow cytometry (absorption/emission: 
518/605 nm) (Rothe and Valet, 1990).  
 
3.3.12.3.1  Preparation of solutions and reagents 
Stock solution (1 mM): 
5 mg Hydroethidine 
16 mL DMSO 
 
3.3.12.4 Assay procedure 
At the end of the incubation period culture media was collected in order to include 
floating cells in the analysis. Cells were washed with 1 mL pre-warmed PBS, harvested 
with trypsin/EDTA solution (300 µL, 4 min incubation) and then 700 µL of complete 
media was added.  Cells were mixed with the collected media of step 1, centrifuged (5 
min, 800 RPM) and cell pellets were resuspended in PBS at a concentration of 
approximately 1x 106 cells/mL. 5 µL of HE-solution in DMSO was added to 1 mL of 
cell suspension. Then cells were incubated for 10 min at 37 °C in the dark, then stored 
on ice and analysed as quickly as possible by flow cytometry. 
For each sample 10.000 cells were analysed and data management was done with 
CellQuest Pro Software (FACScan, BD Biosciences, USA). Experiments were 
performed in triplicates  
 
3.3.13 Measurement of Lipid Peroxidation  
To include a second maker for oxidative stress, malondialdehyde (MDA) was measured. 
MDA constitutes an end product of lipid peroxidation and was determined as described 
earlier (Ramel et al., 2004), with some modifications. 
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Tab 3.13 HPLC conditions used for MDA-determination 
 
3.3.13.1 Preparation of solutions and reagents 
Phosphoric acid (44 mM): 
3 mL orto-phosphoric acid (85%) 
ad 100 mL aqua bidest. 
 
Thiobarbituric acid (TBA): 
0.6 g TBA 
100 mL aqua bidest. 
 
Methanol/ NaOH (90/10, v/v): 
5 mL NaOH (1N) 
45 mL methanol (chromasolv) 
NaOH (1N) 
4 g NaOH 
100 mL aqua bidest. 
 
column: LichroCART 250-4 Lichrosher 100 RP-18.10 µm
pre-column: LichroCART 125-4 Lichrosher 100 RP-18.5 µm
Hitachi F-1050 flourescence detector
HPLC conditions
mobile phase phosphate buffer/ methanol (60/40, v/v)
flow rate 1 mL/min 
injection volume 20 µL
detection fluorescence (emission/excitation: 563/532 nm) sensitivity: 20
Hitachi D-7500 integrator
LaChrom Merck Hitachi chromatography system
Hitachi L-7100 pump 
HPLC system
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KCl (75 mM): 
5.592g KCl/1000 mL aqua bidest. 
 
Phosphate buffer (pH 6.8): 
6.8 g potassium dihydrogen phosphate 
ad 1L aqua bidest. 
 
Tab 3.14 Composition of standard solutions used for MDA-determination 
 
3.3.13.2 Assay procedure 
At the end of the incubation period culture media was collected (to include floating cells 
in the analysis). Cells were washed with 1 mL pre-warmed PBS, harvested with 
trypsin/EDTA solution (300 µL, 4 min incubation), media including floating cells were 
added and centrifuged (5 min, 800 RPM). Cell pellets were resuspended in 2 mL of 
media. A single cell suspension was prepared using an injection cannula and 100 µL 
thereof were used for the determination of cell numbers. The remaining cell suspensions 
were centrifuged (5 min, 800 RPM) again. 150 µL KCl, 400 µL aqua bidest., 700 µL 
phosphoric acid and 260 µL TBA was added to the cell pellets. At the same time 500 
µL aqua bidest., 700 µL phosphoric acid and 260 µL TBA were added to 50 µL of the 
standard solutions. Standards and cell samples were incubated in boiling water for 60 
minutes and then cooled on ice. 100 µL of the cell samples or standards were mixed 
with 100 µL of methanol/NaOH and centrifuged (3 min, 3000 RPM). Then 20 µL were 
injected into the HPLC and MDA was measured by fluorescence detector. 
stock-solution 2 (8.12 µM)
100 µL stock 1
ad 50 mL EtOH/ Aqua bidest. (40/60, v/v)
standard 1 (81.2 µM): 
standard 2 (40.6 µM): 50 µL stock1 + 4.95 mL aqua bidest.
standard 3 (20.3 µM): 1 mL standard 2 + 1 mL aqua bidest.
standard 4 (8.12 µM): = stock 2
standard 5 (4.06 µM): 1 mL stock 2 + 1 mL aqua bidest.
standard 6 (0.81 µM): 100 µL stock 2 + 900 µL aqua bidest.
stock-solution 1 (4.06 mM)
50 µL 2-Thiobarbituric acid 
ad 50 mL EtOH/ Aqua bidest. (40/60, v/v)
100 µL stock1 + 4.9 mL aqua bidest.
standard solutions
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Data was expressed as nanomoles per 109 cells. Experiments were performed in 
triplicates. 
 
3.3.14 Alkaline single cell gel electrophoresis (SCGE) assay 
The single cell gel electrophoresis assay (Comet assay) represents a rapid technique for 
the quantification of DNA damage in individual mammalian cells. The assay was 
designed by Ostling and Johanson (Ostling and Johanson, 1984) for the detection of 
double-strand breaks. Due to further developments (Singh et al., 1988; Olive, 1989) 
today various forms of DNA damage (e.g., single- and double-strand breaks, alkali 
labile sites, oxidative DNA base damage and DNA cross-linking with DNA or protein) 
can be confirmed. 
The principle of the assay is that cells embedded in agarose gel on microscope slides are 
lysed to remove all cellular proteins. Thereafter DNA is allowed to unwind under 
alkaline conditions and later electrophoresed. In the electric field broken DNA 
fragments (damaged DNA) migrates faster than undamaged DNA, as it remains mainly 
in the nucleus. The result looks like a comet with a ‘head’ of intact DNA and a ‘tail’ full 
of DNA fragments. The extent of DNA drifted away from the head of the comet was 
directly proportional to the DNA damage.  
 
 
Fig 3.5 Scheme of the alkaline single cell gel electrophoresis assay 
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3.3.14.1 Preparation of solutions and reagents  
 
Lysis solution 
2.5 M NaCl (146.1 g) 
100 mM Na2EDTA (37.2 g) 
10 mM Tris (1.2 g) 
in 1 L aqua bidest. 
PH was set to 10 by addition of NaOH (~ 8 g). 
Prior to use 1% Triton X 100 and 10% DMSO were added and the lysis solution was 
refrigerated for at least one hour. 
 
Electrophoresis buffer 
stock solutions: 
10 N NaOH (200 g/500 mL aqua bidest.) 
200 mM Na2EDTA (14.89 g/200 mL aqua bidest.) 
For 2200 mL of electrophoresis buffer (pH 13.6-13.7) 2130 mL aqua bidest., 59 mL 
NaOH and 11 mL Na2EDTA was mixed. Electrophoresis buffer should be cooled before 
use. 
 
Neutralising buffer 
0.4 M Tris (48.5 g/1000 mL aqua bidest.) 
pH was set to 7.5 with HCl solution (3.5 %). 
 
Low melting agarose (LMA) 
125 g LMA  
25 mL PBS  
For experiments LMA had to be heated in the microwave and stored at 37 °C in the 
waterbath. 
 
Normal melting agarose (NMA) 
1.5 g NMA  
100 mL PBS  
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NMA was heated in the microwave until near boiling. In order to pre-coate the slides 
they were dipped in hot agarose. On the underside the agarose was wipped off, slides 
were air dried and stored at room temperature until needed. 
 
Ethidium bromide (20 µg/mL) 
10 µL stock solution (10 mg/mL) 
5 mL aqua bidest. 
 
3.3.14.2 Assay procedure 
The SCGE assay (comet assay) was carried out according to the guidelines developed 
by Tice et al. (1990; 2000) and Singh et al. (1988). 
At the end of the incubation period culture media was collected to include also floating 
cells in the analysis. Cells were washed with 1 mL pre-warmed PBS, harvested with 
trypsin/EDTA solution (300 µL, 4 min incubation), mixed with floating cells and 
centrifuged (5 min, 800 RPM). Cell pellets were resuspended in 500 µL of media and a 
single cell suspension was prepared using an injection cannula. 100 µL of the cell 
suspension were mixed with 100 µL of trypan blue solution (incubated 3 min) and cell 
numbers were determined. Aliquotes of 1x105 cells were mixed with 80 µL of LMA and 
transferred to NMA-coated slides. Slides were covered with cover slips and placed on 
ice packs until the agarose has solidified. Then cover slips were removed, slides were 
placed in lysis solution and stored at 4 °C for 24 hours. 
After lysis slides were incubated in alkaline electrophoresis buffer (40 min) for DNA 
unwinding. Then electrophoresis was performed using a horizontal gel electrophoresis 
(25 V, 50 W, 300 mA, 20 min). Thereafter slides were rinsed 2 times with neutralization 
buffer and once with cold aqua bidest. Dried slides were stained with 5 µL ethidium 
bromide solution and analysed using a fluorescence microscope coupled with a 
computerized image analysis system (Komet 5.5, Kineting Imaging, Liverpool, UK). 
For each sample, three replicate gels were analysed and from each replicate slide 50 
cells were randomly selected. As parameter of DNA damage percentage of DNA in the 
tail (% DNA in tail) was determined.  Each experiment was done twice. 
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3.3.15 Statistical analysis of cell assays 
All data are expressed as mean ± SD (standard derivation). Obtained data were analysed 
by the Student’s t-test since they were all normally distributed, using SPSS 15.0 for 
Windows. Statistical differences were considered significant at a value of p < 0.05 and 
are reported as p < 0.05, p < 0.01 and p < 0.001. 
 
3.3.16 Measurement of the uptake of oxidation products in HepG2-cells 
3.3.16.1.1 Extraction of the oxidation products 
At the end of the incubation period culture media was removed and collected separately. 
Cells were harvested using trypsin/EDTA solution (1.5 mL, 4 min), centrifuged (800 
RPM, 5 min), washed twice with PBS and resuspended in 5 mL of KCl (incubation for 
20 min). Then the lipid fraction was extracted from cell and media samples. Therefore 5 
mL of diethyl ether was added and after centrifugation (1200 RPM, 10 min) the ether 
phase was collected. This extraction procedure was repeated 3 times. 
The ether phases of all samples were evaporated and dissolved in ethanol. Then the 
samples were sent to the Department of Applied Chemistry and Microbiology and there 
stored at -20 °C until measurement. 
 
3.3.16.1.2 Sample preparation for HPLC-analysis 
Extracted samples were evaporated again, dissolved in 1 mL of n-heptane/2-propanol 
(95/5, v/v) and filtered (0.45 µm GHP membrane filters) and stored at -20 °C until 
analysis. 
 
3.3.16.1.3 Quantification of the extracted oxidation products by a HPLC-UV-ELSD 
system 
For the separation of the extracted oxides a mobile phase system of n-heptane/2-
propanol (97/3, v/v) and a flow rate of 0.6 mL/min were used based on methods 
published by Kemmo et al. (2005; 2004).  
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In order to ascertain co-elutions of oxysterols and lipid extracts of the cell membrane 
standard solutions consisting of 7-ketocholesterol, 7β-OH-cholesterol, 7α-OH-
cholesterol, the laboratory prepared mixture of 6-β-OH-3-keto-sitosterol/6-α-OH-3-
keto-sitosterol (also used for incubation experiments) and cell lipid residues (derived as 
result of the extraction) were used. 
 
In several pre-testes ELSD conditions were examined with the help of cholesterol oxide 
standard solutions (7-ketocholesterol, 7α-OH-cholesterol and 7β-OH-cholesterol). The 
effect of various temperatures (50 °C/42 °C, 55 °C/42 °C, 60 °C/42 °C and 45 °C/36 °C 
for drift tube/nebulising temperature), nebuliser gas pressures ( 20, 30, 40  and 50 PSI) 
and injection volumes (5 and 10, 20 µL) were tested.  
 
Tab 3.15 HPLC conditions used for the detection of POPs 
 
3.3.16.1.4  Assessment of detection limits and linearity of UV and ELSD responses 
Detection limits and linearity were determined using standard solutions containing 7-
ketocholesterol, 7β-OH-cholesterol and 7α-OH-cholesterol.  
Waters pump (model 515)  (Walters, Milford, USA) 
Waters 996 Photodiode Array Detector  (Walters, Milford, USA) 
Waters 2420 ELS-detector  (Walters, Milford, USA) 
mobile phase n -heptane/2-propanol (97/3, v/v)
flow rate 0.6 mL/min 
injection volume 20 µL
detection UV-detection, 206 nm
ELSD-detection: nebulization temperature 42 ˚C
                           drift tube temperature 50 ˚C
                           pressurised air 20 PSI
HPLC conditions
Supelcosil silica column (250 mm x 2.1 mm i.d., 5 µm)  (Supelco, Bellefonte, PA, USA) 
HPLC system
Waters 717 plus Autosampler (Walters, Milford, USA) 
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Tab 3.16 Cholesterol oxide standard solutions 
 
Detection Limits (LOD) were calculated on the basis of a signal to noise ratio of 3. 
Standard solution 1 was diluted down to one hundred times and multiple injections on 
different days were performed. 
For assessment of linearity triplicate injections of 6 different volumes (5, 10, 20 and 30 
µL of solution 1; 10 and 15 µL of solution 2) of the standard solutions were processed.  
 
3.3.16.1.5 Quantification of sterol oxides 
Quantification was performed by PDA - and ELS - detection. The concentrations of the 
oxidation products were estimated by cholesterol standards of the corresponding 
cholesterol oxidation products, whereas 7-ketocholesterol was also used for the 
quantification of 6α-OH-3-keto-sitosterol and 6β-OH-3-keto-sitosterol. Concentration 
and purity of the standards was confirmed by GC–FID as described above. Standard 
curves were analysed at the beginning and at the end of each compound, concentration 
of the oxides was calculated using the mean standard curve.  
 
3.3.16.1.6 Statistical analysis 
The data was recorded as means ± standard deviations. Analysis was carried out by 
simple regression testing using Statgraphics 4.0 software (STCC Inc., Rockville, ML). 
µg/mL cholesterol oxides
solution 1 63.5 7-keto
79.9 7β-OH
61.9 7α-OH
solution 2 328.6 7-keto
395.6 7β-OH
305.6 7α-OH
standard solutions
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4. Results and Discussion 
 
4.1 Production and isolation of phytosterol oxidation products 
As already mentioned POPs are commercially not available. For the assessment of their 
potentially harmful effects in bacterial and cell culture assays individual oxides had to 
be laboratory-prepared. Various methods for the preparation of sterol oxidation products 
exist. However, most of them are designed for the collection of only small amounts of 
oxides. 
Therefore the initial target of this thesis was the development of a fast, simple and 
effective method for the isolation of common β-sitosterol oxides. 
 
4.1.1 Preparation of oxides by thermo-oxidation 
For the preparation of β-sitosterol oxidation products thermo-oxidation in solid state 
was conducted. Different heating conditions (130 °C/ 24 h, 130 °C/ 48 h and 120 °C/ 48 
h) were tested and generated amounts of oxysterols were estimated by GC-FID. As can 
be seen in figure 4.1 after heat treatment for 24 h at 130 °C highest amounts of the 
single oxides were formed. Longer heat exposure, however, decreased the total amount 
of oxidation products detected. This may be due to conversion reactions to other 
secondary oxidation products or further reactions such as polymerisation leading to non 
polar compounds, dimers and polymers (Soupas et al., 2005).  
Similar to our findings Kemmo et al. (2005) reported that heat treatments at different 
temperatures induced the formation of the same kind of oxidation products, yet the 
amount of the single oxides varied. Already Caboni et al. (1997) noticed that the ratios 
of the formed products were influenced by the oxidation conditions applied. 
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Fig 4.1 Proportion of collected β-sitosterol oxidation products (mg) after different 
oxidation conditions (130 °C/24 h, 120 °C/48 h and 130 °C/48 h) measured by GC-FID.  
 
The oxidation products observed in these experiments, 7-ketositosterol, 7β-OH-
sitosterol, 7α-OH-sitosterol, 5,6β-epoxy-sitosterol, 5,6α-epoxy-sitosterol, 6β-OH-3-
keto-sitosterol, 6α-OH-3-keto-sitosterol, 6β-OH-sitosterol and 6keto-sitosterol, were 
analogous to those commonly found in literature.  
Grandgirard et al. (2004c) generated 7α-OH-, 7β-OH-, 5,6α-epoxy, 5,6β-epoxy- 7keto- 
and triol-compounds of various plant sterols after heat-treatment at 135 °C for 24 h.  
Johnsson and Dutta (2003) heated plant sterols for 72 h at 120 °C and found 7α-OH-, 
7β-OH-, 5,6α-epoxy, 5,6β-epoxy- and 7keto- compounds. Additionally 24-OH-, 25-OH- 
as well as 6-OH-3-keto- compounds were detected. 
Same as (Daly et al., 1983; Apprich and Ulberth, 2004; Conchillo et al., 2005) no triols 
were observed in our experiments, presumably due to the lack of water (Zhang et al., 
2005b).  
The high amount of 7-ketositosterol and the generation of 7β-OH-sitosterol rather than 
7α-OH-sitosterol was in accordance with previous studies (Chien et al., 1998; Kemmo 
et al., 2005). 
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4.1.2 Purification and enrichment of phytosterol oxidation products  
After heat treatment of sterols a mixture of oxidation products, non oxidized material 
and several unknown by-products is formed. Because of the complexity of the gained 
blend usually a combination of different separation techniques is applied (Daly et al., 
1983). 
To exclude the main part of unknown and non oxidized compounds, column 
chromatography using silica gel was conducted. In recent years column chromatography 
and TLC have been gradually replaced by the use of disposable ready-to-use SPE 
cartridges (Guardiola et al., 2004). However, considering the great amount of samples to 
be purified, in our case CC with its higher loading capacity allowed a more efficient 
working procedure. 
Since our interest was focused on POPs with a higher polarity than non oxidized β-
sitosterol a stepwise elution order to remove apolar components up to free β-sitosterol 
was applied. Solvent mixtures of n-heptane/diethyl-ether with increasing polarity in 
combination with silica gel and a final elution of the oxidized components with acetone 
were already successfully employed by others (Apprich and Ulberth, 2004; Lampi et al., 
2002; Piironen et al., 2002).  
The activity of polar sorbents like silica gel depends strongly on the hydration of the 
silanol groups (Guardiola et al., 2004). Therefore, as parts of the oxidation products 
were obviously retained in the column, 10 % of water was added to the silica gel. 
 
Analytical TLC was used to confirm the separation process performed by CC (figure 
4.2). Products with a lower polarity than β-sitosterol were successfully removed. 
Although non oxidized β-sitosterol was still present in the purified samples a relevant 
reduction could be noted. 
Identification of the oxidation products was not only done by comparison of the 
respective Rf-values with those of the corresponding cholesterol oxides, but also by 
colour development after spraying with sulphuric acid and following heat treatment. In 
accordance with earlier publications (Daly et al., 1983; Bortolomeazzi et al., 1999) non 
oxidized sterols, β-sitosterol and cholesterol, turned reddish brown, epoxide epimeres 
yellow and 7α-OH- and 7β-OH-compounds blue. Under the conditions applied 
separation of 7-ketosterols and epoxy derivatives was not achieved. However, 7-
Results and Discussion                                                                                                  74   
ketosterols don’t show colour development but are detectable under UV light (Lebovics, 
2002; Daly et al., 1983). 
Fig 4.2 Oxidation products of β-sitosterol observed on silica TLC plates developed after 
spraying with 50% sulfuric acid and following heat treatment. 
 
4.1.3 Separation of single oxidation products by a NP-HPLC-UV system 
Due to the high sample amounts to be separated and in accordance with earlier 
publications (Daly et al., 1983; Ansari and Smith, 1979) the application of an HPLC 
method was more effective for the isolation of single oxidation products than more 
generally used TCL methods. Further in TLC analysis artefact formation due to the long 
exposure of the samples to air is possible (Rose-Sallin et al., 1995). 
In general both normal (Kemmo et al., 2007; Kemmo et al., 2008; Csallany et al., 1989; 
Chien et al., 1998) and reverse phase chromatography (Osada et al., 1999; Razzazi-
Fazeli et al., 2000; Manini et al., 1998) has already been successfully used for the 
analysis of cholesterol- and plant sterol oxidation products. Yet normal phase 
chromatography is considered to be the more effective option (Saldanha et al., 2006).  
Correspondingly the final separation of the oxidation products was achieved by a 
normal phase HPLC-UV system with a silica column. Based on investigations of 
Kemmo et al. (2007; 2005) different mobile phase systems with changing percentages 
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of n-heptane and 2-propanol were tested. Rapid separation within 20 min could be 
achieved in an isocratic system with a mobile phase of n-heptane/2-propanol (93:7, v/v). 
 
Fig 4.3 Separation of β-sitosterol oxidation products by NP-HPLC. 
 
 
Figure 4.3 shows the elution order in this system: 6β-OH-3-ketositosterol/6α-OH-3-
ketositosterol, 7-ketositosterol, 6β-OH-sitosterol, 7β-OH-sitosterol and 7α-OH-
sitosterol.  
Due to the high injection volume of purified samples 6β-OH-3-ketositosterol and 6α-
OH-3-ketositosterol co-eluted. However, our interest was focussed on the isolation of 
large amounts of the major oxidation products 7-ketositosterol, 7β-OH-sitosterol and 
7α-OH-sitosterol and good separation was achieved for them. Therefore the applied 
method was retained and 6-OH-3-keto - epimeres were collected in one fraction. 
Injection of 1.8 mL oxide sample (containing oxidation products derived from 
approximately 1000 mg β-sitosterol) led to yields in the range of several milligrams for 
the single fractions in one HPLC run (table 4.1). 
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compound retention time (min) mg/ injection overall collected amounts (mg)
6β-OH-3-keto-sitosterol 5.7 430.7
6α-OH-3-keto-sitosterol 4.34 315.7
7keto-sitosterol 11.09 16.9 1753.2
7β-OH-sitosterol 13.36 11.03 1044.4
7α-OH-sitosterol 14.82 6.12 592.6
7.82
 
Tab 4.1 Retention times and yields of single oxidation products (mg) within one HPLC- 
run or in total. 
 
Separation of the sterol oxides was monitored using UV detection at a wavelength of 
206 nm, which is the common wavelength employed for oxysterols (Csallany et al., 
1989). Therefore epoxy-compounds, although being formed during the oxidation 
process, couldn’t be isolated with this method, as in general products without double 
bonds do not absorb well at UV wavelengths (Moreau, 2005). 
 
4.1.4 Purity of the collected oxidation products 
For identification and quantification of the collected fractions GC-MS and GC-FID 
were used, respectively (Soupas et al., 2004b; Lampi et al., 2002).  
The applied commercial β-sitosterol was almost pure, but included approximately 10 % 
of campesterol. Therefore during the heating process campesterol oxides were formed 
too. In accordance with earlier investigations (Dutta and Appelqvist, 1997) it was not 
possible to separate campesterol oxides from their sitosterol counterparts during the 
HPLC run. On average 10 % campesterol oxidation products were present in the 
corresponding β-sitosterol oxides. However - considering the velocity of our method - 
we decided to put up with these impurities.  
Moreover, high proportions of 7-ketositosterol were found in the 6β-OH-sitosterol-
sample. Therefore 6β-OH-sitosterol was excluded from subsequent toxicology testing. 
Table 4.2 gives detailed information on the purity of the respective compounds. 
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Tab 4.2 Purity of the obtained oxidation products as measured by GC-FID.  
 
4.2 Salmonella microsome assay 
For the evaluation of the anti-/mutagenic and anti-/oxidative potential of the collected 
oxidation products, 7-ketositosterol, 7β-OH-sitosterol, 7α-OH-sitosterol, a mixture of 
6β-OH-3-ketositosterol/6α-OH-3-ketositosterol (ratio 4:3) and a mixture containing 
polar β-sitosterol oxides, were tested in Salmonella typhimurium indicator strains 
TA98, TA100 and TA102 in the Ames test. The preincubation assay was applied for all 
test runs. According to the literature this is the most sensitive test form, since it allows a 
closer contact between test compounds and indicator strain, which is an advantage for 
detecting short- living mutagens (Mortelmans and Zeiger, 2000). 
To our knowledge single oxides of β-sitosterol have never been tested before on their 
effects towards Salmonella typhimurium strains. 
 
4.2.1 Mutagenicity testing 
Mutagenicity assays were performed with all three indicator strains (TA98, TA100, 
TA102) with and without metabolic activation. Results are shown in table 4.3 and 4.4, 
respectively.  
campesterol counterpart others
6β-OH-3-keto-sitosterol/
6α-OH-3-keto-sitosterol
7keto-sitosterol 82 10 8
7β-OH-sitosterol 90 10
7α-OH-sitosterol 70 10 20
fraction purity (%) impurities (%)
88 12
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compound concentration TA 98  -S9 TA 98 +S9 TA 100 -S9 TA 100 +S9
(mg/plate)
revertants/ 
plate
revertants/ 
plate 
revertants/ 
plate 
revertants/
 plate 
negative control   22 ±5b)   50 ±11b)   205 ±65b) 199 ±10b)
7keto-sitosterol 5   22 ±5b)   46 ±4b)   236 ±62b) 192 ±12b)
1   27 ±5b)   52 ±13b)   276 ±40a)b) 191 ±22b)
0.2   25 ±3b)   46 ±7b)   237 ±72b) 187 ±14b)
0.04   22 ±5b)   49 ±7b)   210 ±60b) 175 ±20a)b)
7β-OH-sitosterol 5   21 ±4b)   53 ±6b)   202 ±31b) 212 ±10b)
1   23 ±3b)   48 ±4b)   197 ±43b) 183 ±18b)
0.2   24 ±8b)   46 ±5b)   195 ±51b) 175 ±3a)b)
0.04   24 ±3b)   47 ±7b)   195 ±36b) 182 ±16b)
7α-OH-sitosterol 1   17 ±3a)b)   56 ±3b)   220 ±17b) 187 ±48b)
0.2   19 ±3b)   50 ±9b)   209 ±28b) 163 ±6a)b)
0.04   16 ±8b)   46 ±12b)   202 ±45b) 176 ±8a)b)
6α-OH-3-keto/
6β-OH-3-keto
-sitosterol
2.5   25 ±3b)   46 ±3b)   204 ±38b) 179 ±9a)b)
1   24 ±4b)   54 ±6b)   212 ±55b) 180 ±33b)
0.2   23 ±9b)   54 ±9b)   217 ±66b) 175 ±5a)b)
0.04   21 ±4b)   49 ±9b)   240 ±57b) 142 ±26b)
mixture 10   22 ±5b)   37 ±5b)   200 ±56b) 174 ±4a)b)
5   20 ±2b)   44 ±3b)   202 ±44b) 182 ±13b)
1   22 ±8b)   56 ±3b)   216 ±59b) 168 ±11a)b)
0.2   22 ±4b)   48 ±5b)   204 ±71b) 173 ±9a)b)
0.04   22 ±6b)   46 ±4b)   213 ±63b) 173 ±3a)b)
positive control 211 ±15 965 ±74 2553 ±473 468 ±61
 
Tab 4.3 Overview on the data obtained in the preincubation assay with the strains TA98 
and TA100. Numbers of his+ - revertants are listed as means ± SD (a) p< 0.05 to 
negative control, b) p< 0.05 to positive control). In addition values significantly different 
to the negative control are coloured in orange. 
 
For all three strains the spontaneous mutation frequency was in accordance with the 
control levels published (Mortelmans and Zeiger, 2000) and the number of revertants of 
each sample was significantly lower than the positive control (p< 0.05). 
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In the preincubation assay using strain TA98 the number of his+- revertants of each 
sample was in the range of the negative control. Further no concentration dependency 
was observed. Therefore no mutagenic activity could be observed. 
 
In TA100 number of his+- revertants which significantly differed to that of the negative 
control were obtained for individual samples. In assays including metabolic activation, 
contrary to a rather expected mutagenic indication, a certain reduction of revertant 
numbers was observed. However, neither a twofold reduction nor a significant dose 
related decrease was induced. Thus no evidence for a mutagenic or protective effect of 
phytosterol oxides was seen. 
In accordance with Lea et al. (2004), who tested a mixture of oxidized and unoxidized 
products of β-sitosterol using different Salmonella strains (TA98, TA100, TA102, 
TA1535 and TA1537),  in the strains TA98 and TA100 β-sitosterol oxidation products 
were mutagenically not active. However, in the mentioned publication only an 
unspecific mixture containing 30% of phytosterol oxides was used. Differing results for 
individual oxides and mixtures have already been repeatedly documented (O'Sullivan A 
et al., 2005; Leonarduzzi et al., 2001). 
 
Also in TA102 none of the phytosterol oxidation products were able to increase the 
number of his+ - revertants beyond the doubled negative control, which was set as 
threshold for mutagenic activity. Yet for 7-ketositosterol, the mixture of 6β-OH-3-
ketositosterol/6α-OH-3-ketositosterol and the mixture of polar oxides a significant 
increase in revertant numbers was observed. Results for the two mixtures, however, 
were rather inconclusive as no dose relation was found.  
In the case of 7-ketositosterol also a concentration-dependent tendency was seen for the 
lower concentrations but not for the 5%- fraction, mainly due to its higher standard 
deviation. Moreover, in the test with metabolic activation the increase of 7-
ketositosterol (5%) was even more pronounced (figure 4.4).  
On the other hand 7β-OH-sitosterol was rather inactive in the normal preincubation 
assay. In the test approach with metabolic activation a significant reduction of the 
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number of revertants was detected for the highest concentration of 7β-OH-sitosterol 
(5%).  
Besides its capability of detecting cross-linking agents the indicator strain TA102 
additionally informs on oxidative stress (Grey and Adlercreutz, 2003; Mortelmans and 
Zeiger, 2000). Based on the latter, the increase in revertants induced by 7-ketositosterol 
(5%) could be an indication of a pro-oxidant tendency. On the other hand the decline in 
revertant numbers of 7β-OH-sitosterol (5%) could be interpreted as a marginal sign of 
antioxidative effects. However, it could also be the result of increased cytotoxicity 
(Mortelmans and Zeiger, 2000). 
 
Fig 4.4 Effects of 7-ketositosterol and 7β-OH-sitosterol in TA102 without (A) or with 
(B) metabolic activation. The dotted lines represent the doubled negative control. 
Results are expressed as mean + SD (* p < 0.05 to negative control). 
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Publications on the mutagenic properties of plant sterol oxides other than that of Lea et 
al. (2004) are lacking. However, some evidence exists that mixtures of COPs have 
mutagenic effects towards Salmonella typhimurium strains (Ansari et al., 1982; Smith et 
al., 1979). Due to the structural similarity of POPs and COPs analogues biological 
effects are assumed. 
Sevanian and Peterson (1986) investigated pure oxidation products of cholesterol and 
showed α-epoxide and β-epoxide to be mutagenic in V79 Chinese lung fibroblasts. Both 
epoxide epimers can be hydrolysed to triol which was not found to be mutagenic but 
highly cytotoxic. More recently Cheng et al. (2005) investigated three pure COPs, 7-
ketocholesterol, 5,6α-epoxy-cholesterol and triol compounds, in the Ames and in the 
chromosome aberration test. Contrary to the results cited above the mutagenic response 
of triol was clearly demonstrated, whereas 7-keto- and 5,6α-epoxy-cholesterol were not 
active. Similar to Smith et al. (1986) the authors suggested ROS to be involved in the 
mutagenic action since antioxidant enzymes diminished the mutagnic response.  
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compound concentration TA102 TA102 TA102+tBOOH TA102+tBOOH 
(mg/plate) revertants/ plate -S9
revertants/ 
plate +S9
revertants/
 plate -S9
revertants/
 plate +S9
negative control   571 ±44b)   847 ±63b)   747 ±99b) 1589 ±349b)
7keto-sitosterol 5   701 ±82a)b) 1318 ±41a)b)   866 ±24a)b) 2038 ±239b)
1   685 ±16a)b)   926 ±28b)   936 ±66a)b) 1714 ±137b)
0.2   635 ±36a)b)   879 ±108b)   940 ±75a)b) 1891 ±334b)
0.04   575 ±45b)   846 ±81b)   963 ±52a)b) 1974 ±123b)
7β-OH-sitosterol 5   607 ±55b)   675 ±68a)b)   525 ±45a)b) 1374 ±60b)
1   589 ±79b)   853 ±32b)   776 ±58b) 1770 ±146b)
0.2   582 ±76b)   840 ±91b)   840 ±65b) 1679 ±146b)
0.04   606 ±74b)   793 ±37b)   804 ±71b) 1591 ±103b)
7α-OH-sitosterol 1   597 ±101b)   744 ±97b)   684 ±56b) 1222 ±156b)
0.2   510 ±27a)b)   802 ±16b)   812 ±36b) 1252 ±164b)
0.04   452 ±103a)b)   652 ±34a)b)   686 ±111b) 1317 ±93b)
6α-OH-3-keto/
6β-OH-3-keto-
sitosterol 2.5   684 ±88a)b)   1051 ±28a)b)   809 ±51b) 2119 ±90a)b)
1   644 ±51a)b)   979 ±12a)b) 1031 ±42a)b) 2082 ±32a)b)
0.2   609 ±40b)   990 ±29a)b)   801 ±121b) 2338 ±29a)b)
0.04   644 ±62a)b)   953 ±2a)b)   814 ±32b) 2065 ±70b)
mixture 10   713 ±60a)b)  1079 ±107a)b)   891 ±14a)b) 1501 ±35b)
5   648 ±94a)b)   1008 ±54a)b)   797 ±12b) 1879 ±158b)
1   598 ±55b)   967 ±82a)b)   842 ±102b) 1997 ±5a)b)
0.2   556 ±67b)   829 ±41b)   902 ±76a)b) 2003 ±19b)
0.04   625 ±27a)b)   731 ±143 b)   851 ±113b) 2057 ±175b)
positive control 2353 ±422 3480 ±165 2412 ±71 3780 ±271
 
Tab 4.4 Overview on the data obtained in the preincubation assay with the strain 
TA102. Numbers of his+ - revertants are listed as means ± SD (a) p< 0.05 to negative 
control, b) p< 0.05 to positive control). In addition values significantly different to the 
negative control are coloured in orange. 
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4.2.2 Antioxidant testing 
To strengthen the information on oxidative stress challenge tests with the pro- oxidant 
tertiary-butylhydroperoxide (tBOOH) and the strain TA102 were conducted. tBOOH is 
a known initiator of lipid peroxidation, where it leads to the formation of alkoxyl and 
alkyl radicals (figure 4.5). By the use of tBOOH a possible antioxidative action of the 
respective test compounds due to a radical scavenging mechanism is determined (Grey 
and Adlercreutz, 2003). Per definition a reduction of the revertant colony number below 
50% of the negative control level is necessary for an antioxidative effect (Mortelmans 
and Zeiger, 2000).   
Fig 4.5 Decomposition of tBOOH in the presence of Fe2+ (Halliwell and Gutteridge, 
1999a) 
 
After treatment with 7-ketositosterol number of his+ - revertants of all tested 
concentrations differed significantly from those obtained for the solvent control. Lowest 
number of revertants was obtained after incubation with the highest concentrated 
fraction (5%). However, since revertant numbers were still higher than the negative 
control no indication for an antioxidative effect was seen. In the test approach with 
metabolic activation an increase in the number of his+ - revertants for all concentrations 
of 7-ketositosterol, but in particular for the highest concentrated fraction (5%), was 
observed. Yet no significant results were obtained (figure 4.6). 
 
The significant reduction of the number of his+ - revertants of 7β-OH-sitosterol (5%) 
observed in the preincubation assay with TA102 was even more pronounced by the 
addition of tBOOH. However, no dose response was found. Therefore no antioxidative 
effect could be proven, even though an indication for a weak antioxidative behaviour 
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can be presumed. However, with the addition of S9 this antioxidative property was 
attenuated (figure 4.6). 
 
Results for 7α-OH-sitosterol, the mixture of 6β-OH-3-ketositosterol/6α-OH-3-
ketositosterol and the mixture containing polar β-sitosterol oxides were, despite some 
significantly increased values, rather inconclusive. 
 
Fig 4.6 Effects of 7-ketositosterol and 7β-OH-sitosterol in the challenge test using 
tBOOH and TA102 without (A) or with (B) metabolic activation. The dotted lines 
represent the doubled negative control. Results are expressed as mean + SD (* p < 0.05 
to negative control). 
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4.3 Cell culture assays 
Cytotoxicity of the phytosterol oxides 7-ketositosterol, 7β-OH-sitosterol, 7α-OH-
sitosterol, a mixture of 6β-OH-3-keto-sitosterol/6α-OH-3-keto-sitosterol (ratio 4:3) and 
a mixture of polar oxides was examined by the use of HepG2-cells. 3 different 
concentrations (30 µM, 60 µM und 120 µM) of each oxidation products as well as an 
incubation period of 24 hours were chosen for all experiments in order to guarantee 
uniformity and comparability.  
 
4.3.1 Viability assays 
For evaluation of cell viability after treatment with oxide samples the trypan blue 
exclusion assay and the MTT test were applied, respectively. Similar results for both 
test approaches were obtained. 
 
4.3.1.1 Trypan blue exclusion assay 
Using the trypan blue exclusion assay incubation with the test compounds resulted in a 
significant decrease in cell numbers relative to the negative control (p≤ 0.001, except 
7β-OH-sitosterol). Significant concentration dependencies were found for 7α-OH-
sitosterol (p ≤ 0.001), 7-ketositosterol (p ≤ 0.01) and the mixture (p ≤ 0.05). The order 
of cytotoxicity at the highest concentration tested (120 µM) was 7α-OH-sitosterol > 7-
ketositosterol > 6α-OH-3-keto/6β-OH-3-keto-sitosterol = mixture > 7β -OH-sitosterol 
(figure 4.7). 
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Fig 4.7  Cell numbers measured by the TB-assay after 24 h of incubation with β-
sitosterol oxides, expressed as percentage of negative control. Results are expressed as 
mean + SD (* p < 0.05; ** p≤ 0.01; *** p≤ 0.001 to negative control). 
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Fig 4.8 Percentage of cell death measured by the TB-assay after 24h of incubation with 
β-sitosterol oxides. Results are expressed as mean + SD (* p < 0.05; ** p≤ 0.01; *** p≤ 
0.001 to negative control). 
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When the percentage of cell death in control and treated cells was assessed a significant 
(p ≤ 0.001, for 7β -OH-sitosterol (30 µM): p ≤ 0.05) increase for all compounds, except 
for the mixture at 30 µM (p = 0.298), could be seen. Significant dose response was only 
observed for 7-ketositosterol (p≤ 0.01). At all three concentrations tested the increase in 
cell death was particularly pronounced for 7-keto-sitosterol and 7α-OH-sitosterol (figure 
4.8). 
 
4.3.1.2 MTT- assay 
Applying the MTT assay a significant reduction of metabolically active cells compared 
to the negative control was observed for all sterol oxides (p ≤ 0.001, for 7β -OH-
sitosterol p ≤ 0.01) tested (figure 4.9). Further concentration dependencies (p ≤ 0.001) 
were found for 7α-OH-sitosterol, 6α-OH-3-keto/6β-OH-3-keto-sitosterol and the 
mixture. Also for 7β -OH-sitosterol and 7-ketositosterol cell viability after treatment 
with 30 µM of the respective oxides differed significantly (p ≤ 0.001) from that 
obtained after incubation with concentrations of 60 µM or 120 µM. However, no 
significant differences were observed between the results of 60 µM and 120 µM 
treatment. 
Similar to the results of the trypan blue exclusion assay 7α-OH-sitosterol appeared to be 
the most toxic compound, followed by 6α-OH-3-keto/6β-OH-3-keto-sitosterol and 7-
ketositosterol. At the highest concentration tested (120 µM) 7α-OH-sitosterol reduced 
viability of the cells to 23 % of the control level. The order of cytotoxicity at this 
concentration was 7α-OH-sitosterol > 6α-OH-3-keto/6β-OH-3-keto-sitosterol > 7-
ketositosterol > mixture > 7β -OH-sitosterol. 
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Fig 4.9 Cell viability measured by the MTT-assay after 24h of incubation with β-
sitosterol oxides, expressed as percentage of negative control. Results are expressed as 
mean + SD (* p < 0.05; ** p≤ 0.01; *** p≤ 0.001 to negative control). 
 
Thus results of the trypan blue assay were consistent with those obtained by the MTT 
assay (7-ketositosterol: r = 0.609, p ≤ 0.001; 7β -OH-sitosterol: r = 0.389, p ≤ 0.001; 7α-
OH-sitosterol: r = 0.637, p ≤ 0.001; 6α-OH-3-keto/6β-OH-3-keto-sitosterol: r = 0.235, p 
≤ 0.05; mixture: r = 0.466, p ≤ 0.001). In both test approaches viability of the cells was 
significantly reduced after incubation with increasing concentrations of β-sitosterol 
oxides, which corresponds to earlier studies on phytosterol oxides (Maguire et al., 2003; 
Adcox et al., 2001; Ryan et al., 2005; Roussi et al., 2005). 
Ryan et al. (2005) investigated several β-sitosterol oxidation products (7β-OH, 7-keto, 
sitostanetriol, 5α, 6α-epoxide, 5β, 6β-epoxide and a mixture of 5α, 6α-epoxide/5β, 6β-
epoxide (6:1)) and their corresponding oxycholesterols in three cell lines including 
HepG2-cells. In contrast to our results none of the tested phytosterol oxides caused 
significant cell damage at a concentration of 30 µM. Further 7β-OH- and 7-
ketositosterols turned out to be the compounds exerting the highest cytotoxicity.  
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Conversely, in the present study 7β-OH-sitosterol appeared to have the lowest effect on 
the viability of cells. This corresponds to the investigation of Roussi et al. (2005), who 
found a reduction in cell numbers through treatment with 7β-OH-sitosterol only after 
incubation periods longer than 24 h.  
Regarding both viability assays conducted the mixture had the second lowest impact on 
HepG2-cells. Based on several investigations on COPs (Leonarduzzi et al., 2001; 
Aupeix et al., 1995; Biasi et al., 2004), mixtures of oxysterols are thought to be less 
toxic towards cells than isolated oxides. 
No information on the cytotoxic properties of 6α-OH-3-keto- and 6β-OH-3-keto-
compound of phytosterols and cholesterol towards cell lines exist. Compared to the 
other oxides tested moderate inhibition of cell proliferation was observed. Due to the 
lack of comparative data no further conclusion can be drawn. 
Consistently 7-ketositosterol and 7α-OH-sitosterol emerged as those compounds 
exerting the strongest reduction of cell viability. The toxic potential of 7-ketositosterol, 
was already confirmed in various in vitro assays (Ryan et al., 2005), whereas so far data 
on 7α-OH-sitosterol is lacking. Contrary to the present findings its cholesterol 
counterpart was found to exhibit less than or equal toxicity to 7β-OH-cholesterol (Clare 
et al., 1995). However, individual 7α-OH-products of plant sterols have never been 
tested before. 
 
4.3.2 Detection of apoptosis  
To elucidate whether apoptosis was involved in the reduction of cell numbers flow 
cytometry was conducted. Apoptosis is characterised by morphological changes as 
shrunk cell volume, condensed chromatin and finally the formation of apoptotic bodies 
(Samali et al., 1999). These morphological alterations affect the light scattering 
properties of cells. Therefore the analysis of scattered signals as done by flow cytometry 
allows information on cell size and structure. Decreased forward scatter (cell size) and 
increased side scatter (granularity) are characteristic of apoptotic cells (Koopman et al., 
1994; Tuschl and Schwab, 2003). Such subpopulations were observed after treatment of 
cells with 60 and 120 µM of 7-ketositosterol, 7α-OH-sitosterol and 6α-OH-3-keto/6β-
OH-3-keto-sitosterol, thus indicating apoptotic cell death.  
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To further clarify the mode of cell death double staining with PE-labelled AnnexinV 
and 7-AAD was conducted. In the presence of Ca2+ ions Annexin V attaches 
specifically to phosphatidylserine, which is translocated from the inner to the outer cell 
surface during the early phase of apoptosis (Vermes et al., 2000). 
Of all tested compounds only 7-ketositosterol (30 µM) was able to increase (+ 45 %) 
the proportion of AnnexinV positive cells compared to the negative control (figure 
4.10). This increase, however, was not significant. Treatment with higher concentrations 
of 7-ketositosterol led to a reduction in AnnexinV positive cells. Also for all other 
oxides a decrease in the proportions of AnnexinV positive cells with increasing 
concentration of test samples was found. The present observation indicates chosen 
incubation conditions being too intense for detecting early apoptotic events. This 
corresponds to findings of Leonarduzzi et al. (2002) who observed that 7-
ketocholesterol induced apoptosis at low concentrations whereas at higher sample 
amounts necrosis was the predominate mode of cell death.  
At the time point investigated higher percentages of necrotic or late apoptotic than early 
apoptotic cells were detected. Therefore it could either be that apoptosis was already 
initialised at earlier timepoints and the detected results display post apoptotic necrosis 
or that tested oxides induced generally necrosis in HepG2-cells. 
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Fig 4.10 Effects of β-sitosterol oxides on phosphatidlyserine externalization in HepG2-
cells. Values are mean ± SD of 3 separate experiments and expressed as percentage of 
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negative control (dotted line). Columns significantly different to control levels are 
marked with * for p≤ 0.05, ** for p≤ 0.01 or *** for p≤ 0.001. 
 
The induction of apoptosis by POPs has already been determined previously (Roussi et 
al., 2005; Ryan et al., 2005; Maguire et al., 2003). Increase of apoptotic cells, assessed 
by morphological analysis and determination of DNA fragmentation, was found for 7-
keto- and 7β-OH-sitosterol in U937 cells, while no signs of apoptosis were ascertained 
in HepG2 and CaCo2-cells, respectively (Ryan et al., 2005). 
In contrast, Roussi et al. (2005) observed apoptosis, as measured by caspase activation 
and DNA fragmentation, in CaCo2-cells after treatment with 7β-OH-sitosterol using 
same sample concentrations.  
In our study increase in apoptotic cells was observed only after incubation with 7-
ketositosterol, but not with 7β-OH-sitosterol. However, considering the different 
methods applied, no firm comparison can be drawn.  
Phosphatidylserine exposure has not been tested before with phytosterol oxides. 
Concerning cholesterol, 7-keto- and 7β-OH- and 5,6β-epoxy-cholesterol were found to 
induce an increase in AnnexinV positive cells (Lemaire-Ewing et al., 2005). In contrast 
to our study in the case of cholesterol oxides U937 cells were used. Differences in the 
toxicity of oxysterols according to the applied cell lines have already been reported 
before (Miguet et al., 2001). 
 
4.4 Detection of oxidative stress 
Oxidation products of cholesterol were found to rapidly increase O2•- production 
(Monier et al., 2003; Miguet-Alfonsi et al., 2002; Lemaire-Ewing et al., 2005), which in 
general induces cell death. Therefore collected β-sitosterol oxides were tested for their 
oxidative properties. As O2•- constitutes only one type of ROS the measurement of 
MDA as a second maker for oxidative stress was included. 
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4.4.1 Measurement of superoxide anions (O2•-) production 
The generation of O2•- was quantified by flow cytometry after staining with HE. For all 
tested compounds a significant overproduction of O2•- was observed (figure 4.11). 
Highest activity, however, was assessed for 7-ketositosterol (+56 %) and the mixture 
(+54 %) at a concentration of 30 µM. No significant concentration dependency was 
found. 
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Fig 4.11 Effects of β-sitosterol oxides on superoxide anion production in HepG2-cells. 
Values are mean ± SD of 3 separate experiments and expressed as percentage of 
negative control (dotted line). Columns significantly different to control levels are 
marked with * for p≤ 0.05, ** for p≤ 0.01 or *** for p≤ 0.001. 
 
4.4.2 Measurement of lipid peroxidation (MDA)  
The effect of oxysterols on lipid peroxidation was investigated by HPLC-detection of 
MDA.  
A concentration dependent increase in MDA-levels was observed after treatment of 
cells with 7-ketositosterol, 7α-OH-sitosterol and 6α-OH-3-keto-/6β-OH-3-keto-
sitosterol (figure 4.12). At the highest concentration tested (120µM) MDA levels of 194 
% (7-ketositosterol), 298 % (7α-OH-sitosterol) and 140 % (6α-OH-3-keto/6β-OH-3-
keto-sitosterol) of the negative control were found. On the other hand 7β -OH-sitosterol 
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and the mixture had no effect on lipid peroxidation, as MDA levels in the range of the 
negative control were detected. 
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Fig 4.12 Effects of β-sitosterol oxides on Malondialdehyde formation in HepG2-cells. 
Values are mean ± SD of 3 separate experiments and expressed as percentage of 
negative control (dottet line). Columns significantly different to control levels are 
marked with * for p≤ 0.05. 
 
Only limited data exist concerning the oxidative properties of plant sterol oxides. 
Depletion of glutathione levels, but no effect on catalase activity was found in U937 
cells after incubation with a mixture of β-sitosterol oxides (Maguire et al., 2003). 
Similar Ryan et al. (2005) observed a significant decrease in glutathione after treatment 
with 7β -OH-sitosterol (120 µM), but neither β-carotene nor α- and γ-tocopherol could 
protect against POP induced damage. Comparing the oxidative effects of 7β-OH- 
sitosterol and -cholesterol in CaCo2-cells, in contrast to the oxycholesterol the sitosterol 
derivate was found to diminish the intracellular production of reactive oxygen species 
(Roussi et al., 2005).  
Intracellular O2•- production induced by phytosterol oxides has never been measured 
before. In line with previous results on cholesterol oxides (Lemaire-Ewing et al., 2005; 
Miguet-Alfonsi et al., 2002; Monier et al., 2003) all tested oxidation products showed a 
significant increase in O2•- .  
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Data on lipid peroxidation caused by POPs are lacking. Concerning cholesterol oxides 
an increase in MDA levels was found for 7-keto- and 7β-OH-cholesterol, while 7α-OH-
cholesterol showed to be rather ineffective (Miguet-Alfonsi et al., 2002). In contrast to 
the mentioned publication and in order to improve the accuracy of the results in the 
present study MDA was detected by HPLC rather than by the more commonly used 
TBARS assay, which has already been criticized for insufficient specificity and validity 
(Halliwell and Whiteman, 2004). Nevertheless, the increase in MDA levels induced by 
7-ketocholesterol was in line with our results. Data for 7α-OH- and 7β-OH- sitosterol, 
however, differed from those observed for its cholesterol counterparts, as in our case 
7α-OH-sitosterol, in particular at a concentration of 120 µM, proved to strongly increase 
MDA levels. 
However, in line with earlier publications no correlation could be found between the 
increase in lipid peroxidation and the generation of O2•- (Hall, 2006). O2•-, contrary to 
many other ROS, seems to be relatively unreactive with lipids (Halliwell and 
Gutteridge, 1999b). 
Investigations on plant sterol and cholesterol oxides have shown that cytotoxicity was 
not necessarily associated with enhanced oxidative stress (Roussi et al., 2007; Lemaire-
Ewing et al., 2005). Also in our study differences in the cytotoxic effects of the single 
oxides couldn’t entirely be explained by their ability to induce oxidative stress. Yet 7-
keto- and 7α-OH-sitosterol, as those compounds displaying the strongest effect on cell 
viability could enhance both O2•- and levels of lipid peroxidation. Though it is also 
possible that lipid peroxidation was induced through necrosis as a secondary event. 
  
4.5 Detection of DNA damage 
Since ROS have the potential to interact with cellular components including DNA the 
capability of phytosterol oxides to induce DNA strand breaks was also assessed using 
the alkaline single-cell gel electrophoresis assay.  
As presented in figure 4.13 applied oxidation products were rather inactive. For all 
compounds tested measured % DNA in tail were in the range of the negative control. 
Therefore no significant increase of DNA damage could be observed. Further standard 
derivations were found to be very high. Accordingly, in line with reports on the 
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genotoxic action of COPs (Maguire et al., 2003) no increased DNA damage was 
observed. 
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Fig 4.13 Effects of β-sitosterol oxides on DNA in HepG2-cells. Values are mean ± SD 
of 2 separate experiments. Dotted line represents the level of solvent control.  
 
 
4.6 Assessment of phytosterol oxidation products’ uptake in HepG2-
cells 
For a better discussion of the obtained results it was of utmost importance to know 
whether the employed oxidation products were absorped by the cells. A confirmation of 
their accumulation would substantiate the observed cytotoxic actions of the tested 
POPs. 
 
4.6.1 Extraction of phytosterol oxides 
Extraction of oxides from cells and media was done according to Tian et al. (2006). In 
our case, however, diethyl ether was used instead of chloroform/methanol. 
In agreement with Palozza et al. (2007) no time consuming sample pre-treatment other 
than dissolving and filtration was needed as no interfering peaks were present in the 
subsequent HPLC analysis. Hence, unwanted sample losses caused by several 
purification steps could be prevented (Abidi, 2001). 
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4.6.2 Optimization of the HPLC conditions for the separation of oxidized β-
sitosterol compounds 
Complete separation of sterol oxidation products and other cell lipid residues was 
achieved on a silica column by an isocratic elution system of n-heptane/2-propanol. 
Different mobile phase systems with changing percentages of 2-propanol were tested 
based on former investigations by Kemmo et al. (2005; 2007; Säynäjoki et al., 2003). 
Best resolution within 20 min was achieved with a mobile phase of n-heptane/2-
propanol (97/3, v/v) at a flow rate of 0.6 mL/min. Standard solutions of 7-
ketocholesterol, 7β-OH-cholesterol and 7α-OH-cholesterol were used since standards of 
β-sitosterol oxidation products do not exist. Their separation is given in figure 4.14. 
Fig 4.14 NP-HPLC chromatogram of cholesterol standards, 6β-OH-3-ketositosterol and 
6α-OH-3-ketositosterol with (A) UV detection at 206nm and (B) ELS-detection. 
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As neither cholesterol nor plant sterol 6β-OH-3-keto- and 6α-OH-3-ketoproducts are 
available, laboratory prepared sitosterol compounds, used for the cell incubation 
procedure, were employed. In order to ascertain coelutions of oxysterols and other lipids 
of the cell membrane, lipid extracts derived from HepG2-cells were injected together 
with standard solutions as well.   
The elution order in this system was as follows: 6β-OH-3-ketositosterol, 6α-OH-3-
ketositosterol, 7-ketocholesterol, 7β-OH-cholesterol and 7α-OH-cholesterol. 
  
4.6.3 UV-Detection 
Although for single oxysterols their maximum UV absorption was observed at different 
wavelengths (Osada et al., 1999; Kermasha et al., 1994), 206nm is the common 
wavelength employed for sterol oxidation products (Csallany et al., 1989). Therefore 
UV detection performed at 206nm was used for quantification of sterol oxides. 
To enable highly accurate results identification and quantification of the sample peaks 
was done with cholesterol standards of the corresponding oxidation products. As 6β-
OH-3-keto- and 6α-OH-3-ketocholesterol standards were not available amounts had to 
be estimated with the help of 7-ketocholesterol. In general UV absorption depends on 
the number of double bonds in the structure of the analyte. Hence, inaccuracies are 
possible when standards with a different number of double bonds are used (Kemmo et 
al., 2005). As β-sitosterol and cholesterol oxides contain the same number of double 
bonds, misinterpretations were prevented. 
 
4.6.4 ELS-Detection  
For optimal signal to noise ratio, both gas flow rate and drift tube temperature have to 
be adjusted on the respective analyte (Moreau, 2005). Therefore different gas pressures 
(20, 30, 40 and 50 PSI) and temperatures (45 °C/36 °C, 50 °C/42 °C, 55 °C/42 °C, 60 
°C/42 °C, 55 °C/48 °C and 60 °C/48 °C for drift tube/nebulising temperature) were 
tested. Lower gas pressures led to slightly bigger peak areas, but as too low pressures 
could cause contamination of the detector 20 PSI were chosen for the subsequent 
analysis. In accordance with Lakritz and Jones (1997) only minor changes were 
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observed by increasing the temperature. Therefore the initial adjustment, a nebulising 
temperature of 42 °C and a drift tube temperature of 50 °C, were maintained. 
For the analysis of cholesterol and its oxidation products also higher temperatures have 
been applied (Lakritz and Jones, 1997; Osada et al., 1999), but here mobile phases with 
higher proportions of polar solvents were used, which require higher evaporating 
temperatures (Nair et al., 2006). In general the lowest temperature that allows 
acceptable low noise baseline response and the detection of all analytes of interest 
should be chosen (Young and Dolan, 2004).  
 
4.6.5 Linearity of UV and ELSD responses 
For assessment of linearity triplicate injections of the standard solution containing 7-
ketocholesterol, 7β-OH-cholesterol and 7α-OH-cholesterol were processed. As shown 
in table 4.5 good linearity was observed for UV-detection with a determination 
coefficient (r2) between 0.996 and 0.998 at a concentration range of 0.3-9.4 µg (6 
calibration points).  
The response of the ELSD has previously been described as sigmoidal or exponential 
(Lakritz and Jones, 1997). Correspondingly, a non linear respond, especially at lower 
concentrations, was found for the here tested standard mixture. After log transformation 
of peak area versus standard concentration a linear respond of r2 = 0.997 - 0.998 was 
observed for the same concentration range as tested in UV mode (table 4.5). Described 
data transformation is well established in literature (Lakritz and Jones, 1997; Heron et 
al., 2004).  
 
4.6.6 Limits of detection  
LOD were calculated on the basis of a signal to noise ratio of 3 by the use of standard 
dilutions. With UV detection the LODs were in the range of 5-20.8 ng, with 7-
ketocholesterol being the most sensitive (Csallany et al., 1989). In accordance with 
earlier publications (Osada et al., 1999) ELS-detection was less sensitive. The LODs for 
the single oxysterols were found to be about 12 times higher, between 62.5 and 250 ng 
(table 4.5). 
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compounds retention times (min) linearity range (µg) determination coefficient (r2) LOD (ng)
UV 7-ketocholesterol 7.28 0.29 - 10.1 0.998 ± 0.002 5
7β-OH-cholesterol 16.28 0.35 - 11.9 0.998 ± 0.001 15.6
7α-OH-cholesterol 18.61 0.28 - 9.4 0.996 ± 0.001 20.8
ELSD 7-ketocholesterol 7.41 0.29 - 10.1 0.998 ± 0.001 62.5
7β-OH-cholesterol 16.4 0.35 - 11.9 0.998 ± 0.001 250
7α-OH-cholesterol 18.74 0.28 - 9.4 0.997 ± 0.002 250
 
Tab 4.5 Retention times, linearity ranges, determination coefficients and detection limits 
assessed for HPLC - UV and - ELS-detection. 
 
 
4.6.7 Detection and quantification of β-sitosterol oxides in cells and 
corresponding media 
Due to the higher sensitivity of UV detection and the relatively low concentration of 
oxidation products applied for cell assays only UV results were used for quantification. 
To our knowledge so far no information on the uptake of oxyphytosterols in cells is 
published, even though uptake data is necessary to support information on a dose-
response. However, similar to investigations on COPs (Biasi et al., 2004) a 
concentration dependent increase in sterol compounds inside the cells after incubation 
with increasing sample concentrations could be clearly demonstrated (figure 4.15). 
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Fig 4.15 HPLC-UV profiles of β-sitosterol oxidation products extracted from HepG2-
cells after incubation with 0, 30, 60 and 120 µM of 7-ketositosterol (A), 7β-OH-
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sitosterol (B), 7α-OH-sitosterol (C), 6α-OH-3-keto/6β-OH-3-keto-sitosterol (D) and the 
mixture of polar oxides (E). Peaks: 1=6β-OH-3-keto-sitosterol, 2=6α-OH-3-keto-
sitosterol, 3=7-ketositosterol, 4=7β-OH-sitosterol, 5=7α-OH-sitosterol. 
 
Further for 7-ketositosterol, 7β-OH-sitosterol and 7α-OH-sitosterol a significant (p ≤ 
0.05) raise in intracellular concentrations of the single oxidation products was found. 
Similar to Miguet et al. (2001) for oxycholesterols different absorption affinities of the 
single oxyphytosterols were observed. Considering the distribution pattern of the POPs 
between cell and media compartments corresponding trends could be found irrespective 
of the added concentration of the oxidation product. Whereas for 7-ketositosterol and 
7α-OH-sitosterol after 24 hours the majority of the detected oxides (~ 70 %) was found 
inside the cells, for 7β-OH-sitosterol no definite tendency was observed. For the 
mixture of 6α-OH-3-keto- and 6β-OH-3-keto-sitosterol only 30 % of the α-compound 
was detected inside the cells, whereas for the β-counterpart similarly 50 % were 
assessed in the cells and the media, respectively. Considering the combined uptake as a 
mixture of these two compounds, larger parts (55-60 %) of the oxidation products were 
located in the media (for details see figure 4.16).  
Interestingly, for those compounds exhibiting a higher reactivity in the various cell 
assays also higher amounts of oxidation products inside the cells than in the 
corresponding media were detected (7-keto- and 7α-OH-sitosterol), whereas for the 
rather inactive 7β-OH-sitosterol no specific uptake trend was observed.  
Due to the very small amount of the single oxides present in the mixture a precise 
quantification was not possible. 
 
Further the obtained uptake data correlates negatively with the outcomes of the MTT- (r 
= -0.667, p ≤ 0.05 for 7-ketositosterol; r = - 0.874, p ≤ 0.01 for 7β-OH-sitosterol; r = - 
0.781, p ≤ 0.01 for 7α-OH-sitosterol; r =-0.655, p ≤ 0.05 for 6α-OH-3-keto-/6β-OH-3-
keto-sitosterol) and the TB-test (r = -0.689, p ≤ 0.05 for 7-ketositosterol; r = - 0.823, p ≤ 
0.01 for 7α-OH-sitosterol), respectively. Accordingly, a link between differences in 
absorption levels of the single oxides and their diverse toxic effects may be possible. 
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Fig 4.16 Detected amounts (µg) of β-sitosterol oxides (7-ketositosterol, 7β-OH-
sitosterol, 7α-OH-sitosterol, 6α-OH-3-keto-sitosterol and 6β-OH-3-keto-sitosterol) in 
HepG2-cells and corresponding media after 24 hours of incubation.  
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5. Conclusion 
 
Since the variety of products fortified with phytosterols has increased rapidly during the 
last decade, investigations for a better understanding of the biological significance of 
their oxidation products are needed.  
However, POPs are not commercially available. Therefore the first objective of our 
project was to develop a method for the isolation of common phytosterol oxides. The 
method based on heat treatment (130°C, 24h) in a ventilated oven, purification steps and 
a preparative HPLC-UV system showed to be simple and effective for the isolation of 
four different oxide fractions (7-ketositosterol, 7β-OH-sitosterol, 7α-OH-sitosterol and a 
mixture of 6β-OH-3-keto-sitosterol/6α-OH-3-keto-sitosterol (ratio 4:3)). In addition a 
mixture of all polar oxidation products was generated. Sufficient amounts of the single 
oxides could be obtained for the subsequent test approaches, as yields in the range of 
several milligrams per fraction were obtained by one single HPLC run.  
The following safety assessment was based on various bacterial and cell culture assays 
which are in accordance with the OECD guidelines. The Salmonella microsome assay 
was performed as preincubation method with and without metabolic activation using 
three different indicator strains (TA98, TA100 and TA102). The concentrations of the 
samples tested ranged from 0.04 to 5 mg/plate. To further investigate their anti-/pro-
oxidative effects, challenge tests with the pro-oxidant tBOOH were conducted. 
Especially in test setups using strain TA102 number of his+ - revertants significantly 
different to that of the solvent control were observed for individual oxides. However, in 
general none of the tested compounds could increase the revertant colony numbers 
beyond the doubled negative control, which was set as threshold for mutagenic activity. 
In addition no dose dependent increase could be observed. Since these two criteria must 
be fulfilled in order to identify a compound as a possible mutagen our tests showed no 
increased risk by the investigated POPs. 
Further the effects of the collected oxidation products towards HepG2-cells were 
investigated. To enable overall uniformity and comparability for all conducted cell 
culture applications 3 different concentrations (30 µM, 60 µM and 120 µM) of each 
oxidation product and an incubation period of 24 hours was chosen. Corresponding 
results were found when cell viability was evaluated using two different types of test 
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approaches. Whereas in the Typan blue exclusion assay the term vital cells refers to 
cells with intact cell membranes, in the MTT-assay metabolically active cells are 
determined. Incubation with increasing concentrations of oxide samples induced a 
significant (p<0.01) reduction of cell viability, for most oxides also in a concentration 
dependent way. 7-ketositosterol and 7α-OH-sitosterol were those compounds with the 
highest toxic potential, whereas cytotoxicity of 7β-OH-sitosterol was far less 
pronounced.  
The mode of cell death was assessed by flow cytometry using PE-labelled AnnexinV. It 
specifically binds to phosphatidylserine, which is translocated to the outer cell 
membrane during the early phase of apoptosis. 7-ketositosterol (30µM) was the only 
compound inducing an increase in apoptotic cells. However, as the proportion of 
AnnexinV positive cells decreased with increasing concentrations of oxidation products, 
the applied incubation conditions seemed to be too intense for detecting early events of 
apoptosis. At the time point investigated higher percentages of necrotic or late apoptotic 
than early apoptotic cells were detected.  
Intracellular generation of super oxide anions was significantly increased after treatment 
with all sample compounds, as measured by staining with hydroethidium. To include a 
second marker of oxidative stress malondialdehyde concentration, as an endproduct of 
lipid peroxidation, was assessed by HPLC. A concentration dependent increase was 
observed for 7keto-, 7αOH- and 6β-OH-3-keto-/6α-OH-3-keto-sitosterol. Similar to 
other publications (Hall, 2006) no correlation between O2•- and MDA concentrations 
was found. Apparently, differences in cytotoxicity of the single fractions do not 
necessarily depend on their ability to induce oxidative stress. 
When samples were investigated in the alkaline single-cell gel electrophoresis assay no 
increase in DNA strand breaks was observed. 
In order to estimate the outcomes of the toxicity assays it was of utmost importance to 
know whether the tested compounds were absorbed by the cell lines applied. Therefore 
the different oxidation products were extracted from both the cells and the 
corresponding media and analysed using an HPLC-UV-ELSD system. Due to the lower 
sensitivity of ELS-detection, only UV data were used for quantification of oxides. 
Uptake of all applied compounds could be clearly demonstrated. Obtained results 
correlated negatively with the outcomes of the MTT and TB assay. Accordingly, 
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differences in the levels of oxides accumulated in the cells seem to take a responsible 
part for their diverse toxic effects observed.
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6. Summary 
 
The aim of the present study was to assess the effects of common phytosterol oxidation 
products in various bacterial and cell culture assays.  
As POPs so far are not commercially available, the first challenge of this work was to 
scale up a method for the isolation of adequate amounts of different β-sitosterol oxides. 
Several milligrams of 7-ketositosterol, 7β-OH-sitosterol, 7α-OH-sitosterol, a mixture of 
6β-OH-3-keto-sitosterol/6α-OH-3-keto-sitosterol (ratio 4:3) and a mixture of polar 
oxidation products were obtained after heat treatment of β-sitosterol (130 °C, 24 h) 
followed by chromatographic purification steps and preparative HPLC.  
Salmonella typhimurium strains TA98, TA100 and TA102 and the pro-oxidant tertiary-
butyl hydroperoxide (tBOOH) were used to examine the collected oxides in the 
Salmonella microsome assay. However, the samples showed no mutagenic or pro-
oxidative properties. 
Further their cytotoxic effects towards HepG2-cells were evaluated and particularly 7-
keto- and 7α-OH-sitosterol showed to be highly active. All tested oxides caused a 
significant reduction (p<0.05) in cell viability as determined by two different viability 
assays. Although treatment with 7-ketositosterol induced an increase in early apoptotic 
cells, at the time point investigated the prevailing mode of cell death was late apoptosis 
or necrosis. While a significant increase in intracellular superoxide anion concentration 
(O2•-) was detected, malondialdehyde (MDA) concentration was enhanced by 7-keto-, 
7α-OH- and 6β-OH-3-keto- /6α-OH-3-keto-sitosterol only. Therefore differences in the 
reduction of cell viability couldn’t entirely be explained by their ability to induce 
oxidative stress. Further no induction of DNA strand breaks was observed.  
The uptake of oxidation products in HepG2-cells could be clearly demonstrated. 
Different absorption affinities of the single oxyphytosterols were found. Accordingly, a 
link between different uptake levels and diverse cytotoxic effects may be possible. 
Although not being mutagnic towards Salmonella typhimurium strains, isolated oxids 
showed different cytotoxic effects in cell culture asssays using HepG2-cells. Varieties 
could be explained by their diverse uptake affinities into cells. While oxide mixtures are 
often thought to be less toxic than isolated compounds, in the present study 7β-OH-
sitosterol displayed the lowest reduction of cell viability.
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7. Zusammenfassung 
 
Ziel der vorliegenden Studie war es die Wirkung bekannter 
Phytosterinoxidationsprodukte (POPs) in verschiedenen Bakterien- und Zellversuchen 
zu bestimmen.  
Da POPs bislang kommerziell nicht erhältlich sind, war die erste Herausforderung 
dieser Arbeit die Hochskalierung einer Methode zur Isolierung einer ausreichenden 
Menge an verschiedenen β-Sitosterinoxiden. Mehrere Milligramm an 7-Ketositosterin, 
7β-OH-Sitosterin, 7α-OH-Sitosterin, einer Mischung aus 6β-OH-3-Keto-Sitosterin/6α-
OH-3-Keto-Sitosterin (Verhältnis 4:3) und einer Mischung polarer Oxidationsprodukte 
wurden durch Erhitzung von β-Sitosterin (130 °C, 24 h) gefolgt von 
chromatographischen Reinigungsschritten und präparativer HPLC isoliert. 
Die Salmonella typhimurium Stämme TA98, TA100 and TA102 sowie das Pro-Oxidant 
tertiär-Butyl-hydroperoxid (tBOOH) wurden zur Untersuchung der gesammelten POPs 
im Salmonella microsome assay eingesetzt. Allerdings zeigten die Probesubstanzen 
keine mutagenen oder pro-oxidativen Eigenschaften. 
Weiters wurden ihre zytotoxischen Effekte gegenüber HepG2-Zellen evaluiert und hier 
zeigten besonders 7-Ketositosterin und 7α-OH-Sitosterin hohe Aktivitäten. Alle 
getesteten Oxide führten zu einer signifikanten Reduktion (p<0.05) der Zellviabilität, 
was in zwei unterschiedlichen Viabilitätstests bestimmt wurde. Obwohl eine Belastung 
mit 7-Ketositosterin zu einem Anstieg an früh apoptotischen Zellen führte, war zum 
untersuchten Zeitpunkt späte Apoptose oder Nekrose die vorherrschende Art des 
Zelltods. Während eine signifikante Steigerung an intrazellulärer 
Superoxidanionenkonzentration (O2•-) festgestellt werden konnte, wurde die 
Malondialdehydkonzentration (MDA) nur durch 7-Keto-, 7α-OH- und 6β-OH-3-keto-
/6α-OH-3-keto-Sitosterin erhöht. Somit kann die unterschiedlich starke  Reduktion der 
Zellviabilität nicht ganzheitlich durch die Fähigkeit oxidativen Stress zu induzieren 
erklärt werden. Weiters wurde keine Induktion von DNA Strangbrüchen festgestellt. 
Die Aufnahme von Oxidationsprodukten in HepG2-Zellen konnte klar demonstriert 
werden. Unterschiedliche Absorptionsaffinitäten der einzelnen Phytosteroloxide 
konnten nachgewiesen werden. Demzufolge wäre ein Zusammenhang zwischen den 
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verschiedenen Aufnahmelevels und den unterschiedlichen zytotoxischen Effekten 
möglich. 
Obwohl die getesteten Oxidationsprodukte keine Mutagenität gegenüber Salmonella 
typhimurium Stämmen zeigten, konnten in Zellkulturversuchen mit HepG2-Zellen 
unterschiedliche zytotoxische Effekte der einzelnen isolierten Oxide beobachtet werden.  
Diese Unterschiede könnten durch ihre verschiedenen Aufnahmeaffinitäten in die 
Zellen erklärt werden. Während Mischungen an Oxidationsprodukten häufig für 
weniger toxisch als isolierte Einzelsubstanzen gehalten werden, zeigte in der 
vorliegenden Studie 7β-OH-Sitosterin die geringste Beeinträchtigung der Zellviabilität. 
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Abstract 
The recent increase in phytosterol-enriched functional food provokes questions 
concerning the safety of their oxidation products. However, most of the existing toxicity 
studies have been performed with mixtures instead of single compounds, a consequence 
of the lack of pure phytosterol oxidation product (POP)-standards.  
The objectives of this study were to take in use a method for the isolation of β-sitosterol 
oxidation products and to assess their mutagenic and pro-oxidative potential. Oxides 
were prepared by thermo-oxidation, purified by column chromatography and separated 
by a NP-HPLC-UV system. 7-ketositosterol, 7β-OH-sitosterol, 7α-OH-sitosterol, a 
mixture of 6β-OH-3-keto-sitosterol/6α-OH-3-keto-sitosterol (ratio 4:3) and a mixture of 
polar oxides were fractionated. Yields in the range of several milligrams per fraction 
were achieved within one HPLC-run. Identification and quantification was done by GC-
MS and GC-FID, respectively. 
In the Ames test the collected fractions failed to show a mutagenic activity towards 
Salmonella typhimurium strains TA98, TA100 and TA102.  
 
 
Key words: phytosterol oxidation products, HPLC, Salmonella microsome assay 
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Introduction 
Recently phytosterols (plant sterols) have become a focus of interest due to their serum 
cholesterol lowering effect and consequently their protection against cardiovascular 
diseases (Piironen, Lindsay, Miettinen, Toivo & Lampi, 2000). According to the 
literature an uptake of 1.5 to 3 g phytosterols per day is recommended in order to 
achieve a reduction of 10-15 % in serum LDL cholesterol (Katan, Grundy, Jones, Law, 
Miettinen & Paoletti, 2003). As the daily intake from natural sources is estimated to 
range from 150 to 440mg a day, a wide variety of products fortified with phytosterols 
has been introduced to the market in order to reach the advised uptake levels. However, 
besides their positive aspects concerns in terms of health are emerging.  
It is well known that during food preparation and storage cholesterol oxidation products 
(COPs) are formed from cholesterol through autoxidation, photoxidation and enzymatic 
oxidation (Boesinger, Luf & Brandl, 1993). Mutagenic, carcinogenic, angiotoxic, 
cytotoxic and atherogenic properties of the thereby generated COPs are generally 
accepted and have already been extensively documented (for review see Osada, 2002).  
Similar to cholesterol, phytosterols consist of a tetracyclic cyclopenta[α]phenanthrene 
ring, they mainly differ in their side chain (Piironen et al., 2000). Because of their 
structural similarities, phytosterols are expected to undergo analogous chemical 
reactions as cholesterol, including oxidation. But information on phytosterol oxidation 
products (POPs) is still rather limited. 
Existing knowledge on POPs is mainly concentrated on their quantification in food. In 
first studies concerning their absorption in vivo a significant uptake of POPs was proven 
(Grandgirard et al., 2004). 
Regarding their possible harmful effects only a few studies were conducted and most of 
them dealt with a potential cytotoxicity. Investigations with different cultured 
mammalian cells showed comparable damage to that caused by COPs, but higher 
concentrations of POPs were needed (Adcox, Boyd, Oehrl, Allen & Fenner, 2001; 
Maguire, Konoplyannikov, Ford, Maguire & O'Brien, 2003; Ryan, Chopra, McCarthy, 
Maguire & O'Brien, 2005). So far only Lea, Hepburn, Wolfreys and Baldrick (2004) 
investigated the mutagenic potential of POPs in the Ames test and reported no evidence 
of genotoxicity. However, in this investigation only a non specified mixture with 30 % 
of POPs was analysed. Due to the lack of commercial POP-standards in most cases a 
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blend instead of single oxidation products has been used for toxicity studies. But 
evidence exists that compared to mixtures individual POPs behave in a different way 
(Maguire et al., 2003). Therefore the biological and safety aspects of POPs remain 
rather unclear. 
Hence, the aim of the present study was to scale up a method for the isolation of single 
phytosterol oxidation products. ß-sitosterol served as the model compound as it is the 
most abundant plant sterol in nature. Gram scale amounts of toxicologically relevant 
oxidation products with sufficient purity were collected in order to undergo toxicity 
tests.  
The second objective of this study was to investigate the collected oxides regarding 
their possible mutagenic and pro-oxidative properties in the Ames test. Since it is 
assumed that the toxicity of oxidation products varies depending on their chemical 
structure (Osada, 2002) a hierarchy of toxicity of the isolated compounds would be 
essential. In addition a mixture of all oxidation products was prepared and analysed in 
the same way, to further investigate whether or not single isolated products react 
differently from mixtures. 
 
 
 
Materials and methods 
Chemicals 
24β-Ethylcholest-5-en-3β-ol (purity: β-sitosterol ~76 %, sitostanol ~13 %, campesterol~ 
8 %, campestanol~ 1 %) was purchased from Fluka Chemie (Buchs, Switzerland). 5-
Cholesten-3β-ol (cholesterol), Cholest-5-en-3β-ol-7-one (7-ketocholesterol) and 
Cholestan-5α,6α-epoxy-3β-ol (5α,6α-epoxycholesterol) were provided by Sigma 
Chemical Co (St.Louis. MO, USA). Cholest-5-en-3β,7α-diol (7α-hydroxycholesterol), 
Cholest-5-en-3β,7β-diol (7β-hydroxycholesterol) and 5-Cholesten-3β,19-ol (19-
hydroxycholesterol), the latter was used as an internal standard (ISTD) in GC- analysis, 
were obtained from Steraloids (Wilton, NH, USA). All the other cholesterol oxides 
were used as reference solutions in TLC and HPLC analysis, as standards of phytosterol 
oxides are not available. 
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Silica gel  60 (0.2–0.5 mm) for column chromatography and thin layer chromatography 
(TLC) plates (silica gel 60, 20 x 20 cm) were purchased from E. Merck (Darmstadt, 
Germany). Spots were visualized by staining with 10% sulphuric acid (H2SO4) (E. 
Merck) in methanol (Rathburn Chemicals Ltd., Walkerburn, Scotland). 
Bis(trimethylsilyl) trifluoroacetamide (BSTFA) and trimethylchlorosilane (TMCS) were 
obtained from E. Merck and Fluka Chemie respectively, and were used as a 99:1 (v/v) 
mixture for silylation of the oxidation products. Analytical grade pyridine (>99 %) from 
Sigma was also used. Ethyl acetate (E. Merck), diethyl ether (J.T.Baker, Deventer, The 
Netherlands), n-heptane and acetone (Rathburn Chemicals Ltd.), 99,5 % ethanol 
(Primalco, Rajamäki, Finland) and water (purified by Milli-Q Plus, Millipore, 
Molsheim, France) all of analytical grade, were used.  
All chemicals used for the Ames test were obtained from Sigma (Vienna, Austria), 
unless otherwise stated. The Salmonella thyphimurium strains TA98, TA100 and 
TA102 were obtained from Discovery Partners International (San Diego, USA) and 
from Trinova Biochem GmbH (Giessen, Germany). The S9 liver homogenate (from 
Sprague–Dawley rats induced with Aroclor 1254 prepared as a KCL homogenate) was 
obtained from MP Biomedicals (Illkirch, France). Agar no. 1 and Nutrient Broth were 
obtained from Oxoid/Bertoni (Vienna, Austria), Dulbecco's PBS was from PAA 
(Pasching, Austria). All mutagens and other reagents were of analytical reagent grade or 
higher and stored at – 80 °C if necessary.  
 
Production and isolation of phytosterol oxidation products 
Preparation of oxides by thermo-oxidation 
POPs were formed by thermo-oxidation. Commercial available β–sitosterol was heated 
in open glass vials (300 mg, 25 mm, I.D.) in a ventilated oven for 24 hours at 130 °C. 
Optimal heating conditions were evaluated in pre-tests. Different temperatures and time 
periods (130 °C/24 h, 120 °C/48 h and 130 °C/48 h) were tested and resulting oxidation 
mixtures were analysed using GC-FID and GC-MS. After the heating period the 
samples were cooled down in a dessicator, dissolved in 15 mL of n-heptane/diethyl-
ether (90:10, v/v), solubilised using a sonicator and finally stored in a freezer (-20 °C). 
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Purification and enrichment of phytosterol oxidation products by column 
chromatography (CC) 
The purification method used was based on former investigations by Lampi, Juntunen, 
Toivo and Piironen (2002) and Apprich and Ulberth (2004). Briefly, 72 g silica gel 
(loaded with 10 % distilled water) was dry packed into a glass column and pre-wetted 
with 150 mL n-heptane. The whole sample (300 mg heated β–sitosterol/15 mL n-
heptane/diethyl-ether (90:10, v/v)) was applied to the column and first nonoxidized 
sterols and apolar components were eluted with 150 mL n-heptane/diethyl-ether (90:10, 
v/v) followed by 450 mL n-heptane/diethyl-ether (50:50, v/v). Thereafter POPs were 
extracted with 150 mL acetone. The acetone fraction was evaporated to dryness. To get 
rid of the water ethanol was added during the evaporation step. The residue was 
dissolved in 550 µL n-heptane/2-propanol (93:7, v/v).  
 
To confirm the performance of the CC TLC was conducted. 100 µL of the purified 
sample were applied to silica gel G 60 TLC plates (0.5 mm layer thickness). The 
identification of the single oxidation products was done using a standard solution, which 
contained 5α,6α-epoxy-, 7-hydroxy- and 7-ketocholesterol. As eluent n-heptane/ethyl-
acetat (50:50, v/v) was used. Components were visualized by spraying with 10 % 
sulphuric acid in methanol followed by heating for a few minutes at 100 ˚C.  
 
Separation of single oxidation products by a NP-HPLC-UV system 
For the collection of single oxidation products a preparative normal-phase HPLC-
method was used. The method was based on papers published by Kemmo et al. 
(Kemmo, Soupas, Lampi & Piironen, 2005; Säynäjoki, Sundberg, Soupas, Lampi & 
Piironen, 2003) with some modifications. A preparative HPLC-instrument (Waters 
Delta Prep 3000, Milford, USA) equipped with a silica Supelcosil column (250 mm x 
21.1 mm, 12 µm; Supelco, Bellefonte, PA, USA) and a UV detector at 206 nm (Waters 
484 Milford, USA) was applied. Several mobile phase systems (90:10, 92:8, 93:7, 94:6, 
95:5 and 97: 3 n-heptane/2-propanol) and flow rates ( 5, 7, 9.9, 15 and 17 mL/min) were 
examined. Determination of purity levels and identification of the collected fractions 
was done by GC-MS. The best separation was achieved at room temperature under 
isocratic conditions using a mobile phase of n-heptane/2-propanol (93:7, v/v) with a 
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flow rate of 17 mL/min. The injection volume was 1.8 mL. The performance of the 
separation was checked daily using a cholesterol oxides standard solution (7-
ketocholesterol, 7β-hydroxycholesterol and 7α-hydroxycholesterol) by monitoring the 
retention times. For the generation of the mixture no HPLC separation was performed, 
therefore it includes all polar β-sitosterol oxidation products. 
 
Identification and quantification  
For identification and quantification of the collected fractions GC-mass spectrometry 
(GC-MS) and GC-flame ionization detection (GC-FID) were used, respectively. Both 
methods have been developed earlier by co-workers (Lampi et al., 2002; Soupas, 
Juntunen, Säynäjoki, Lampi & Piironen, 2004) and are routinely used for analysing 
POPs. 
Prior to the GC analysis the samples were converted to TMS-ether derivatives. 
Therefore 100 µL aliquots of each fraction and 1mL of internal standard solution (19-
OH-cholesterol, 18.55 µg/mL) were evaporated to dryness under nitrogen, dissolved in 
100 µL of pyridine and subjected to silylation by 100 µL BSTFA/TMCS (100 µL, 99:1, 
v/v) over night at room temperature. The reagent mixture was then evaporated and the 
residue was dissolved in 200 µL n-heptane before GC analysis. 
 
GC–MS analysis 
For identification of the collected oxidation products and verification of the purity of the 
fractions GC–MS was used as described in Soupas et al. (2004). The GC–MS 
equipment consisted of a Hewlett Packard 6890 Series gas chromatograph (Wilmington, 
PA, USA) including a Rtx-5MS w/Integra fused-silica capillary column (60 m x 0.25 
mm i.d., crossbond 5 % diphenyl – 95 % dimethyl polysiloxane, 0.1 µm film with 10 m 
Integra-Guard column; Restek, Bellefonte, PA, USA) and was coupled to an Agilent 
5973 mass spectrometer (Palo Alto, CA, USA). Helium was used as carrier gas at 240 
kPa. Initial oven temperature was 70 °C, after 1 min the temperature was raised to 280 
°C at 40 °C/ min and was then held at 280 °C for 35 min. Interface temperature and ion 
source were 280 °C and 230 °C, respectively. Spectra were scanned within the mass 
range of m/z 100-600 using the electron impact mode (70 eV).  
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GC–FID analysis 
The quantification was done by GC- FID measurements using a Hewlett Packard 6890 
Series II gas chromatograph equipped with an HP-7673 autosampler (Hewlett-Packard, 
Karlsruhe, Germany), an automated on-column injection system, a flame ionization 
detector (FID), ChemStation 3.1 software and a RTX-5w/Integra fused-silica capillary 
column (60 m x 0.32 mm i.d., 5 % diphenyl–95 % dimethyl polysiloxane, 0.1 µm film 
with 10m Integra-Guard column; Restek, Bellefonte, PA, USA).  Helium (99.996 % 
AGA, Espoo, Finland) was used as the carrier gas at a constant flow (110 kPa at 200 
°C). The initial temperature was 70 °C, which increased after 1min to 245 °C by 60 
°C/min. After 1min at 245 °C it raised by 3 °C/min to 275 °C and remained at this 
temperature for 41 min. The detector temperature was 300 °C. The concentrations of the 
POPs were quantified by the added internal standard (19-OH-cholesterol). 
 
Salmonella microsome assay 
Preparation of reaction mixtures 
Three individual oxidation products, 7-ketositosterol, 7β-OH-sitosterol, 7α-OH-
sitosterol, a mixture of 6β-OH-3-keto-sitosterol/6α-OH-3-keto-sitosterol (ratio 4:3) and 
a mixture of the polar oxidation products of β-sitosterol were investigated. Considering 
the results of pre-tests, four concentrations (0.04, 0.2, 1.0 and 5.0 mg per plate (≈ %)) of 
each compound were analysed. The concentrations range used was a broad spectrum 
from very low physiological to nonphysiologically high concentrations, all below the 
solubility range, which is recommended for this test procedure. 
Due to precipitation in the highest concentration of 7α-OH-sitosterol, only 3 doses of 
this compound could be used (0.04 – 1 %). There were similar but minor solubility 
problems with the mixture of 6β-OH-3-keto-sitosterol/6-α-OH-3-keto-sitosterol, 
therefore as highest concentration 2.5 mg/plate was tested. On the other hand the 
mixture of all oxidation products showed very good solubility, so a 10 mg/plate dilution 
could also be included in the experiments (Table1). 
In order to obtain appropriate dilutions, each sample was pre-dissolved in a mixture of 
acetone/tween80 (3:1, v/v). Afterwards two parts of sterile, distilled water was added to 
keep the concentration of acetone as low as possible and to avoid potential toxic effects 
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on the bacterial strains. This procedure was tested to be safe for the strains in pre-
experiments. 
 
Metabolic activation 
In order to simulate in vivo conditions the oxidation products were treated with a rat 
liver enzyme mixture (S9, which mainly consists of phase I enzymes) for metabolic 
activation. The S9 mix was prepared according to the recipes of Maron and Ames 
(1984) consisting of 19.75 mL destilled water, 25 mL of PBS buffer, 0.5 mL of MgCl2 
(0.85 M), 0.5 mL of KCl (1.65 M) and 2 mL of NaDP (90.8 mM), 250 µL of glucose-6-
phosphate (1.08 M), and 2 mL of S9. The reagent was stored on ice throughout the 
whole experiment and discarded after 50 min. 
 
Experimental design 
The Ames Salmonella/ microsome mutagenicity assay (Salmonella test, Ames test) was 
performed according to Maron and Ames (1984). The preincubation assay with an 
incubation period of 25 min (37 °C) was chosen, as reported earlier (Wagner, 
Reichhold, Koschutnig, Cheriot & Billaud, 2007). Briefly, 500 µL of PBS or S9 mix, 
200 µL of reaction mixture and 100 µL of overnight bacterial culture were added to test 
tubes. The tubes were shortly vortexed and then placed in an incubator on a rotary 
shaker and incubated for 25 min at 37 °C. After this period 2 mL of molten top agar 
were added to each tube. The mixture was vortexed and poured on minimum glucose 
plates. As soon as the agar had solidified the plates were inverted and stored in an 
incubator for 48 h at 37 °C. Thereafter his+- revertants were counted manually. 
In the present study three generally recommended tester strains (TA98, TA100 and 
TA102) were applied. TA98 gives information on frame-shift mutations, TA100 on 
base-pair substitutions and TA102 detects cross-linking agents, additionally it is 
specifically used to inform on oxidative stress. To further investigate the anti-/pro-
oxidative effects the pro-oxidant tertiary-butyl hydroperoxide (t-BOOH, 0.7 mM) was 
used for a challenge test. The concentration of the oxidant was chosen in order to obtain 
suitable numbers of revertants on the plates. This test was performed with and without 
metabolic activation. 
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Each experiment included a positive control (2,4,7-Trinitro-9-fluorenone, Sodiumazide 
or 2-Aminofluorene), which confirmed the reversion capacity of the bacterial strains as 
well as a negative control, the sample solvent. All concentrations and the positive 
control were tested in triplicate. For the negative control even six plates were prepared. 
Each test was done at least twice (n = 6 in total). 
 
Statistical analysis and evaluation of the mutagenic experiments 
All data are expressed as mean ± SD (standard derivation). Obtained data (n = 6 for 
each concentration used) were analysed by one-way analysis of variance (ANOVA) and 
the Student’s t-test since they were all normally distributed, using SPSS 15.0 for 
Windows. Statistical differences were considered significant at a value of p < 0.05. 
In addition to the statistical, a nonstatistical evaluation was carried out. According to 
Mortelmans and Zeiger (2000) a compound is considered as “mutagenic” if the total 
number of his+- revertants per plate was at least twice as high as the negative control 
(200 %). Moreover a dose related increase of the number of his+- revertants has to be 
shown. 
 
Results and Discussion 
As already mentioned POPs are not commercially available, so they have to be 
laboratory-prepared. Applied methods are based on chemical synthesis (Bortolomeazzi, 
De Zan, Pizzale & Conte, 1999; Zhang et al., 2005), thermo-oxidation in solid state 
(Lampi et al., 2002) or aqueous dispersion (Dutta & Appelqvist, 1997). Existing 
techniques are mostly very complex and time-consuming with the requirement of 
special equipment. Besides they are usually designed for the production of only small 
amounts of oxidation products. Therefore the initial target of this study was the 
development of a fast, simple and effective method for the isolation of common β-
sitosterol oxides.  
 
Performance of the method 
Preparation of the test compounds by thermo-oxidation 
In the present study thermo-oxidation in solid state was used for formation of oxides. 
Different temperatures and heating periods were tested and generated amounts of 
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oxysterols were estimated by GC-FID (Figure 1). Heat treatment for 24 h at 130 °C 
showed to be the best option, yielding to an oxidation rate of nearly 20 %. The total 
amount of oxidation products decreased throughout longer heat exposure, even at a 
lower temperature (120 °C compared to 130 °C). This observation can be explained by 
conversion reactions to other secondary oxidation products as well as further reactions 
such as polymerisation, leading to non polar compounds, dimers and polymers. The 
latter occurs further particularly at higher heating conditions. The oxidation products 
observed in the heating experiments were analogous to those cited in the literature, 
mainly 7-ketositosterol followed by 7β-OH-sitosterol, 7α-OH-sitosterol, 5,6β-epoxy-
sitosterol, 5,6α-epoxy-sitosterol, 6β-OH-3-keto-sitosterol, 6α-OH-3-keto-sitosterol, 6β-
OH-sitosterol and 6keto-sitosterol. Our findings supported those of Kemmo et al. 
(2005), who assessed that at different heating temperatures the same kind of oxidation 
products were formed, but the amount of the single products varied. Already Caboni, 
Costa, Rodriguez-Estrada and Lercker (1997) noticed that the ratios of the formed 
products were influenced by the oxidation conditions. 
The high amount of 7-keto-sitosterol and the generation of 7β-OH-sitosterol rather than 
7α-OH-sitosterol was in accordance with previous studies (Chien, Wang & Chen, 1998; 
Kemmo et al., 2005). 
 
Purification and enrichment of the test compounds 
When β-sitosterol is heated a mixture of oxidation products, non oxidized material and 
several unknown by-products is formed. Because of the complexity of the gained blend 
usually a combination of different separation techniques is applied to isolate single 
oxidation products. In this work CC was used for the first separation step. In contrast to 
the often employed solid-phase extraction (SPE) cartridges self prepared glass columns 
offer a higher loading capacity. Since our interest was focused on POPs with a higher 
polarity than non oxidized β-sitosterol a stepwise elution order to remove apolar 
components up to free sitosterol was applied. 
Solvent mixtures of n-heptane/diethyl-ether in combination with silica gel and a final 
elution of the desired components with acetone were already successfully applied by 
others (Apprich et al., 2004; Lampi et al., 2002; Piironen, Toivo & Lampi, 2002). TLC 
was used to confirm the separation process. No products with a lower polarity than β-
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sitosterol were detected. In addition a relevant reduction of non oxidized β-sitosterol 
could be noted. In other publications preparative TLC was also used to fractionate 
oxidation products. But this is only appropriate when small amounts of samples for 
analytical purpose are separated. In addition to its low loading capacity it also allows 
long exposure of the sample to air, which facilitates the possibility of artefact formation. 
 
Separation, Isolation and Fractionating of the oxidation products by NP-HPLC-
UV 
The final separation of the oxidation products was achieved by a NP-HPLC-UV system. 
Due to its mild characteristics preparative HPLC is particularly suitable for the isolation 
of oxides. Both normal- and reverse phase chromatography has already been 
successfully used for the analyses of cholesterol (Caboni et al., 1997; Chien et al., 1998; 
Csallany, Kindom, Addis & Lee, 1989; Mazalli, Sawaya, Eberlin & Bragagnolo, 2006) 
and plant sterol (Kemmo, Ollilainen, Lampi & Piironen, 2007; Kemmo et al., 2005) 
oxidation products. In general normal phase chromatography is considered to be the 
more effective option.  
Different mobile phase systems with changing percentages of IPA were tested based on 
former investigations by Kemmo et al. (2007; 2005; Säynäjoki et al., 2003). Best 
separation was achieved with a mobile phase of n-heptane /IPA (93:7, v/v). The same 
solvent system was already used earlier for the separation of COPs (Csallany et al., 
1989). The elution order in this system was as followes: 6β-OH-3-ketositosterol/6α-OH-
3-ketositosterol, 7-ketositosterol, 6β-OH-sitosterol, 7β-OH-sitosterol and 7α-OH-
sitosterol (Figure 2). A rapid separation in one single HPLC-run was achieved within 20 
minutes. The application of a big preparative silica column (25 cm x 21.2 mm, 12 µm) 
allowed an injection volume of 1.8 mL of the obtained oxidation mixture, containing the 
oxidation products derived from about 1000 mg unoxidized β-sitosterol (collected 
oxides of several purification steps by CC were combined). This led to yields in the 
range of several milligrams for the single fractions. Within one HPLC run, for example, 
15-20 mg of 7-ketositosterol could be collected. For detailed information see table 2. 
However, as already ascertained earlier no full resolution of the entire polarity range of 
the oxidation products is possible under isocratic conditions (Guardiola, Bou, Boatella 
& Codony, 2004). 6β-OH-3-ketositosterol and 6α-OH-3-ketositosterol co-eluted, so 
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they were collected in one fraction. When analysing the collected fractions with GC-
FID high proportions of 7-ketositosterol were found in the 6β-OH-sitosterol-sample. 
Therefore 6β-OH-sitosterol was excluded from subsequent toxicology tests. 
Moreover as already observed in earlier investigations (Dutta et al., 1997) it was not 
possible to separate campesterol oxides from their sitosterol counterparts. Since the 
applied commercial β-sitosterol included some amount of campesterol (~8 %) also a 
low amount of campesterol oxides (~10 %) was present in the oxidation mixture. 
Average values of the purity of the collected compounds are listed in table 3 and GC-
FID chromatograms of each isolated oxide fraction are given in figure 3. However, 
bearing in mind the velocity of our method we put up with these minor impurities. 
Among all detection systems available UV detection is still the most frequently applied 
for sterol analyses. Separation of the oxidation products was monitored using a 
wavelength of 206 nm. It is the common wavelength employed for oxysterols (Csallany 
et al., 1989). Since products without double bonds like epoxy- compounds and triols 
have poor UV absorption they were not included in collected oxides.  
 
Bacterial tests 
Although indications for adverse health effects exist, knowledge on biological 
properties of POPs is rather small. Further almost all of the so far conducted toxicology 
studies were done with cell lines, among others because of the small sample amounts 
needed for these assays. As data concerning the mutagenic potential of isolated POPs is 
lacking, the collected oxidation products were tested in Salmonella typhimurium strains 
TA98, TA100 and TA102 in the Ames test. To our knowledge it is the first time that 
single oxides of β-sitosterol are tested on their behaviour towards Salmonella 
typhimurium strains. 
 
Mutagenicity testing 
According to literature the here applied preincubation assay is the most sensitive form 
of the Ames test. It allows a closer contact of the test compounds and the indicator 
strain since the bacteria are able to react in a small volume, which is an advantage for 
detecting short- living mutagens (Mortelmans et al., 2000).  
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Throughout the whole test period the spontaneous mutation frequency of the strains was 
in accordance with the control levels published (Mortelmans et al., 2000) and each POP 
sample was significantly different to the positive control (p < 0.05). 
In strain TA98 no mutagenic activity could be seen; neither with nor without metabolic 
activation. Also in TA100 the number of his+- revertants remained in the range of the 
negative control and therefore were mutagenic not active (data not shown).  
These results were in accordance with those published recently by Lea et al. (2004) who 
tested a mixture of oxidized and unoxidized products of β-sitosterol by using different 
Salmonella strains (TA98, TA100, TA102, TA1535 and TA1537). However, the 
amount of oxidation products in their tested samples was only 30 %.  
It is already well known that oxide mixtures react differently from individual oxidation 
products (Maguire et al., 2003). Also additive, synergistic as well as inhibitory effects 
of single oxidation products in mixtures have been noted (O'Sullivan A, O'Callaghan Y 
& O'Brien N, 2005). Therefore, in contrast to our study, the results of Lea et al. (2004) 
allow no sufficient information about the safety aspects of single oxidation products.  
In the aforementioned publication also toxicity and precipitation problems during their 
work with TA102 were reported. Consequently in these experiments sample amounts 
had to be reduced. Throughout all of our research work no problems in this regard were 
observed. 
Although in the present study none of the oxidation products were able to increase the 
number of revertants beyond the doubled negative control, yet for some oxides a certain 
response was observed in strain TA102 (Table 4). In the preincubation test without 
metabolic activation the highest concentrated fraction of 7-keto-sitosterol (5 %) 
increased the number of his+ - revertants significantly, but not beyond twice of the 
negative control, which was set as threshold for mutagenic activity. Moreover a 
concentration- dependent tendency was seen for the lower concentrations but not for the 
5 %- fraction, mainly due to its higher standard deviation. With the addition of S9 the 
increase of 7-keto-sitosterol (5 %) was even more pronounced (p < 0.05). On the other 
hand the highest concentrated fraction of 7β-OH-sitosterol (5 %) reduced the number of 
his+-revertants significantly compared to its lower concentrated fractions (p < 0.05). 
The strain TA102 was chosen as besides its capability of detecting cross-linking agents 
it additionally informs on oxidative stress (Grey & Adlercreutz, 2003; Mortelmans et 
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al., 2000). Based on that, the increase in revertants induced by 7-keto-sitosterol (5 %) 
could be an indication of a pro-oxidant tendency. On the other hand the decline in 
revertant numbers of 7β-OH-sitosterol (5 %) could be interpreted as a marginal sign of 
antioxidative effects. However, it could also be the result of increased cytotoxicity 
(Mortelmans et al., 2000). 
To date no papers other than the one by Lea et al.(2004) had been published dealing 
with possible mutagenic actions of POPs. Hence, more information is available on 
mutagenic effects of COPs. Due to their structural similarity an analogous mode of 
action is expected. As early as in 1979 mixtures of COPs have been shown to possess 
mutagenic effects towards Salmonella typhimurium strains TA98, TA1535 and TA1537 
(Smith, Smart & Ansari, 1979). Several studies followed and in spite of contradictory 
results it seems that particularly epoxy and triol compounds of cholesterol possess 
mutagenic activity. Epoxy and triol compounds of β-sitosterol had never been tested 
before in regard of their mutagenicity and they were also not included in the present 
study. Oxysterols might in general possess rather cytotoxic properties whereas for 
epoxide epimeres and triols a mutagenic action could also be possible. For the 
mutagenic reactivity of COPs the authors also suggested ROS to be involved in the 
mutagenic action (Cheng, Kang, Shih, Lo & Wang, 2005; Smith et al., 1979), as 
antioxidant enzymes diminished the mutagenic response.  
 
Antioxidant testing 
To strengthen the information on oxidative stress challenge tests with the pro-oxidant t-
BOOH were included in our experiments. t-BOOH is commonly used in in vitro assays, 
as it is known as an initiator of lipid peroxidation, where it leads to the formation of 
alkoxyl and alkyl radicals (Grey et al., 2003). 
A prevention of the thereby caused mutagenicity would indicate possible antioxidant 
properties of the tested compounds. Per definition a reduction of the revertant colony 
number below 50 % of the negative control level is necessary for an anti-mutagenic 
effect (Mortelmans et al., 2000).  This was never seen in any of our conducted tests 
(Table 4). However, the addition of t-BOOH 7β-OH-sitosterol (5 %) caused a 
significant decrease in his+- revertants (p < 0.05); even though not lower than the 
threshold level. With the addition of S9 the number of his+-revertants was still lower 
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compared with the less concentrated fractions, but here this tendency was not significant 
(p = 0.196).  
 
Conclusion 
The applied method was proven to be a powerful tool for the collection of oxidation 
products, as yields in the range of several milligrams per fractions were achieved within 
only one HPLC-run. Thus the collection of oxysterols for a later application in toxicity 
tests was possible. 
The results of the Ames test demonstrated that the analysed common oxidation products 
of β-sitosterol were not mutagenic towards Salmonella typhimurium strains TA98, 
TA100 and TA102. Even though literature on the mutagenic response of COPs is 
conflicting, for some oxidation products a mutagenic action could be proved. In spite of 
their similar structure there could still be a difference in the mutagenic behaviour of 
cholesterol- and plant sterol oxidation products.  
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Figure1: Proportion of collected β-sitosterol secondary oxidation products (mg) after 
different oxidation conditions (130 °C/24 h, 120 °C/48 h and 130 °C/48 h) 
measured by a GC-FID system. Results are average values of at least two 
different heat treatments. 
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Table 1: Overview of the used concentrations of the sterol oxides in the study 
  10 % 5 % 2.5 % 1 % 0.2 % 0.04 % 
7-ketositosterol  x  x x x 
7β-OH-sitosterol  x  x x x 
7α-OH-sitosterol    x x x 
6α-OH-3-keto-/ 
6β-OH-3-keto-
sitosterol 
  x x x x 
mixture x x   x x x 
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Figure 2: Preparative NP-HPLC chromatogram of thermo-oxidized (130 °C/24 h) 
sitosterol with UV detection at 206 nm. 
 
 
 
 
Table 2:  Retention times and yield of single oxidation products (mg) within one HPLC- 
run (average values were obtained in over hundred HPLC-runs). 
      
compound retention time (min) mg/ injection 
6β-OH-3-keto-sitosterol 5.7 
6α-OH-3-keto-sitosterol 
7.62 
4.34 
7-ketositosterol 11.09 16.9 
7β-OH-sitosterol 13.36 11.03 
7α-OH-sitosterol 14.82 6.12 
 
 
Table 3: Purity of the obtained oxidation products as measured by GC-FID.  
        
fraction purity (%) campesterol counterpart (%) others (%)
6β-OH-3-keto-sitosterol/ 
6α-OH-3-keto-sitosterol 
88 12  
7-ketositosterol 82 10 8 
7β-OH-sitosterol 90 10  
7α-OH-sitosterol 70 10 20 
6β-OH-3-ketositosterol/
6α-OH-3-ketositosterol
7-ketositosterol
6β-OH-sitosterol
7β-OH-sitosterol
7α-OH-sitosterol
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Figure 3: GC-FID chromatograms of isolated β-sitosterol oxide fractions ((A) 7α-
hydroxysitosterol; (B) 7β-hydroxysitosterol; (C) 7-ketositosterol; (D) 6α-OH-3-keto-
sitosterol/6β-OH-3-keto-sitosterol) as TMS ether derivatives on a RTX-5w/Integra 
fused-silica capillary column (60m×0.25 mm i.d., 0.1 µm film). Analytical conditions 
are described in Material and Methods part. Peaks are identified as: (I) 19-
hydroxycholesterol (ISTD); (II) 7α-hydroxycampesterol; (III) 7α-hydroxysitosterol; 
(IV) 7β-hydroxysitosterol; (V) 7β-hydroxycampesterol; (VI) + (VII) unidentified 
compounds; (VIII) 7-ketocampesterol; (IX) 7-ketositosterol; (X) 6β-OH-3-keto-
campesterol; (XI) 6β-OH-3-keto-sitosterol; (XII) 6α-OH-3-keto-campesterol; (XIII) 6α-
OH-3-keto-sitosterol. 
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Table 4: Overview of all obtained data in the preincubation assay with the strain TA102.  
            
compound concentration TA102 TA102  TA102+tBOOH TA102+tBOOH  
  
(mg/plate) revertants/  plate -S9 
revertants/ 
plate +S9 
revertants/ 
 plate -S9 
revertants/ 
 plate +S9 
      
negative 
control    571 ±44b)   847 ±63b)   747 ±99b) 1589 ±349b) 
      
7-
ketositosterol 5   701 ±82a)b) 1318 ±41a)b)   866 ±24a)b) 2038 ±239b) 
  1   685 ±16a)b)   926 ±28b)   936 ±66a)b) 1714 ±137b) 
  0.2   635 ±36a)b)   879 ±108b)   940 ±75a)b) 1891 ±334b) 
  0.04   575 ±45b)   846 ±81b)   963 ±52a)b) 1974 ±123b) 
      
7β-OH-
sitosterol 5   607 ±55b)   675 ±68a)b)   525 ±45a)b) 1374 ±60b) 
 1   589 ±79b)   853 ±32b)   776 ±58b) 1770 ±146b) 
 0.2   582 ±76b)   840 ±91b)   840 ±65b) 1679 ±146b) 
 0.04   606 ±74b)   793 ±37b)   804 ±71b) 1591 ±103b) 
      
7α-OH-
sitosterol 1   597 ±101b)   744 ±97b)   684 ±56b) 1222 ±156b) 
  0.2   510 ±27a)b)   802 ±16b)   812 ±36b) 1252 ±164b) 
  0.04   452±103a)b)   652 ±34a)b)   686 ±111b) 1317 ±93b) 
      
6α-OH-3-keto/ 
6β-OH-3-keto-
sitosterol 2.5   684 ±88a)b)   1051±28a)b)   809 ±51b) 2119 ±90a)b) 
 1   644 ±51a)b)   979 ±12a)b) 1031 ±42a)b) 2082 ±32a)b) 
 0.2   609 ±40b)   990 ±29a)b)   801 ±121b) 2338 ±29a)b) 
 0.04   644 ±62a)b)   953 ±2a)b)   814 ±32b) 2065 ±70b) 
      
mixture 10   713 ±60a)b) 
 
1079±107a)b)   891 ±14a)b) 1501 ±35b) 
  5   648 ±94a)b)   1008±54a)b)   797 ±12b) 1879 ±158b) 
  1   598 ±55b)   967 ±82a)b)   842 ±102b) 1997 ±5a)b) 
  0.2   556 ±67b)   829 ±41b)   902 ±76a)b) 2003 ±19b) 
  0.04   625 ±27a)b)   731 ±143 b)   851 ±113b) 2057 ±175b) 
      
positive 
control  2353 ±422 3480 ±165 2412 ±71 3780 ±271 
            
a) p < 0.05 to negative control, b) p < 0.05 to positive control; numbers of his+- revertants 
are mean ± SD 
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Abstract 
While health implications caused by cholesterol oxidation products (COPs) seem to be 
generally accepted, research on phytosterol oxidation products (POPs) is still limited. 
Since POPs are commercially not available knowledge on their toxic activities is mainly 
derived from blends instead of pure compounds. 
Therefore the aim of the present study was to examine the cytotoxicity of three 
individual oxidation products of β-sitosterol, 7-ketositosterol, 7β-OH-sitosterol, 7α-OH-
sitosterol, a mixture of 6β-OH-3-keto-sitosterol/6α-OH-3-keto-sitosterol (ratio 4:3) and 
a mixture of polar oxides towards HepG2-cells. All tested compounds were found to 
reduce cell viability in a significant and concentration dependent way, particularly 7-
keto- and 7α-OH-sitosterol showed to be highly active. Only for 7-ketositosterol an 
increase in early apoptotic cells was observed. Enhancement of O2•- production was 
assessed for all oxides, whereas malondialdehyd (MDA) levels were increased by 7-
keto- and 7α-OH-sitosterol only. However, cell death didn’t appear to be necessarily 
dependent on the generation of oxidative stress. Further no DNA strand breaks were 
observed with the COMET assay. By assessing the accumulation of single oxidation 
products in the cells a link between higher proportions of oxides inside the cells and 
their cytotoxic potential could be found. 
 
Key words 
phytosterol oxidation products; HepG2; cytotoxicity; apoptosis; superoxide anions; 
MDA; COMET; cellular uptake 
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Introduction 
Due to their cholesterol lowering effects plant sterols have become important 
representatives of the broad range of functional foods in many countries. A daily intake 
of 1.5 to 3 g phytosterols is recommended in order to reduce serum LDL cholesterol 
levels at 10-15 % (Katan, et al., 2003). Added amounts of phytosterols to the increasing 
number of enriched products are far higher than in naturally sources. Since phytosterols 
are susceptible to oxidation, possible negative side-effects of elevated plant sterol 
consumption have recently started to attract attention (Oehrl and Boyd, 2004). 
Similar to cholesterol, their counterpart in animal cells, phytosterols are prone to 
oxidation during heat treatments and long time storing, thereby forming oxidation 
products analogous to those derived from cholesterol (Dutta and Savage, 2002). 
While health implications, including mutagenic, carcinogenic, angiotoxic, cytotoxic and 
atherogenic properties of COPs can be considered as generally acknowledged 
(extensively reviewed by Guardiola, et al., 1996, Osada, 2002), information on POPs is 
rather scarce. However, in the first reports cholesterol and phytosterol oxides were 
found to cause similar toxic effects, although in general higher concentrations of POPs 
were needed (Roussi, et al., 2005, Ryan, et al., 2005).  
The lack of commercially available POP-standards is one major reason for the limited 
research on plant sterol oxides but it also accounts for the use of blends rather than 
individual oxides in most investigations on their biological effects. Yet it was shown 
that mixtures of sterol oxidation products act in a different way compared to single 
purified compounds (Maguire, et al., 2003). Thus biological and safety aspects of POPs 
remain relatively unclear. 
Therefore, the objective of the present study was to investigate the effects of the main 
oxidation products of β-sitosterol, which represents the most important phytosterol 
structure, on HepG2 cells, a cell line which is commonly used for toxicity evaluations. 
In order to assess their toxicological potential, viability of cells as well as the generation 
of apoptotic cell death, production of superoxide anions (O2•-), lipid peroxidation 
(MDA) and DNA damage (COMET assay) were determined and compared with the 
effects of a mixture containing polar β-sitosterol oxides. For the first time the uptake of 
the single oxides in cells was observed in order to establish whether different absorption 
affinities are responsible for diverse toxic effects. 
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Material & Methods 
Chemicals and reagents 
All chemicals were obtained from Sigma (Vienna, Austria), unless otherwise stated. 
Minimal Essential Medium Eagle (MEM), Dulbecco's PBS, MEM non-essential Amino 
Acids, fetal bovine serum (FBS), trypsin (0.05 %)-EDTA (0.02 %) and sodium 
bicarbonate (NaHCO3) were purchased from PAA (Pasching, Austria). Low melting 
agarose (LMA) and normal melting agarose (NMA) were taken from Invitrogen Life 
Technologies (Paisley, Scotland). Annexin V-FITC detection kit was from BD 
Biosciences (Becton Dickinson, Schwechat, Austria). Cholest-5-en-3β,7α-diol (7α-
hydroxycholesterol), Cholest-5-en-3β,7β-diol (7β-hydroxycholesterol) and 5-Cholesten-
3β,19-ol (19-hydroxycholesterol) were obtained from Steraloids (Wilton, NH, USA). 
Cholest-5-en-3β-ol-7-one (7-ketocholesterol) was provided by Sigma Chemical Co 
(St.Louis. MO, USA). All organic solvents used were HPLC grade and purchased from 
Rathburn Chemicals Ltd. (Walkerburn, UK). Tissue culture plastics were obtained from 
Dr. F.Bertoni GmbH (Vienna, Austria). 
 
Cell maintenance 
Human hepatoma cells (HepG2) cells were cultured as monolayers in MEM 
supplemented with 10 % (v/v) FBS, 2 mM L-glutamine, 1 mM sodium pyruvate and 1 
% (v/v) non-essential amino acids in a humidified atmosphere at 37 °C in 5 % CO2 in 
the absence of antibiotics. Cultures were allowed to reach 80 % confluence before 
experiments were performed. 
 
Production of β-sitosterol oxides 
Phytosterol oxidation products are not commercially available, so they had to be 
laboratory-prepared. Oxides were generated by thermo-oxidation of β-sitosterol (130 
°C, 24 h), purified by column chromatography and separated by a NP-HPLC-UV 
system, consisting of a preparative HPLC - instrument (Waters Delta Prep 3000, 
Milford, USA) equipped with a silica Supelcosil column (250 mm x 21.1 mm, 12 µm; 
Supelco, Bellefonte, PA, USA) and a UV detector at 206 nm (Waters 484 Milford, 
USA). Separation was achieved under isocratic conditions using a mobile phase of n-
heptane/2-propanol (93/7, v/v) and a flow rate of 17 mL/min. Three individual 
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oxidation products, 7-ketositosterol, 7β-OH-sitosterol 7α-OH-sitosterol, a mixture of 
6β-OH-3-keto-sitosterol/6α-OH-3-keto-sitosterol (ratio 4:3) and a mixture of polar 
oxides were fractionated. For identification and quantification of the collected fractions 
GC-mass spectrometry (GC-MS) and GC-flame ionization detection (GC-FID) were 
used, respectively (Lampi, et al., 2002, Soupas, et al., 2004). Purity of the respective 
compounds is given in table 1. 
 
Cell treatment 
For treatment cells were cultured in different multiwell dishes depending on the 
respective experiment at a density of either 2x104 cells/well in 250 µL (96-well), 2x105 
cells/ well in 2 mL (24-well) or 1x 106 cells/ well in 3 mL (6-well) of complete medium. 
After 24 hours medium was removed and cells were incubated with the different β-
sitosterol oxide samples. Within all experiments 3 different concentrations (30 µM, 60 
µM, 120 µM) and an incubation period of 24 hours were considered. For delivery to the 
cells all compounds were dissolved in ethanol and added to reduced serum media (2.5 
% (v/v) FBS). The final concentration of ethanol in cultures did not exceed 0.4 % (v/v) 
and did not affect cell proliferation. Equivalent quantities of ethanol were added to 
control cells. After incubation, both floating and attached cells were collected for 
analysis. 
 
Cytotoxicity 
MTT (3,(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-tetrazolium-bromid) assay 
Cell viability was determined by using the MTT assay (Mosmann, 1983), which is 
based on a reaction catalysed by dehydrogenases of the mitochondria. With this assay 
the number of metabolic active cells can be established. Briefly, after incubation with 
sterol oxides the culture medium was discarded, cells were washed with PBS, 200 μL of 
MTT in culture medium (final concentration 0.5 mg/mL) was added and incubated for 1 
hour. The medium was carefully removed, cells were washed with PBS and the 
formazan crystals were dissolved in DMSO. Absorbance was read at 540 nm with a 
Fluostar Optima microplate reader (BMG labtechnologies, Germany) and expressed as 
the number of viable cells as percentage (%) of control cells. Measurements were made 
in triplicates. 
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Measurement of trypan blue exclusion  
At the end of the incubation period cells were harvested using trypsin/EDTA solution 
and aliquots of cell suspensions were mixed with equal amounts of trypan blue (0.1 % 
(v/v)).  
For the determination of cell numbers dead (blue) and living cells were counted within a 
haemocytometer and results were presented as number of viable cells expressed as 
percentage (%) of negative control. In addition the percentage of dead cells in the total 
cell population of control and treated cells was calculated. Experiments were performed 
in triplicates. 
 
Flow cytometric measurments 
Detection of apoptosis 
For detection of apoptosis an Annexin V-PE detection kit (BD Pharmingen) was used 
and analysis was done following the manufacturer’s instructions. After incubation cells 
were washed and harvested using trypsin/EDTA solution. Cells were centrifuged (800 
RPM, 5 min), washed twice with cold PBS and resuspended in binding buffer (0.1 M 
HEPES/NaOH (pH 7.4) 1.4 M NaCl, 25 mM CaCl2) at a concentration of 1x 106 
cells/mL. 100 µL of this suspension was transferred to 5 mL culture tubes and stained 
with 5 µL of Annexin V-PE and 7-ADD, respectively. After 15 min of incubation at RT 
in the dark 400 µL of binding buffer was added to each tube and cells were analysed by 
flow cytometry within one hour. For each sample 10.000 cells were acquired and data 
management was done with CellQuest Pro Software (FACScan, BD Biosciences, USA). 
Experiments were performed at least in triplicates. Annexin V positive/7-AAD negative 
cells were defined as early apoptotic, while Annexin V positive/7-AAD positive cells 
were classified as late apoptotic or necrotic.  
 
Intracellular Superoxide anion (O2•-) generation 
The production of superoxide anions was determined by the use of hydroethidine (HE) 
(Rothe and Valet, 1990). HE is a nonfluorescent compound, which diffuses easily 
through the cell membrane. Under the action of O2•- HE is dehydrogenated to ethidium 
bromide and intercalates DNA. The red fluorescence of ethidium can be measured by 
flow cytometry (absorption/emission: 518/605 nm). 
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Briefly, after incubation with oxide samples cells were harvested as described above, 
centrifuged (800 RPM, 5 min) and resuspended in PBS at a density of 1x106 cells/mL. 5 
µL of HE-solution in DMSO (20 µM) were added, cells were incubated at 37 °C for 10 
min and then stored on ice until measurement by FACSCalibur flow cytometer (BD 
Biosciences). For each sample 10.000 cells were analysed and data management was 
done with CellQuest Pro Software (FACScan, BD Biosciences, USA). 
 
Measurement of Lipid Peroxidation (MDA) 
Malondialdehyde (MDA) constitutes an end product of lipid peroxidation and was 
determined as described earlier (Wagner, et al., 2004), with some modifications. 
Briefly, at the end of the incubation period, cells were collected, washed with PBS and 
counted. Cells were centrifuged and resuspended in a mixture of 150 µL of potassium 
chloride solution (KCl, 75 mM), 700 µL phosphoric acid (44 mM), 250 µL TBA(60 
mg/L) and 400 µL acqua bidest. Suspensions were heated in boiling water for 60 min 
and after cooling, to 100 µL of the cell samples 100 µL of methanol/NaOH (90/10, v/v) 
was added. An aliquot of 20 µL was injected into the HPLC and MDA was measured by 
fluorescence detector (553 nm). Data was expressed as nanomoles per 109 cells.  
 
Alkaline single cell gel electrophoresis (SCGE) 
The SCGE assay (comet assay) was carried out according to the guidelines developed 
by Tice et al. (2000, 1990) and Singh et al. (1988). After the incubation period cells 
were harvested using trypsin/EDTA solution and counted by the trypan blue method. 
Aliquotes of 1x105 cells were mixed with 80 µL 0.5 % LMA and transferred to NMA-
coated slides. Slides were covered and cooled (4 °C). As soon as the agarose gel has 
solidified cover slides were removed and slides were transferred to a lysis buffer 
solution (2.5 M NaCl, 100 mM Na2EDTA, 10 mM Tris, 1 % Triton X, 10% DMSO, pH 
10.0) for ≥ 1 hour at 4 °C. After lysis the slides were incubated in alkaline 
electrophoresis buffer (300 mM NaOH, 1 mM Na2EDTA, pH ≥ 13) at 4 °C for 40 min 
for DNA unwinding. Electrophoresis was performed at 25 V and 300 mA for 20 min 
using a horizontal gel electrophoresis (VWR, Vienna, Austria). The slides were 
neutralized by rinsing them two times for 8 min with cold neutralization buffer (0.4 M 
trizma base, pH 7.5) and once with cold aqua bidest. Then they were dried at room 
temperature. For evaluation the slides were stained with 40 µL ethidium bromide 
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solution (20 µg/mL) and examined using a fluorescence microscope (Axioskop 20, 
Zeiss, Austria) coupled with a computerized image analysis system (Komet 5.5, 
Kineting Imaging, Liverpool, UK). For each sample, three replicate gels were analysed 
and from each replicate slide 50 randomly selected cells were analysed. As parameter of 
DNA damage percentage of DNA in the tail (% DNA in tail) was determined.  Each 
experiment was done twice. 
 
Measurement of the uptake of oxidation products in HepG2-cells 
Extraction of the oxidation products 
At the end of the incubation period media was removed and collected separately. Cells 
were harvested using trypsin/EDTA solution, centrifuged (800 RPM, 5 min), washed 
twice with PBS and resuspended in 5 mL of KCl (75 mM). After 20 min of incubation 
the lipid fraction was extracted 3 times from cells and media with 5 mL of diethyl ether. 
The ether phase was evaporated, extracts were dissolved in 1ml of n-heptane/ 
isopropanol (95/5, v/v), filtered through 0.45 µm GHP membrane filters (PALL, 
Gelman laboratory, USA) and stored in a freezer (-20 °C) until measurement. 
 
Quantification of the extracted oxidation products by a HPLC-UV-ELSD system 
For quantification of the extracted compounds an HPLC-UV-ELSD system was applied. 
The method used was based on papers by Kemmo et al. [(2005), (2004) and (Säynäjoki, 
et al., 2003)] with some modifications.  
The HPLC instrument consisted of an Waters 717 plus Autosampler (Milford, USA), a 
silica Supelcosil column (250 mm x 2.1 mm i.d., 5 µm; Supelco, Bellefonte, PA, USA), 
a Waters pump (model 515) and a Photodiode Array Detector (model Waters 996) as 
well as an ELS-detector (model Waters 2420, Milford, USA). The separation was 
achieved at room temperature with a mobile phase of n - heptane/ isopropanol (97/3, 
v/v) at a flow rate of 0.6 mL/min. The injection volume was 20 µL and each sample was 
injected twice. 
Detection was performed simultaneously by PDA detection at 206 nm and ELSD 
(nebulization temperature 42 ˚C, drift tube temperature 50 ˚C, pressurised air 20 psi), 
whereas quantification was done based on UV data only.  
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The concentrations of the oxidation products were estimated by cholesterol standards of 
the corresponding oxidation products (7-ketocholesterol, 7α-OH-cholesterol and 7β-
OH-cholesterol), whereas 7-ketocholesterol was also used for the quantification of 6α-
OH-3-keto-sitosterol and 6β-OH-3-keto-sitosterol. Concentration and purity of the 
standards was confirmed by gas chromatography–flame ionization detection (GC–FID) 
as described by Lampi et al. (2002). Standard curves were analysed at the beginning and 
at the end of each compound, concentration of the oxides was calculated using the mean 
standard curve. Detection Limits (LOD) were calculated on the basis of a signal to noise 
ratio of 3 by the use of standard dilutions and for UV detection they were 5, 15.6 and 
20.8 ng/injection for 7-ketocholesterol, 7β-OH-cholesterol and 7α-OH-cholesterol, 
respectively. 
 
Statistical analysis 
All data are expressed as mean ± SD (standard derivation). Obtained data were analysed 
by the Student’s t-test since they were all normally distributed, using SPSS 15.0 for 
Windows. Statistical differences were considered significant at a value of p < 0.05 and 
are reported as p < 0.05, p < 0.01 and p < 0.001. 
 
 
Results 
Cytotoxicity of β-sitosterol oxidation products on HepG2 cells 
Cytotoxicity of the tested compounds was determined using the MTT assay after 24 
hours of incubation. Viability of the control samples was set at 100 %. All sterol oxides 
induced a significant (p ≤ 0.001, for 7β -OH-sitosterol p ≤ 0.01) reduction of cell 
viability relative to the negative control (Fig 1A). In addition a significant concentration 
dependency (p ≤ 0.01) was observed for all samples except for 7β -OH-sitosterol and 7-
keto-sitosterol between the concentrations 60 and 120 µM. The most toxic agent was 
7α-OH-sitosterol reducing viability to 23 % of the control value at 120 µM. At the 
highest concentration tested the order of cytotoxicity was 7α-OH-sitosterol > 6α-OH-3-
keto/6β-OH-3-keto-sitosterol > 7-keto-sitosterol > mixture > 7β -OH-sitosterol. 
Similar results were obtained when counting viable cells in the Trypan blue exclusion 
assay (Fig 1B). A significant reduction in cell numbers compared to the negative control 
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(p≤ 0.01, except 7β-OH-sitosterol) was observed after treatment with the tested 
oxidation products. Concentration dependencies were found for 7α-OH-sitosterol (p ≤ 
0.001), 7-keto-sitosterol (p ≤ 0.01) and the mixture (p ≤ 0.05). Considering the 
percentage of cell death in control and treated cells a significant (p ≤ 0.001, for 7β -OH-
sitosterol at 30 µM p ≤ 0.05) increase for all compounds, except for the mixture at 30 
µM (p = 0.272), could be seen (Fig 1C). Only for 7-keto-sitosterol changes were based 
on the concentrations (p≤ 0.01). The increase in cell death was particularly pronounced 
for 7-keto-sitosterol and 7α-OH-sitosterol. 
 
Effect of β-sitosterol oxidation products on apoptosis  
To elucidate whether apoptosis was involved in the reduction of cell numbers flow 
cytometry was used. Decreased forward scatter (cell size) and increased side scatter 
(granularity) are typical signs for apoptotic cells (Koopman, et al., 1994, Tuschl and 
Schwab, 2003). Described subpopulations were observed in cells incubated with 7-
ketositosterol, 7α-OH-sitosterol and 6α-OH-3-keto/6β-OH-3-keto-sitosterol at 
concentrations of 60 and 120 µM indicating apoptotic cell death (data not shown). To 
further clarify the mode of cell death double staining with FITC-labeled Annexin V and 
7-AAD was conducted. As shown in figure 2A only 7-ketositosterol (30 µM) was able 
to increase (+ 45 %) the number of Annexin V positive/7AAD negative cells compared 
to the negative control, even though not in a significant way. For all compounds a 
decrease in the proportions of Annexin V positive/7AAD negative cells with increasing 
concentration of test samples was found.  
 
Generation of superoxide anions (O2•-) and lipid peroxidation (MDA) by β-
sitosterol oxidation products 
The production of reactive oxygen species (ROS) and the resulting oxidative stress 
precedes cell death. Therefore the generation of O2•- was quantified by flow cytometry 
after staining with HE. For all tested compounds a significant (p ≤ 0.05) overproduction 
of O2•- could be noted (Fig 2B). No concentration dependency was found for the single 
oxides. 
The effect of oxysterols on cellular lipid peroxidation was investigated by HPLC-
detection of MDA. MDA concentration in control cells was found to be 3.35 nM/109 
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cells. Incubation with 7β -OH-sitosterol and the mixture appeared to have little effect on 
lipid peroxidation, as MDA levels were found to be in the range of the negative control. 
For 7-ketositosterol, 7α-OH-sitosterol and 6α-OH-3-keto-/6β-OH-3-keto-sitosterol to 
some extent a concentration dependent increase of MDA-levels in surviving cells was 
shown. At 120 µM a remarkable raise in MDA concentration to 194 % (7-
ketositosterol), 298 % (7α-OH-sitosterol) and 140 % (6α-OH-3-keto/6β-OH-3-keto-
sitosterol) of control levels was observed. However, none of these effects were 
significant (figure 2C). 
 
Effect of β-sitosterol oxidation products on DNA damage 
In order to detect the potential of β-sitosterol oxides to induce DNA-strand breaks the 
alkaline single-cell gel electrophoresis assay was conducted. Tested compounds showed 
to be quite inactive, measured % DNA in tail were in the range of the negative control 
(data not shown). Therefore no significant increase of DNA damage could be observed.  
 
Concentration dependent uptake of β-sitosterol oxidation products by HepG2-cells 
To assess the uptake of the individual oxidation products in HepG2 cells, lipid extracts 
of cell residues and corresponding media were analysed by a HPLC-UV-ELSD system. 
After incubation with increasing concentrations of sterol compounds amounts inside the 
cells were increased as a matter of concentration, whereas in control cells no plant sterol 
oxides were detected. 
The raise in the intracellular uptake of the single oxidation products was significant for 
7-ketositosterol, 7β-OH-sitosterol and 7α-OH-sitosterol (p ≤ 0.05) (Fig 3). Considering 
the distribution pattern of the POPs between cell and media compartments 
corresponding trends could be found irrespective of the added concentration of the 
oxidation product. Whereas for 7-ketositosterol and 7α-OH-sitosterol after 24 hours the 
majority of the detected oxides (~ 70 %) were found in the cell extracts, for 7β-OH-
sitosterol no definite tendency was observed. Regarding the mixture of 6α-OH-3-keto- 
and 6β-OH-3-keto-sitosterol only 30 % of the α-compound was detected inside the 
cells, whereas for the β-counterpart similarly 50 % were assessed in the cells and the 
media, respectively. Considering the combined uptake as a mixture of these two 
compounds larger parts (55-60 %) of the oxidation products were located in the media. 
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Further the obtained uptake data correlates negatively with the outcomes of the MTT- (r 
= -0.667, p ≤ 0.05 for 7-ketositosterol; r = - 0.874, p ≤ 0.001 for 7β-OH-sitosterol; r = - 
0.781, p ≤ 0.01 for 7α-OH-sitosterol; r =-0.783, p ≤ 0.01 for 6α-OH-3-keto-/6β-OH-3-
keto-sitosterol) and the TB-test (r = -0.868, p ≤ 0.001 for 7-ketositosterol; r = - 0.878, p 
≤ 0.001 for 7α-OH-sitosterol), respectively. 
 
 
Discussion 
Although consumption of plant sterols is steadily increasing little is known about the 
biological effects of their oxidation products. So far only a limited number of studies 
using pure phytosterol oxides had been published. However, to allow a comprehensive 
evaluation of their safety aspects more information on single oxides is essential. 
The present study clearly demonstrates the cytotoxic effect of β-sitosterol oxidation 
products towards HepG2 cells. In line with earlier results (Adcox, et al., 2001, Maguire, 
et al., 2003, Roussi, et al., 2005, Ryan, et al., 2005) viability of cells as measured by the 
trypan blue exclusion – and the MTT assay were significantly decreased by incubation 
with increasing concentrations of sterol oxides (Fig1). However, in contrast to others 
(Ryan, et al., 2005) in the present study cytotoxic effects were already observed at low 
sample concentrations of 30 µM.  
Consistently 7-ketositosterol and 7α-OH-sitosterol emerged as those compounds 
exerting the strongest reduction in cell viability. While the toxic potential of 7-
ketositosterol, as the most abundant oxyphytosterol, was already confirmed in various in 
vitro assays, data on 7α-OH-sitosterol is lacking. Contrary to the present findings its 
cholesterol counterpart was found to exhibit less than or equal toxicity to 7β-OH-
cholesterol (Clare, et al., 1995). However, individual 7α-OH-products of plant sterols 
have never been tested before. 
Interestingly it was 7β-OH-sitosterol that together with the mixture appeared to have 
little effect on the viability of cells. Whereas Ryan et al. (2005) investigating the impact 
of phytosterol oxides on various cell lines, including HepG2-cells, reported 7β-OH-
sitosterol to exhibit the strongest effects on cell viability. 
It is already well known that individual oxidation products and their mixtures react in a 
different way (Maguire, et al., 2003). Moreover, synergistic as well as inhibitory effects 
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of single sterol oxides in mixtures have been noted (O'Sullivan A, et al., 2005). In 
general a reduction of the toxic potential is the predominant effect (Aupeix, et al., 1995, 
Hall, 2006, Leonarduzzi, et al., 2002), which also contributes to our findings. 
To further elucidate the mode of cell death Annexin V binding was assessed. Annexin V 
attaches specifically to phosphatidylserine which is translocated from the inner to the 
outer cell surface during the early phase of apoptosis (Vermes, et al., 1995). Only 7-
ketositosterol (30 µM) was able to increase the proportion of Annexin V positive/7AAD 
negative cells relative to control levels (Fig 2A). For all other compounds early 
apoptotic cells were in the range of the negative control or lower. The reduction of the 
amount of Annexin V positive/7AAD negative cells with increasing concentrations of 
oxidation products indicates chosen incubation conditions being too intense for 
detecting early apoptotic events. This corresponds to findings of Leonarduzzi et 
al.(2002) who observed that 7-ketocholesterol induced apoptosis at low concentrations 
whereas at higher sample amounts necrosis was the predominate mode of cell death. At 
the time point investigated higher percentages of necrotic or late apoptotic than early 
apoptotic cells were detected. It may be that apoptosis occurred at an earlier time point, 
after 24 hours showing mainly late apoptotic cells. However, also necrosis as principal 
mode of cell death is possible. In order to fully exclude a β-sitosterol induced apoptotic 
cell death further experiments at earlier time points would be necessary. 
Apoptosis induced by POPs has already been observed previously (Ryan, et al., 2005) 
(Maguire, et al., 2003) (Roussi, et al., 2005). In contrast to our findings in the major part 
of studies investigating phytosterol and cholesterol oxidation products 7β-OH-
compounds appeared to be the highly potent inducers of apoptotic cell death. These 
diverse findings could be explained by the cell specific effect of oxysterols to induce 
apoptosis (Miguet, et al., 2001). While β-sitosterol oxides caused apoptosis in U937 
cells, no indication was found instead in HepG2 and CaCo2 cells (Ryan, et al., 2005). 
However, reports on the cell death mode of oxidation products seem to be conflicting, 
as in contrast to Ryan et al. (2005) Roussi et al. (2005) observed apoptosis for 7β-OH-
sitosterol in CaCo2 cells using same sample concentrations. In general induction of 
apoptosis was mainly analysed in non adherent cell lines (Wielkoszynski, et al., 2006). 
Oxysterols were found to rapidly increase O2•- production (Lemaire-Ewing, et al., 2005, 
Miguet-Alfonsi, et al., 2002, Monier, et al., 2003), which in general induces cell death. 
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Also phytosterol oxides were reported to induce an upregulation of several antioxidant 
enzyme activities (Ryan, et al., 2005), POP induced intracellular O2•- production 
however, has never been measured before. Consistently with previous results on COPs 
all tested oxidation products showed a significant increase in O2•- (Fig 2B). 
Interestingly, although being not reactive in all other assays conducted, treatment with 
the mixture also resulted in a remarkable raise of HE positive cells. As O2•- constitutes 
only one type of ROS the measurement of MDA as a second maker for oxidative stress 
was included. To improve the accuracy of the results in the present study MDA was 
detected by HPLC and not by the TBARS assay, which has already been criticized for 
insufficient specificity and validity (Halliwell and Whiteman, 2004). No information is 
available on lipid peroxidation caused by POPs and investigations on COPs are also 
rather limited. For 7-keto- and 7α-OH-sitosterol an increase in MDA levels was found 
(Fig 2C). Again results for 7α-OH-sitosterol differed from those observed for its 
cholesterol counterpart as 7α-OH-cholesterol appeared to possess only negligible effects 
on oxidative stress (Miguet-Alfonsi, et al., 2002). However, in line with earlier 
publications no correlation could be found between the levels of lipid peroxidation and 
the generation of O2•- (Hall, 2006). O2•-,contrary to many other ROS, seems to be 
relatively unreactive with lipids (Halliwell and Gutteridge, 1999). 
Previous investigations on plant sterol oxides reported that cytotoxicity was not 
necessarily associated with enhanced oxidative stress, which was true for 7β-OH-
sitosterol and the mixture. On the other hand enhanced levels of lipid peroxidation were 
found after incubation with 7-keto- and 7α-OH-sitosterol which also emerged as the 
most potent inducers of cell death. Though it is also possible that lipid peroxidation was 
induced through necrosis as a secondary event. 
As ROS have the potential to interact with cellular components including DNA their 
capability to induce DNA strand breaks was also assessed. In line with reports on the 
genotoxic action of COPs (Maguire, et al., 2003) no increased DNA damage was 
observed. 
Throughout the whole study differences in the cytotoxic potential of the single 
oxidation products, especially α- and β- hydroxy sterols, were prevailing. Considering 
the uptake of the individual β-sitosterol oxides in respect of their toxicity data may help 
to explain these differences. To date no information on the uptake of plant sterol oxides 
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in cell lines is available. Hence, similar to investigations on COPs (Biasi, et al., 2004) in 
the present study a concentration dependent accumulation of all oxidation products was 
confirmed (Fig 3).  
So far, in contrast to the present study concentration of oxides in the corresponding 
media remained disregarded. Interestingly, different affinities of the single oxidation 
products regarding their distribution between media and cell compartment could be 
found. Higher percentages of oxides incorporated into the cells were observed for those 
compounds (7-keto-, 7α-OH-sitosterol and 6α-OH-3-keto-/6β-OH-3-keto-sitosterol) 
exerting the highest reactivity, whereas for the rather inactive 7β-OH-sitosterol no 
specific uptake trend was found. Further uptake data in cells correlated negatively with 
the results of the viability assays indicating that different uptake tendencies seem to be 
responsible for their cytotoxic actions. Similar Miguet et al. (2001) found a twofold 
higher accumulation of 7α-OH-cholesterol than of 7-keto- and 7β-OH-cholesterol in 
U937 cells, however 7α-OH- cholesterol displayed no cytotoxic effects.  
In conclusion, the present study could demonstrate that individual oxidation products of 
β-sitosterol exhibit cytotoxic effects towards HepG2-cells. While 7-keto- and 7α -OH -
sitosterol proved to be highly active, treatment with 7β -OH -sitosterol and the mixture 
of polar oxides showed little effects. Reduction in cell viability was found to be 
significant and concentration dependent. Under the conditions tested only for 7-
ketositosterol an increase in early apoptotic cells was detected. Although a significant 
increase in O2•- was assessed after treatment with all tested oxides MDA levels were 
insignificantly enhanced only by 7-keto- and 7α -OH -sitosterol. A link between cell 
death and oxidative stress didn’t seem to exist for all tested compounds. The different 
levels of oxide uptake in the cells seem to take a responsible part for the diverse toxic 
effects. 
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Table 1: Purity of the tested β-sitosterol oxidation products as measured by GC-FID. 
Campesterol counterpart represents the oxidation product of the respective fraction but 
derived from campesterol instead of sitosterol. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1: Cell viability measured by the MTT-test (A) as well as number of viable cells 
(B) and percentage of cell death (C) measured by the TB-assay after 24h of incubation 
with β-sitosterol oxides. Values are mean ± SD of 3 separate experiments and are 
marked with * when significantly different to control levels (* p≤ 0.05; ** p≤ 0.01; *** 
p≤ 0.001).  
      
fraction purity (%) campesterol counterpart (%) others (%) 
    
6β-OH-3-keto-
sitosterol/ 
6α-OH-3-keto-
sitosterol 
88 12 
 
    
7keto-sitosterol 82 10 8 
    
7β-OH-sitosterol 90 10  
    
7α-OH-sitosterol 70 10 20 
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Figure 2: Effects of β-sitosterol oxides on phosphatidlyserine externalization (A), 
superoxide anion production (B) and Malondialdehyde (C) formation in HepG2-cells. 
Values are mean ± SD of 3 separate experiments and expressed as percentage of 
negative control. Columns significantly different to control levels are marked with * for 
p≤ 0.05, ** for p≤ 0.01 or *** for p≤ 0.001. 
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Figure 3: Detected amounts (µg) of β-sitosterol oxides (7-ketositosterol, 7β-OH-
sitosterol and 7α-OH-sitosterol) in HepG2-cells and corresponding media after 24 hours 
of incubation.  
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